Tissue microvascular flow and oxygenation in critically ill patients by Jhanji, Shaman
Tissue microvascular flow and oxygenation in critically ill patients
Jhanji, Shaman
 
 
 
 
 
The copyright of this thesis rests with the author and no quotation from it or information
derived from it may be published without the prior written consent of the author
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/jspui/handle/123456789/3121
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
  
 
 
 
Tissue microvascular flow and 
oxygenation in critically ill patients 
 
 
 
Thesis submitted for PhD 
 
University of London 
 
 
 
 
 
Shaman Jhanji 
William Harvey Research Institute 
Barts and the London School of Medicine and Dentistry 
London. 
 2 
 
 
 
 
 
 
 
To  
Elhum, Mischka and Talia 
 3 
Abstract 
 
The use of fluid resuscitation and vasoactive agents to optimise global haemodynamics 
has been demonstrated to improve outcomes in patients undergoing major surgery and in 
early sepsis. Whether changes in global haemodynamics result in similar improvements in 
the microcirculation in critically ill patients remains unclear. The aim of this thesis was to 
investigate the changes in tissue microvascular flow and oxygenation that occur in patients 
undergoing major surgery and in those with sepsis, and specifically how haemodynamic 
therapies may affect these changes.  
 
The first part of this thesis investigates the treatment pathway of the high risk surgical 
patient. Analysis of two large health databases was performed and confirmed the 
existence of a high risk sub-population within the local surgical population. Only about a 
third of these high-risk patients were admitted to a critical care unit at any stage during 
their hospital admission. 
 
An observational trial was performed examining the relationship between global oxygen 
delivery, microvascular flow and tissue oxygenation in 25 surgical patients receiving usual 
care. Data including global haemodynamics, sublingual and cutaneous microvascular flow, 
and tissue oxygenation were collected before, and for eight hours after surgery. 
Abnormalities in sublingual microvascular flow were found to be associated with worse 
outcomes. 
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A randomised controlled study investigating the effects of two goal directed 
haemodynamic therapy (GDHT) algorithms on tissue microvascular flow and oxygenation 
compared to central venous pressure guided fluid therapy in 135 perioperative patients 
was performed. For eight hours after surgery, intravenous fluid therapy was guided by 
measurements of central venous pressure (CVP group) or stroke volume (SV group). In a 
third group stroke volume guided fluid therapy was combined with dopexamine (SV & DPX 
group). In the SV & DPX group, increased global oxygen delivery was associated with 
improved sublingual and cutaneous microvascular flow. Microvascular flow remained 
constant in the SV group but deteriorated in the CVP group. Cutaneous PtO2 improved 
only in the SV & DPX group. There were no differences in complication rates between 
groups. 
 
The importance of derangements in microvascular flow in patients with established sepsis 
is well recognized. However, little data is available to describe microvascular changes in 
early sepsis. Observational data were collected in 16 healthy volunteers and within six 
hours of presentation in 48 patients with sepsis and severe sepsis. Sublingual 
microvascular flow was impaired in patients with sepsis and severe sepsis compared to 
healthy volunteers. Greater alterations in flow were seen with increasing severity of illness. 
 
The dose-related effects of vasopressor therapy on microvascular flow and tissue 
oxygenation in sepsis have not been previously fully investigated. The effects of increasing 
doses of noradrenaline, targeted to achieve successively greater mean arterial pressures, 
on microvascular flow and tissue oxygenation in 16 patients with septic shock were 
investigated. Increasing doses of noradrenaline were associated with improvements in 
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global oxygen delivery, cutaneous PtO2 and cutaneous microvascular red blood cell flux. 
No changes in sublingual microvascular flow were identified. 
 
This thesis confirms the existence of a large sub-population of high risk surgical patients. It 
demonstrates that abnormal microvascular flow in the perioperative period may be 
associated with poor outcomes. The use of flow guided fluid therapy alongside low dose 
dopexamine infusion is shown to improve global haemodynamics, microvascular flow and 
tissue oxygenation in perioperative patients. Microvascular abnormalities are shown to 
occur in the earliest stages of sepsis with increasing severity of disease being associated 
with greater changes. Increasing doses of noradrenaline were found to improve global 
haemodynamics, cutaneous microvascular flow and cutaneous tissue oxygenation in 
septic shock. Further work is required to investigate the effects of haemodynamic 
therapies on microvascular flow and organ dysfunction in critically ill patients and the use 
of the microcirculation as a resuscitation endpoint. 
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Chapter 1 
Review of the relevant literature 
 
 
1.1 The clinical problem 
 
There are approximately 234 million surgical procedures performed worldwide each year.1 
This translates to 4000 procedures per 100,000 population overall which increases to 
11,000 procedures per 100,000 population in high income countries. The care of the 
surgical patient is an important public health issue and in 2007 the World Health 
Organisation (WHO) launched, as part of their patient safety programme, the Safe Surgery 
Saves Lives Challenge.2 
 
In spite of perceived improvements in perioperative care in the UK, there was little change 
in the 30 day mortality in surgical patients between 1990 and 2003.3,4 It is generally 
accepted that patients of advanced age with co-existing medical disorders undergoing 
major surgery are those most at risk of post-operative complications and death.3,4 A recent 
study of surgical practice in the UK identified a total of 4.1 million non-cardiac surgical 
procedures performed over a five year period with an overall mortality rate of 0.44%.5 The 
authors identified within this, a small subgroup of patients that accounted for only 12.5% of 
in-patient surgical procedures but over 80% of deaths. This study confirmed that although 
the overall post-operative mortality rate is low, a large sub-population of patients exists 
who are at high risk of post-operative complications and death. Another important finding 
of this study was that only 15% of these high risk patients were admitted to a critical care 
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area following surgery. The high mortality rates and prolonged hospital stays described for 
high-risk patients in this study are also consistent with published data from Europe and 
North America.6,7 Complications, in particular, infectious complications, are common 
following surgery and have been associated with poor long term outcomes.8 There is a 
clear need to improve identification of patients at high risk of post-operative complications 
and death and to provide clinical interventions which can reduce this risk. 
  
Sepsis is a major cause of death and disability worldwide. It is estimated that 750,000 
people develop sepsis each year in North America alone.9 In the UK, approximately 
35,000 patients are admitted to intensive care each year, of whom 45% do not survive to 
leave hospital.10 The number of severe sepsis cases is projected to increase by 1.5% per 
annum.9 Often, sepsis related deaths result from multi-organ failure which generally 
develops in the early stages of the septic process.11 With the aim of reducing global 
mortality from severe sepsis, a number of international critical care organisations joined 
forces in 2002 to develop the Surviving Sepsis Campaign.12 This campaign aimed to raise 
awareness of severe sepsis as a major healthcare issue, to create guidelines for the 
management of sepsis and to translate these guidelines into practice internationally. 
Despite an apparent improvement in outcomes from severe sepsis, perhaps in part related 
to these guidelines, there remains a need for further research into clinical interventions 
which may further improve outcomes.13 
 
One of the most important areas of clinical practice is determining the optimal use of 
intravenous fluid and vasoactive agents in critically ill and high risk surgical patients.14 For 
over forty years there has been particular interest in the utility of measuring cardiac output 
and related variables as haemodynamic goals to better determine the use of these 
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treatments. Various terms have been coined to describe this approach including 
optimisation and goal directed haemodynamic therapy (GDHT). In effect, these are 
treatment algorithms which guide the clinician to select the dose of intravenous fluid or 
vasoactive drug therapy at any given time point. It has been suggested that GDHT 
improves tissue microvascular flow and thus tissue oxygenation but this hypothesis 
remains untested. In fact there is some data suggesting that there is little relationship 
between changes in global haemodynamics and microvascular flow in patients with severe 
sepsis.15 Thus there is a clear need for further investigations of tissue microvascular flow 
and oxygenation in patients undergoing major surgery and those with severe sepsis, to 
confirm the importance of these abnormalities and how haemodynamic therapy may 
modify them.  
 
 
1.2 Historical perspective 
Current concepts of the delivery of oxygen from the atmosphere to the tissues began in 
the late Renaissance when Andreas Vesalius (1514-1564) began to question the 
teachings of Galen, the Greek philosopher and physician. Galen’s theory regarding the 
circulation had been accepted for almost 1300 years. Galen believed that the circulation 
was composed of two entirely separate systems. In the arterial system, blood was 
produced by the heart which then pumped blood around the body where the blood was 
then consumed by various organs. In the separate venous system, blood was produced in 
the liver and again consumed after flowing to other organs. Miguel Serveto (1511-1553) 
discovered the link between the two circulations (the pulmonary circulation) when looking 
for a passage between the right and left heart. Jacques Dubois (1475-1555), also known 
as Jacobus Sylvius, was the first person to suggest that venous blood flowed from the 
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periphery to the heart. In the early 1600’s, William Harvey (1578-1657) produced a series 
of elegant experiments including animal dissection, some simple mathematical work and 
observations of the flow of venous blood after tying a ligature around a patient’s upper 
arm. These led to the publication of ‘An anatomical study of the motion of the heart and of 
the blood in animals’ in which he proposed the presence of a single intact circulation with 
blood being pumped from the left side of the heart to the tissues and then returning via the 
pulmonary circulation. It was Marcello Malphigi (1628-1694) who found the link between 
the arteries and veins that eluded William Harvey. Unlike Harvey, Malphigi had access to a 
microscope and on inspection of a partially inflated frog’s lung he discovered multiple small 
blood vessels between the arteries and veins. He coined the term capillary from the Latin 
word capillus meaning hair. It was a century later before oxygen was discovered by 
Joseph Priestley (1733-1804) and Antoine- Laurent Lavoisier (1743-1794) conducted his 
seminal animal experiments which linked energy production to the consumption of oxygen. 
The next steps in the understanding of oxygen delivery to the tissues were the discovery 
of haemoglobin by Felix Hoppe-Seyler in the 19th century and then the demonstration of 
its oxygen-carrying capacity by George Gabriel Stokes. In 1919 Krogh published his 
seminal work exploring the relationship of capillary geometry with the diffusion of oxygen 
into the tissues with a geometrical model of the microcirculation.16 The optimal method for 
improving microcirculatory blood flow, how this varies in different disease states and its 
effect on prognosis remains unclear. 
 
The administration of intravenous fluid as a therapy dates back to 1492 when Pope 
Innocent VIII received a blood transfusion from three youths. This was not a successful 
experiment however as, unfortunately, all involved died. In 1831, William O’Shaughnessy 
published a series of fascinating observations concerning blood drawn from sufferers of 
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cholera. He described a reduction in the water content of blood, uraemia and low 
bicarbonate concentrations. He also noted that all the patients had the symptom of 
‘depressed urine’ and a failure of arterialisation [oxygenation] of the blood. He reported his 
findings to the Lancet but did not attempt to give fuid therapy to any of his patients.17 A few 
months later, Thomas Latta infused saline and sodium bicarbonate to some moribund 
victims of cholera in Sunderland with some success.18 Despite this, however, venesection 
remained the most common treatment for cholera. The use of intravenous fluids for the 
treatment of shock was described further in the late 19th Century but it was not until the 2nd 
World War that the role of fluid therapy in the treatment of haemorrhagic shock was widely 
acknowledged. The United States Army led the world in this respect and later published 
work reporting improved outcomes with the use of fluid therapy during surgery in combat 
casualties from the Korean War. The optimal dose of fluid for the treatment of shock, 
however, remains unclear.  
 
Fick’s method for calculating cardiac output was first described in 1870.19 Its use for 
calculating cardiac output in man was not possible, however, until Werner Forsmann 
devised a method of sampling mixed venous blood in 1929.20 Forssman passed a ureteric 
catheter through his own cephalic vein and into his right ventricle, before walking to the X-
ray department to confirm its position, an experiment that led both to his dismissal and the 
award of the Nobel prize. The following year Otto Klein became the first person to draw 
mixed venous blood and calculate cardiac output in man using the Fick principle.21 This 
technique was then perfected by Cournand and colleagues during the 1940’s.22 Use of the 
Fick principle to calculate cardiac output was, however, difficult at the bedside. Cardiac 
output monitoring only became routine practice with the development of indicator dilution 
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techniques,23-28 in particular thermodilution,29,30 and the introduction of the flow directed 
balloon tipped pulmonary artery catheter.31  
 
1.2.1 Early investigations of cardiac output measurement in surgical 
patients 
Some of the first data linking surgical outcome to cardiac output was provided by Clowes 
and colleagues.32 These investigators found that the survivors of thoracic surgery and 
abdominal surgery for peritonitis tended to achieve a higher cardiac output after surgery 
than those who died. There were no differences in blood pressure between the groups. 
William Shoemaker repeated this work in a larger group of patients in a series of 
observational studies and produced a list of haemodynamic variables that correlated with 
survival after major surgery.33-35 These variables were a Cardiac Index (CI) > 4.5 L min-1 
m-2, oxygen delivery index (DO2I) > 600 ml min-1 m-2 and oxygen consumption (VO2I) > 
170 ml min-1 m-2. It is important to note that although these values are often termed ‘supra-
normal goals’, they were in fact the median values achieved by surviving patients and 
were also achieved by a smaller proportion of those patients who subsequently died. One 
of these studies suggested that changes early in the post-operative period were perhaps 
most important.36 This paper demonstrated that differences between survivors and non-
survivors were greatest in the first twelve hours following surgery. Some point to the 
heterogeneity of the surgical population in Shoemaker’s work which included patients 
undergoing surgery for major trauma, as a weakness of the data. However there have 
been similar findings in a homogenous group of patients undergoing elective oesophageal 
surgery.37 In this observational study, 115 consecutive patients undergoing 
oesophagectomy and reconstruction via a laparotomy and right thoracotomy were 
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recruited. Significant reductions in stroke volume, CI and DO2I were identified in non-
survivors six hours after surgery. These changes were no longer apparent 24 hours after 
surgery. Reductions were also apparent in those patients who developed anastomotic 
leak. The median DO2I in survivors was similar to previous work at 600ml min-1 m-2 six 
hours after surgery. Similar to Shoemaker’s work, this study suggested that changes early 
in the post-operative period were important to clinical outcomes. 
  
1.2.2 Goal Directed Haemodynamic Therapy (GDHT) 
Many terms have been coined in attempt to describe algorithms which utilise cardiac 
output related treatment end-points. These include ‘optimisation’, ‘flow-guided therapy’ and 
‘goal-directed haemodynamic therapy’ or ‘GDHT’. These descriptive terms continue to 
evolve with the algorithms they are used to describe. For convenience, the term GDHT will 
be used here to describe this treatment approach. GDHT involves the use of intravenous 
fluids and vasoactive agents to achieve pre-defined cardiac output or related parameters. 
GDHT has been successfully utilised in the care of peri-operative patients, trauma and in 
early sepsis.38-45 Its use, however, in other groups of patients has shown no benefit or 
even harm.46,47 GDHT has been associated with reductions in mortality,39,43 complications 
41,44,48
 and more recently the post-operative incidence of acute kidney injury.49 
 
GDHT was, initially, dependent on the pulmonary artery catheter for cardiac output and 
related data and this resulted in controversy due to concerns regarding the safety of this 
measuring device.50,51 Early work in this area commenced GDHT protocols in critical care 
areas prior to surgery. However, routine pre-operative admission to critical care in the UK 
is often not possible due to limited resources. GDHT has still to become part of routine 
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perioperative care despite potential solutions to these issues. Less invasive cardiac output 
monitors are now available and recent evidence of improved patient outcomes utilising 
GDHT commenced in the immediate post-operative period has less resource 
implications.38 One explanation for the lack of enthusiasm for the use of GDHT is the 
absence of a physiological explanation for its apparent benefit. Originally, it was thought 
that the beneficial effects of GDHT were related to improvements in DO2I, VO2I and 
reversal of an ‘oxygen debt’. It was believed that, in critical illness, a phenomenon termed 
‘supply dependency’ occurred whereby oxygen delivery is insufficient even at high levels. 
However, it now seems likely that this observation was largely explained by mathematical 
coupling of the variables used to calculate both oxygen delivery and oxygen 
consumption.52 The most likely explanation is that GDHT improves tissue perfusion and 
thus oxygen delivery to the tissues. However, the theory that optimising global 
haemodynamic parameters leads to an improvement in tissue oxygenation and 
microvascular flow remains unproven. A detailed evaluation of the effects of GDHT on 
tissue perfusion and oxygenation would significantly improve our understanding of the 
effects of GDHT and might encourage more widespread use of the technique. As such, it 
is a necessary step towards reducing the disability and death which often follows common 
high-risk surgical procedures.  
 
A number of investigators have explored the effect of different doses of peri-operative 
intravenous fluid prescribed according to body mass. There have been a number of clinical 
trials comparing ‘liberal’ and ‘restrictive’ protocols for peri-operative intravenous fluid 
prescription according to body mass, with varying results.53-56 The findings of these trials 
have led to a certain amount of confusion regarding optimal fluid management during the 
peri-operative period. Given that the stress response to surgery will induce fluid and salt 
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retention, it seems logical to prescribe maintenance fluids at a reduced rate in the post-
operative period.57 However, it should be noted firstly that whilst maintenance fluid can 
and should be prescribed according to body mass, this is not a rational method of 
estimating fluid losses and the need for resuscitation of the circulation. Furthermore, in 
many of these trials, the protocol termed ‘restrictive’ most closely reflects routine clinical 
care whilst ‘liberal’ protocols risk excessive fluid administration. Nonetheless, the findings 
of these trials have proved inconsistent. It is clear that those patients who develop oedema 
are more likely to develop post-operative complications.58 However, this may relate as 
much to the patient and the nature of the surgical procedure as to the fluid strategy.58 
Intravenous fluid resuscitation should be prescribed according to relevant physiological 
end-points. The administration of excessive maintenance fluids is no more or less 
preferable than the failure to adequately resuscitate a hypovolaemic patient. 
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1.3 Microcirculation 
 
The microcirculation is the major site of gas exchange, delivery of nutrients and removal of 
cellular waste products. Until recently microvascular function has remained somewhat of a 
mystery due to limitations in monitoring. Thus clinicians have concentrated on 
investigations of the more easily accessible macrocirculation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The microvascular unit consists of the smallest blood vessels (<100 µm diameter) 
including arterioles, capillaries and post-capillary venules. The microcirculation is also 
considered to include the blood flowing within these vessels including red and white blood 
Figure 1.1 Structure of the microcirculation 
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cells and coagulation factors. Numerous cytokines play important roles in microvascular 
function. In health, microvascular flow is controlled by myogenic, metabolic and 
neurohumoral mechanisms.59 Autocrine and paracrine interactions ensure distribution of 
blood flow to meet tissue metabolic demands. Cell-to-cell signalling between endothelial 
cells allows upstream microvessel recruitment based on conditions downstream in the 
capillary bed.60 The endothelium is fundamental to this process sensing flow and 
metabolic substances to regulate smooth muscle tone and thus capillary recruitment.61 
Other functions of the endothelium include control of coagulation, leucocyte adhesion / 
migration and immune function. 
 
The central nervous system exerts significant control over the microcirculation, integrating 
it with baroreceptor reflexes. Through sympathetic innervation of arterioles and venules, 
afterload and venous return to the heart is controlled through neuronal release of 
noradrenaline. Circulating vasoactive hormones also act on endothelium and vascular 
smooth muscle to mediate changes in vessel tone. Arterioles with low tone will be patent, 
allowing perfusion of capillaries, whereas arteriolar constriction will reduce the number of 
perfused downstream capillaries. This is important as perfused capillary density may be a 
key determinant of tissue oxygenation through effects on the average inter-capillary 
distance, blood capillary transit time and the surface area available for nutrient and gas 
exchange.62 Other factors which also influence blood flow include the myogenic response 
to flow and endothelial nitric oxide (NO) production.62,63 Microvascular blood flow is 
strongly influenced by vascular topology, blood viscosity and the interaction of cellular 
constituents of blood and endothelium.63 Recent research suggests that red blood cells 
can regulate perfusion by releasing vasodilators including nitric oxide and ATP when 
exposed to a hypoxic environment.64,65 
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1.3.1 Sepsis and the microcirculation 
Abnormalities of microvascular function are central to the pathophysiology of the systemic 
inflammatory response to severe sepsis. During sepsis, there is disruption of 
autoregulatory mechanisms leading to microvascular dysfunction characterised by a 
decrease in the number of perfused capillaries and heterogeneous flow allowing shunting 
of blood through dilated microvessels.66 This is likely to result from a decreased response 
to vasoconstrictor agents,62,67 dysfunction of endothelial signalling,62 changes in NO 
production and loss of the glycocalyx.68 
Endothelial activation results from inflammatory stimuli leading to reduced vasomotor tone 
due to loss of signal transduction pathways,61,69 a procoagulant and proadhesive cell 
surface and compromised barrier function.62,67 Activated endothelial cells mediate 
leucocyte trafficking through a multistep process of rolling, firm adhesion and 
transmigration.70,71 Red blood cells become less deformable and have an increased 
tendency for aggregation.72,73 They also may lose their ability to release nitric oxide in the 
presence of hypoxia so decreasing local vasodilation.74,75  
Nitric oxide is thought to play a pivotal role in microvascular homeostasis in health by 
regulating microvascular tone, leucocyte adhesion, microthrombi formation and 
microvacular permeability.76-79 The systemic inflammatory response associated with sepsis 
can lead to localised areas of NO deficiency despite a total body excess of NO. This leads 
to the classical pattern of heterogeneity of microvascular flow.66,80,81 Functionally 
vulnerable microvascular units are rendered hypoxic, in part explaining the oxygen 
extraction deficit associated with sepsis.80,82-84 This effect can result in a decrease in 
capillary pO2 below the venous pO2 and is an indicator of microvascular shunting of 
arteriolar blood into the venous system.59,82,83,85 
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The glycocalyx is a gel-like structure that forms the interface between the capillary lumen 
and endothelial cells. Its integrity is highly sensitive to the oxidative stress that may 
accompany sepsis, hypovolaemia or trauma.68 It is likely that the endothelial dysfunction 
and changes in microvascular flow are contributed to by the loss of the glycocalyx.86 
Leucocyte adhesion follows and a loss of barrier function, which can lead to changes in 
Starling forces and oedema formation.87,88 It is possible that intravenous starch solutions 
may beneficially modulate some of these changes in the glycocalyx though this remains 
poorly understood.89 
 
With the advent of new in vivo microscopy techniques,90 it is now possible to visualise the 
microcirculation in human subjects. The techniques of orthogonal spectral imaging (OPS) 
and sidestream darkfield imaging have been validated in experimental models and human 
subjects.90-93 The first clinical study demonstrating sublingual microvascular changes 
associated with sepsis was performed by De Backer and colleagues.66 They found that 
microvascular density and flow was reduced in patients with established severe sepsis 
compared to non-septic intensive care unit patients and healthy volunteers. Other workers 
have also identified the prognostic significance of abnormalities of microvascular flow.94 
Similar findings have been reported in early sepsis.45,95   
 
1.3.2 Surgery and the microcirculation 
The effects of surgery and the associated inflammatory response on microvascular flow 
remain unclear. It is conceivable that one may see similar changes to the classical 
inflammation induced abnormalities associated with sepsis, including reduced capillary 
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density and heterogeneity of flow but this has yet to be characterised fully. The effects of 
haemodynamic therapies on microvascular flow in surgical patients has also yet to be 
investigated and may shed some light on the biological mechanisms behind the apparent 
clinical benefit of GDHT in this patient group. 
  
1.3.2.1 Abdominal surgery 
A number of studies have investigated microvascular flow in abdominal surgery though 
there are few studies to date using direct visualisation of the microcirculation. Vignali and 
colleagues used laser Doppler flowmetry to investigate microvascular changes in 55 
patients following colonic surgery.96 Transmural colonic flow was assessed before bowel 
manipulation and after anastomotic formation. 76% of patients showed a reduction in 
blood flow after anastomotic formation. 15% of patients suffered anastomotic leak. The 
mean rectal stump flow reduction was 6% in patients without anastomotic leak and 16% in 
those with anastomotic breakdown (p<0.01). A later study using a similar group of patients 
investigated the use of gastric and colorectal anastomotic tonometry.97 These authors 
investigated 90 patients undergoing colorectal surgery measuring intramucosal pH at 
these two sites 48 hours post-operatively. 11% of patients developed an anastomotic leak. 
After multivariate analysis, only anastomotic pH was found to be an independent predictor 
of leak (p=0.001). A pilot study investigating the use of near infrared spectroscopy (NIRS) 
for investigation of colorectal anastomotic tissue oxygen saturation (StO2) found NIRS to 
be a safe and reliable technique.98 In this study of 20 patients, only two suffered 
anastomotic complications. StO2 was reduced in these 2 patients when compared to those 
without complications. Further work is needed to investigate the utility of NIRS to predict 
postoperative complications. In the only study to date to directly visualise the 
microcirculation using OPS imaging following non-cardiac surgery, Boerma found no 
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difference in intestinal stoma flow flow within 24 hours of construction compared to stoma 
more than three months after surgery.99 
 
Anastomotic complications are an important cause of morbidity following oesophageal 
surgery. Pierie and colleagues investigated 30 patients undergoing transhiatal 
oesophagectomy with gastric tube reconstruction and cervical oesophagogastric 
anastomosis.100 Pefusion of the anastomosis (assessed by laser Doppler flowmetry) of 
less than 70% of pre-construction levels was a predictor of anastomotic stricture (p=0.02) 
but not leakage. In a study of 39 patients undergoing thoracic oesophagectomy, blood flow 
within the gastric tube was assessed with laser Doppler flowmetry alongside gastric and 
rectal tonometry.101 These authors found that gastric pHi values correlated significantly 
with measurements of blood flow at the anastomotic site (p<0.01). A post-hoc analysis of 
those patients who suffered anastomotic leak demonstrated a failure to improve gastric 
pHi from the nadir two hours following surgery. In those patients who did not have a leak, 
gastric pHi improved to day 2 post-operatively. Microvascular changes have also been 
found to be associated with abdominal aortic aneurysm surgery. Nakatsura and 
colleagues investigated in eight patients the effect of infrarenal aortic cross clamping on 
gastric tonometry and colonic serosal perfusion using laser Doppler.102 These investigators 
found small reductions in gastric mucosal pHi and colonic perfusion associated with cross-
clamping that returned to pre-cross-clamp levels 60 minutes after release of the cross-
clamp.  
 
1.3.2.2 Cardiac surgery 
A number of studies have investigated changes in microvascular flow during 
cardiopulmonary bypass (CPB). There are a number of factors that may influence 
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microvascular flow including haemodilution, hypothermia, non-pulsatile flow, and 
vasoactive drugs. More recent studies have used OPS or SDF imaging to directly visualise 
microvascular flow, identifying derangements during CPB which subsequently resolve.103-
105
 Similar to sepsis, no obvious correlation between global and microvascular flow was 
identified suggesting a distributive nature of microvascular dysfunction. The aetiology of 
this distributive shock is unclear but may relate to the effects of CPB on endothelial 
function.106 The use of vasoactive drugs during CPB is routine to control mean arterial 
pressure (MAP). Ketanserin was not associated with any change in microvascular flow,107 
whilst GTN initially improved flow with an associated fall in MAP but at higher doses was 
associated with reduced sublingual flow.108 Phenylephrine use during CPB resulted in 
significant reduction of sublingual microvascular flow and a simultaneous increase in 
microcirculatory haemoglobin saturations suggesting shunt across the microcirculatory 
units.109  
 
1.3.2.3 Effects of anaesthetic agents 
In almost all patients undergoing major surgery some type of anaesthesia is required 
which has the potential to alter normal autoregulation and vasoreactivity of the 
microcirculation. In contrast to ketamine’s sympathomimetic actions, both propofol and 
thiopental inhibit central sympathetic nervous tone.110-112 Thiopental, propofol and 
ketamine all have vasodilatory properties.113-116 Sublingual microvascular flow has been 
shown to fall during short term administration of propofol.117 A more recent study showed 
no effect of propofol on CO2 vasoreactivity of the human cerebral microcirculation 
assessed by laser Doppler flowmetry.118 Propofol may affect microvascular flow by its 
effects on NO production, increasing constitutive NOS and reducing inducible NOS.119 The 
effect of volatile anaesthetic agents on splanchnic blood flow is unclear but in general it 
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appears that organ perfusion remains sufficient for oxygen demand.120,121 A number of 
experimental studies suggest an increase in gastrointestinal perfusion with thoracic 
epidural anaesthesia / analgesia.122,123 Clinical studies, however, have produced 
conflicting results. Intraoperative laser Doppler flowmetry during bowel surgery 
demonstrated an increase in colonic blood flow in patients receiving thoracic epidural 
analgesia in one study.124 However, a subsequent study using similar techniques showed 
a decrease in colonic serosal flow.125  
 
1.3.3 Fluid therapy and the microcirculation in critical illness 
Findings of worse outcomes associated with impaired microvascular flow in sepsis have 
prompted investigations of therapeutic interventions to counteract these changes. Almost 
invariably, the first step in the treatment of a shocked patient is the administration of 
intravenous fluid. Traditionally fluid resuscitation has been targeted to macrocirculatory 
variables but the optimal target for fluid resuscitation remains unclear and the impact of 
fluids on the microcirculation is poorly understood. It is likely that fluids influence 
microvascular flow in a number of ways. The most obvious is enhanced filling of the 
vasculature leading to greater forcing pressures resulting in enhanced microvascular flow. 
Fluids will also change the haemorheology of blood with effects varying according to the 
type of fluid.126 It has also been shown that excessive haemodilution can reduce regional 
tissue oxygenation by causing shunting in the microcirculation.127 Fluid resuscitation has 
been shown to improve sublingual microvascular blood flow in two clinical studies of 
patients with septic shock.128,129 In the first of these studies,128 improvements in perfused 
vessel density were found in those patients with ‘early’ sepsis (less than 24 hours after 
diagnosis of severe sepsis) but not in those with ‘late’ sepsis (more than 48 hours after 
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diagnosis). There were no associated changes in global haemodynamics. The second 
study investigated the effects of passive leg raise and fluid boluses on 
macrohameodynamics and microvascular flow in patients within 24 hours of their ICU 
admission for sepsis.129 These investigators found increases in cardiac ouput and 
improvements in microvascular flow associated with both passive leg raise and volume 
expansion. 
 
The choice of fluid for resuscitation will also influence acid-base status, with solutions 
containing high chloride concentrations, such as 0.9% saline, resulting in a reduction of 
strong ion difference and metabolic acidosis. 0.9% saline appears also to have deleterious 
effects on the microcirculation and organ function.14,130 Choice of resuscitation fluid may 
also modulate the inflammatory process in critical illness. Saline has been implicated in 
worsening the pro-inflammatory insult, whereas there is limited data suggesting that 
certain colloids dissolved in balanced solutions may help to ameliorate the pro-
inflammatory response.131,132 Colloids have also shown improved microvascular flow 
compared to saline in a variety of experimental models using intravital microscopy to 
directly observe leucocyte – endothelial interaction.133,134 Some reports suggest that the 
use of crystalloids for resuscitation may impair microvascular flow and cause fluid shifts 
into the interstitium.135,136 Increased diffusion path length alongside poor oxygen solubility 
in aqueous solutions may then result in a reduction in oxygen availability to the cells. In 
general, clinical trials have shown improved microvascular flow associated with colloids (in 
particular starches) compared to crystalloids. Two prospective randomised studies 
comparing crystalloid and colloid (hydroxyethyl starches) in perioperative patients using 
gastric tonometry found improved gastric perfusion associated with starches.137,138 A 
recent study by Dubin and colleagues, found that fluid resuscitation with 6% HES 130/0.4 
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caused a greater improvement in sublingual microvascular flow and perfused vessel 
density assessed using SDF imaging compared to saline resuscitation in a group of 
patients with early sepsis.139 Comparing gelatins to starches has given mixed results, with 
some investigators finding improvements in gastric perfusion 140,141 whilst others found no 
difference.142 A prospective randomised trial of a ‘balanced’ (plasma adapted) starch 
solution versus starch suspended in 0.9% saline found improved gastric perfusion using 
the ‘balanced’ starch.143 Hypertonic saline used for the treatment of hypovolaemic shock 
has been shown to increase microvascular blood flow and perhaps reduce endothelial cell 
oedema.144 Despite these findings, a recent large pragmatic multicentre trial of colloid 
(albumin) versus crystalloid (0.9% saline) as fluid resuscitation in a hetergeneous group of 
critically ill patients demonstrated no difference in outcome.145 It appears that choice of 
fluid type amongst clinicians will continue to vary (‘colloid vs crystalloid debate’). 
 
There is little data describing the effects of fluid resuscitiation aimed at 
macrohaemodynamic goals on microvascular flow. Hiltebrand, Kimberger and colleagues 
published two papers in March 2009 investigating the effects of goal directed fluid therapy 
in a porcine model of surgery. In the first of these papers, 27 pigs underwent open 
laparotomy.146 They were randomly assigned to one of three treatment groups. All groups 
received Ringer’s lactate (RL) at 3ml/kg/hour. The ‘restrictive’ group (R-RL) received no 
further fluid, the goal directed RL group (GD-RL) received 250ml boluses of RL, and the 
goal directed colloid group (GD-C) received 250ml boluses of 6% hydroxyethyl starch 
(130/0.4). The boluses were given when mixed venous saturations fell to below 60%, 
although there was a ‘lockout’ period of 30 minutes. This group found improvements in 
global haemodynamics and regional blood flow assessed by mesenteric artery flow in both 
the GD-RL and GD-C groups compared to the R-RL group. Microcirculatory flow in the 
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intestinal mucosa assessed by laser Doppler increased in the GD-C group but was 
unchanged in the other groups. Similarly, tissue oxygen tension assessed by intramural 
Clark type electrodes increased in the GD-C group, remained unchanged in the GD-RL 
group and fell in the R-RL group. The authors concluded that GDHT using colloid 
improved microcirculatory blood flow in the small intestine. A further study that included 
the addition of a hand sewn colonic anastomosis investigated the changes in 
microvascular flow and oxygenation in healthy and anastomotic colon.147 With exactly the 
same treatment groups, they found a significant increase in tissue oxygenation and 
microvascular flow in the healthy and injured (anastomotic) colon in the colloid goal 
directed group compared to the crystalloid goal directed and restrictive groups.  
 
1.3.4 Microcirculation and vasoactive medications 
 
Cellular oxygen delivery is dependant on three main factors. Microcirculatory perfusion is 
dependant on the net effect of precapillary inflow pressure minus venular outflow pressure. 
As previously described, at times of venular hypoxia, cell-to-cell signalling between 
endothelial cells allows upstream microvessel recruitment based on conditions 
downstream in the capillary bed.61 The second factor is the diffusion distance from 
capillaries to cells.148 The third factor affecting microcirculatory oxygen delivery is changes 
in capillary haematocrit. The characteristics of blood flow within blood vessels leads to a 
plasma layer next to the vessel wall and increased haematocrit in the centre. Blood flow 
velocity also has a parabolic shape with greater flow in the centre of the vessel and low 
flow at the vessel walls. This leads to a decrease in red cell transit time and thus dynamic 
lowering of capillary haematocrit compared to arteriole and venular haematocrit. This is 
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known as the Fahraeus effect.149 Capillary haematocrit is also affected by a phenomenon 
described by Krogh as ‘plasma skimming’.150 This describes the distribution of red blood 
cells at diverging branches of the capillary network. The greater the diameter of the the 
daughter vessel, the greater the haematocrit found in that vessel. The use of exogenous 
vasopressors is conventionally thought to worsen microvascular flow due to all three of 
these factors. Vasopressors may increase pre- and post-capillary pressures leading to a 
reduction in perfusion pressure across the capillary bed and may also prevent endothelial 
derived vasodilatation aimed at preventing local hypoxia.151 Diffusion distances may 
increase due to the closure of capillaries in order to maintain perfusion pressure.148 During 
in vitro experiments, capillary haematocrit ranged from 6.8% during vasoconstriction, to 
38% during vasodilatation when systemic haematocrit was 50%.152 
 
An ideal drug to recruit the microcirculation would stabilise the endothelial dysfunction 
associated with inflammation and vasodilate low flow areas. Despite abundant 
experimental data, the effects of vasoactive compounds on microvascular flow in critically 
ill patients remains unclear. Early studies used agents with vasodilatory actions 
(prostacyclin) or combined inotropic / vasodilator properties (dobutamine).153,154 These 
studies found an increase in systemic oxygen uptake (VO2) with the authors concluding 
that that this was due to successful microvascular recruitment. The use of regional or 
systemic surrogates of microvascular flow are unable to demonstrate the heterogeneity of 
capillary flow which is a hallmark of distributive shock due to sepsis / inflammation. Thus 
recent studies have utilised in vivo microscopy to directly visualise the changes in the 
sublingual microcirculation. De Backer and colleagues have reported improvements in 
sublingual microvascular function with dobutamine,15 and drotrecogin alfa activated.155 Of 
interest, the changes with dobutamine were independent of changes in global 
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haemodynamics. The microvascular effects of glyceryl trinitrate (GTN) have also been 
investigated. An initial study by Spronk and colleagues found that in a group of eight 
patients with septic shock, GTN resulted in a marked improvement in sublingual 
microvascular flow.156 This has been followed by a recently reported randomised clinical 
trial in 70 patients with septic shock performed by the same group.157 Patients were 
randomised to GTN or placebo alongside protocol driven resuscitation. These authors 
found that protocolised resuscitation resulted in recruitment of sublingual microvascular 
flow over 24 hours but there was no additional benefit of GTN. There were no differences 
in global haemodynamics between groups. Interestingly this study revealed an 
insignificant but substantial difference in hospital mortality of 31.4% (n=11) in the GTN 
group and 11.4% (n=4) in the placebo group (p=0.09). The authors hypothesised that this 
may have been due to enhanced production of peroxynitrite and other reactive oxygen 
species that might aggravate endothelial dysfunction, alter mitochondrial pores or 
interference with the adaptive mechanisms that close microcirculatory beds as a result of 
mitochondrial failure. Levosimendan is a calcium channel sensitiser that improves 
myocardial contractility and exhibits vasodilatory properties through activation of ATP-
dependent potassium channels.158 Levosimendan also exerts anti-inflammatory, anti-
ischaemic and anti-apoptotic properties that may be important in critically ill patients.159 
Morelli and colleagues recently randomised 40 patients with fluid resuscitated septic shock 
to receive either levosimendan or dobutamine for 24 hours.160 They found no differences 
in systemic haemodynamic variables at 24 hours apart from an increase in cardiac index in 
the levosimendan group. Levosimendan was associated with an improvement in 
microvascular flow index and a reduction in the heterogeneity of flow at 24 hours. There 
were also relative increases in the proportion of perfused vessels and perfused vessel 
density in those patients who received levosimendan. There was no correlation between 
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systemic and microcirculatory parameters. Trzeciak and colleagues investigated the 
changes in microvascular flow associated with GDHT in a series of patients in the early 
stages of severe sepsis.161 This group used a protocol including fluid resuscitation, blood 
transfusion and dobutamine using central venous oxygen saturations as an endpoint. They 
found significant improvements in sublingual microvascular flow assessed by SDF imaging 
in those patients in whom there was an improvement in Sequential Organ Failure 
assessment (SOFA score) in the first 24 hours of hospital admission. Interestingly, they 
found no significant improvement in global haemodynamics in these patients. They 
concluded that microvascular alterations in sepsis are caused by intrinsic microcirculatory 
abnormalities as opposed to being a by-product of global haemodynamic changes. 
Microvascular changes may yield physiological and prognostic information that global 
haemodynamic monitoring is unable to provide. Further work is needed to investigate the 
benefits of therapies aimed at recruiting the microcirculation on organ failure in sepsis and 
possibly the use of microvascular flow as an endpoint for haemodynamic therapies. 
 
A number of investigators have also looked at the microvascular effects of therapies aimed 
at improving haemodynamics during the perioperative period although there is little data 
describing direct visualisation of the microcirculation in this group. Miyakazi and 
colleagues investigated a group of 44 patients undergoing oesophagectomy.162 Serosal 
tissue blood flow assessed using laser Doppler was lower in five patients who developed 
an anastomotic leak. This group also randomised half of the patients to receive the 
intravenous vasodilator prostaglandin E1 (PGE1). There was no significant improvement in 
blood flow with PGE1. Buise and colleagues looked at a series of 14 patients undergoing 
oesophagectomy with gastric tube formation and cervical anastomosis.163 Their aim was to 
determine whether the decrease in anastomotic blood flow was the result of arterial 
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insufficiency or venous congestion. In an elegant study they measured microvascular 
blood flow using laser Doppler, microvascular haemoglobin concentration and 
microvascular oxygen saturations using reflectance spectrophotometry. This group found 
that although blood flow did not change at the pylorus, it decreased progressively at the 
fundus during surgery. There were no changes in microvascular oxygen saturations or 
haemoglobin concentration. After completion of the anastomosis, glyceryl trinitrate applied 
topically for two minutes was associated with a significant increase in microvascular flow. 
The authors concluded that the decrease in microvascular blood flow at the anastomosis 
during oesophagectomy may be the result of venous congestion. The authors had 
hypothesised that if venous congestion resulted in poor microvascular flow they would also 
see an increase in the microvascular haemoglobin concentration and decrease in 
microvascular oxygen saturation. However, they point to the short interval of 
measurements as a possible explanation for their findings. The same group then 
performed a single-centre prospective double blind randomised controlled trial of 
intravenous glyceryl trinitrate versus placebo intraoperatively in a group of 32 patients 
undergoing oesophagectomy.164 They found a similar reduction in microvascular blood 
flow and microvascular haemoglobin oxygen saturations in both groups during surgery. 
Post-operative anastomotic leak was identified in 13% in the treatment group and 31% in 
the control group (p=0.19).  
 
1.4 Tissue oxygenation 
For obvious reasons, maintenance of adequate tissue oxygenation is believed to be a key 
goal in the care of peri-operative and critically ill patients. In the peri-operative period 
tissue oxygenation may be impaired for a variety of reasons including smoking history, 
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anaesthesia, use of vasoconstrictor drugs, mechanical effects of surgery, tissue injury 
related to surgery and post-operative pain. A number of studies have explored the effects 
of tissue hypoxia and treatments which may prevent its occurence. 
 
1.4.1 Supplemental oxygen therapy 
Oxygen is an important substrate for oxidative killing by neutrophils and thus resistance to 
infection may relate to the partial pressure of oxygen in the wound. Oxygen is also 
fundamental for collagen synthesis and for cell signalling pathways for growth factors 
involved in wound healing.165 Any surgical wound will disrupt the local vasculature and 
thus may result in wound hypoxia. Wound infections are a common and serious 
complication following surgery and may occur in 10-30% of patients undergoing colon 
surgery.54,166,167 Wound infections prolong hospital stay, may result in intensive care unit 
admission and thus increase healthcare related costs.168-170 
 
There are some concerns associated with oxygen therapy. High concentrations of oxygen 
can cause direct pulmonary toxicity, although this usually only develops after several days 
of exposure and it is unlikely that oxygen induced lung injury will develop within the 
timeframe of a surgical procedure.171 It is possible, however, to develop pulmonary 
atelectasis rapidly when breathing high fractional concentrations of oxygen.172 Clinical 
trials in surgical patients, however, have not demonstrated clinically or radiologically 
evident atelectasis associated with high intraoperative oxygen concentrations.173,174 
 
A number of experimental and clinical studies have examined the physiological effects of 
supplemental oxygen. In a porcine model, supplemental oxygen was demonstrated to 
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increase both limb tissue oxygen tension and intestinal intramural oxygen tension.175 In a 
study of 45 patients undergoing colorectal surgery, patients were randomised to 30% or 
80% perioperative oxygen therapy.176 Intragastric and colonic anastomotic catheters were 
placed in each patient. Significant differences in gastric and anastomotic pHi, and pCO2 
gap were found both during surgery and for six hours following surgery. A further group 
investigated 30 patients randomised to 30 or 80% oxygen perioperatively.177 These 
investigators found an increase in markers of oxidative stress in those patients receiving 
the lower concentration of oxygen. The authors hypothesized that in the high inspired 
fractional concentration of oxygen (FiO2) group, intestinal hypoxia was prevented, thereby 
limiting the effects of ischaemia-reperfusion injury. Hopf and colleagues found that tissue 
oxygenation in a surrogate wound of the upper arm was inversely correlated with post-
operative wound infection rate in a group of general surgical patients thought to be at high 
risk of wound infections (r=0.91, p<0.01).178 
 
In a landmark study, Greif and colleagues investigated the effects of intra- and post 
operative hyperoxia on the incidence of wound infections.170 A group of 500 patients 
undergoing colorectal resection were randomised to receive an FiO2 of 0.3 or 0.8 during 
and for two hours following surgery. The group assigned to receive more oxygen were 
found to have significantly higher arterial and subcutaneous partial pressures of oxygen. 
Associated with improved oxygenation was a lower incidence of surgical wound infection 
(5.2% vs 11.2% p=0.01). Patients who suffered wound infections, stayed in hospital a 
week longer than uninfected patients. 
 
In a subsequent smaller study by Pryor and colleagues,167 however, findings differed with 
an increase in the incidence of surgical site infections with higher perioperative oxygen 
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concentrations. However, there are a number of factors that may have contributed to these 
findings, including a lack of guidance on peri-operative care such as anaesthesia, fluid, 
temperature and pain management. Two further randomised controlled trials have 
produced conflicting results with Belda and colleagues finding that the incidence of 
surgical site infection was lower with higher inspired oxygen concentrations179 and Meyhoff 
and colleagues, in the largest study to date (1400 patients), finding no difference.173 Thus 
at present, the use of high concentrations of supplemental oxygen perioperatively is not 
standard practice. 
 
1.4.2 Intra-venous fluid therapy and tissue oxygenation 
A number of factors have been identified as influencing tissue oxygen tension. Smoking, 
uncontrolled surgical pain and epinephrine administration all reduce tissue oxygen 
tension.180-182 All of these factors suggest a pathophysiological process relating to 
impaired tissue blood flow as one cause for the impairment of oxygenation. Clearly 
supplemental oxygen cannot improve oxygenation in nonperfused tissues.183 Thus a 
number of investigators have explored the effect of perioperative intravenous fluids on 
tissue oxygenation. One of the first studies compared ‘conservative’ (8ml.kg-1.hour-1) or 
‘aggressive’ (16ml. kg-1. hour-1) fluid management using crystalloids.184  Subcutaneous 
tissue oxygenation in a surrogate wound in the upper limb was found to improve in the 
‘aggressive’ fluid group. However, subsequent studies did not confirm these findings in 
porcine models of major surgery.185,186 In one small study, the effects of crystalloids and 
colloids on tissue oxygenation were compared. Lang and colleagues compared lactated 
Ringer’s solution and 6% hydroxyethyl starch (HES) in a group of 42 patients undergoing 
elective major abdominal surgery. 187 Ringer’s lactate was associated with a decrease in 
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tissue oxygenation whilst 6% hydroxyethyl starch was associated with an increase. Further 
work is needed to investigate the effects of fluid resuscitation and other measures aimed 
at improving tissue perfusion in perioperative patients. 
 
1.4.3 Other therapies and tissue oxygenation 
Adequate pain control has been shown to ameliorate the fall in tissue oxygenation post-
operatively.181  A number of investigators have looked specifically at the role of epidural 
anaesthesia and analgesia on tissue oxygenation perioperatively. The findings of a 
number of studies suggest that regional analgesia and anaesthesia results in an increase 
in tissue oxygenation, both in healthy volunteers,188 and surgical patients.189 Given the 
vasodilator effects of regional analgesia through a reduction in sympathetic tone, the most 
plausible mechanism for such changes would relate to improved tissue blood flow in turn 
suggesting that impaired microvascular flow may play an important role in abnormalities of 
tissue oxygenation. 
 
Some studies have demonstrated an improvement in subcutaneous oxygenation 
associated with mild hypercapnia.190,191 This may be due to increased cardiac output or to 
a right shift in the oxy-haemoglobin dissociation curve. Hypercapnia has also been 
demonstrated to improve intramural intestinal oxygenation in a porcine model.175 These 
findings were confirmed in a clinical trial of normocapnia (end-tidal carbon dioxide tension 
35 mmHg) versus mild hypercapnia (end tidal carbon dioxide tension 50 mmHg) in 
patients undergoing elective bowel resection.192 An interesting study by Akca and 
colleagues investigated the effects of hypercapnia on tissue oxygenation in patients 
undergoing cardiac surgery using cardiopulmonary bypass (fixed blood flow).193 They 
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found no improvement in tissue oxygenation and concluded that hypercapnia results in 
improvements in tissue oxygenation through changes in cardiac output rather than 
vasodilation. 
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1.5 Discussion / summary 
Major surgery and severe sepsis are important causes of death and disability. With the 
ageing population and the increasing use of invasive procedures, the number of high risk 
surgical procedures and incidence of severe sepsis are likely to increase.1,9 This will place 
an increasing burden on healthcare resources. Many previous investigators have used 
surrogate global markers to diagnose organ hypoperfusion in these patient groups such as 
global oxygen delivery, mixed venous oxygen saturations and blood lactate 
concentrations. The introduction of direct in-vivo microscopy has allowed the investigation 
of microcirculatory changes at the bedside. Abnormalities of microvascular flow have been 
identified in established sepsis and interestingly, these changes are not necessarily 
obvious using routine global haemodynamic parameters. There is little data, however, 
describing changes in the earliest phases of sepsis or following major surgery and the 
relationship of these changes to outcome. We hypothesised that microvascular flow would 
deteriorate in the early phase of sepsis, as well as during the inflammatory response to 
surgery and that these changes would be related to outcome.  
 
The use of intravenous fluids and vasoactive medications are a routine and fundamental 
aspect of care for critically ill patients. Their optimal use, however, is poorly understood 
and remains hotly debated. Whether the use of fluid resuscitation and / or vasoactive 
agents to optimise global haemodynamics results in similar improvements in the 
microcirculation in critically ill patients remains unclear.15,160,161 Thus there is a clear need 
for further investigations of tissue microvascular flow and oxygenation in patients 
undergoing major surgery and in those with sepsis, to confirm the importance of these 
abnormalities and how they may be modified by haemodynamic therapies. GDHT has 
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been demonstrated in a number of perioperative studies to improve outcome. It is believed 
that this is due to improvements in tissue perfusion and oxygenation, although this 
hypothesis has yet to be confirmed. Dopexamine, an inodilator, has been used in a many 
of these perioperative GDHT trials. We hypothesised that a fixed dose infusion of 
dopexamine alongside stroke volume guided fluid therapy would improve microvascular 
flow and tissue oxygenation in a group of high risk perioperative patients. Noradrenaline is 
recommended to maintain mean arterial pressure greater than 65 mmHg after fluid 
resuscitation in patients with septic shock. Some clinicians advocate targeting higher 
arterial pressures, but the effects of such as approach on the microcirculation and tissue 
oxygenation are unknown. We aimed to investigate the effect of escalating doses of 
noradrenaline titrated to achieve successively higher mean arterial pressures in a group of 
patients with septic shock. 
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1.6 Aims of thesis 
1) To confirm the existence of a high risk sub-population within the local surgical 
population and characterise this population in more detail (in particular with regard to 
treatment pathways) 
2) To investigate the changes in tissue microvascular flow and oxygenation in patients 
receiving usual care following major abdominal surgery and their relationship to 
outcome 
3) To investigate the effects on tissue microvascular flow and oxygenation of two 
commonly used GDHT algorithms compared to central venous pressure guided fluid 
therapy in perioperative patients 
4) To investigate the effects of GDHT on renal outcomes in a group of perioperative 
patients 
5) To describe the changes in microvascular flow in patients with early sepsis and its 
association with outcome 
6) To investigate the effects of increasing doses of noradrenaline on tissue oxygenation 
and microvascular flow in patients with septic shock 
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Chapter 2 
Methods 
 
2.1 Cardiac output monitoring 
One of the earliest attempts to take physiological measurements of the circulation was 
made in 1733 by the Reverend Stephen Hales who measured arterial pressure by 
attaching a manometer to the carotid artery of a horse. However, the measurement of 
blood flow has proved to be much less straightforward than the measurement of blood 
pressure. As a consequence, an undue emphasis has been placed on the value of arterial 
pressure measurements which often give a poor indication of tissue blood flow.194,195 It 
was not until the early 1970’s that the introduction of the balloon tipped pulmonary artery 
catheter finally allowed the routine measurement of cardiac output at the bedside.30,31   As 
use of the pulmonary artery catheter became more widespread, a number of 
commentators voiced concerns that this technique might be associated with an increase in 
mortality.50,51,196 This debate was in particular fuelled by the publication of a retrospective 
analysis of data collected prospectively on 5735 patients for a study on decision making in 
ICU. The outcome of patients who received a pulmonary artery catheter in the first 24 
hours of ICU admission was compared to that of those who did not. The groups were 
adjusted with the use of a severity of illness propensity score and the authors found that 
mortality was higher among patients who received a pulmonary artery catheter. There are 
a number of problems with this retrospective analysis. Firstly the database was not 
originally compiled for this purpose. Secondly patients in whom a pulmonary artery 
catheter was inserted after the first 24 hours of ICU admission were analysed as not 
having received one at all. Lastly the relevance of outcome data adjusted using a 
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retrospective propensity score is questionable. It is possible that there were a number of 
co-variables which could account for the difference found. Although the belief that the use 
of PA catheters worsens outcome has now been refuted by three large multi-centre trials, 
which showed no difference in outcomes197-199 there has, in the meantime, been a shift 
towards the use of less invasive technology. A number of different cardiac output 
monitoring devices are now commercially available. The requirements for the ideal 
monitoring technique to be used in the post-operative surgical patients are that it should 
be readily tolerated by conscious patients, convenient to use and well validated. 
 
2.1.1 Fick Principle 
In 1870, Adolf Fick suggested that blood flow through an individual organ might be 
calculated by measuring the arterio-venous concentration gradient of an indicator, a 
known mass of which had previously been added to the arterial circulation.19 Fick originally 
suggested the calculation of pulmonary blood flow and therefore total cardiac output by 
taking measurements of oxygen consumption and carbon dioxide production along with 
the pulmonary arterial and venous concentrations of these gases (equation 1 and figure 
1). Fick’s principle was subsequently used to measure cardiac output in animals,200,201 but 
it was not until 1929, when Werner Forssman devised a method of sampling mixed venous 
blood that the application of the Fick principle became possible in man. Forssman passed 
a ureteric catheter through his own cephalic vein and into his right ventricle, before walking 
to the X-ray department to confirm its position, an experiment that led both to his dismissal 
and the award of the Nobel prize.20 The following year Otto Klein became the first person 
to draw mixed venous blood and calculate cardiac output in man using the Fick 
principle.202 This technique was then perfected by Cournand and colleagues during the 
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1940’s.203,204 The Fick technique is still regarded by many as the most accurate method of 
cardiac output measurement currently available; however, it is rarely used clinically due to 
the availability of more practical alternatives.  
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Figure 2.1 Fick equation. Blood flow (Q), or in this example cardiac output, is equal to oxygen 
uptake (VO2) divided by the arteriovenous oxygen difference. The arteriovenous oxygen difference is 
calculated by subtracting the mixed venous oxygen content (CvO2) from the arterial oxygen content 
(CaO2). This equation can be adapted to look at blood flow across individual organs. 
 
 
 
Figure 2.2 Fick principle. Blood flow (Q) across the tissue bed is equal to the oxygen consumption 
divided by arteriovenous oxygen difference (arterial oxygen content [CaO2} minus the venous 
oxygen content [CvO2]). 
 
 53 
2.1.2 Indicator dilution technique 
The use of exogenous indicators to determine circulation time was first reported as early 
as 1761, when Haller described the measurement of pulmonary circulation time in an 
animal model using coloured dye.205 During the 1890’s, George Stewart further developed 
the concept of indicator dilution in a series of papers on circulation time.206-208 By using a 
hypertonic saline indicator, Stewart was able to detect a signal in circulating blood by 
measuring changes in electrical conductance. William Hamilton then developed Stewart’s 
work to allow the measurement of cardiac output using an indicator dilution technique.28 
Hamilton used phenolphthalein as an indicator and, with the help of an automated system 
of blood sampling, was able to plot the systemic arterial concentration of dye against time. 
This now familiar curve was characterised by a brief delay following injection during which 
dye transits the pulmonary circulation followed by a rapid rise to a peak value before an 
exponential decline with a second much smaller peak due to indicator recirculation (figure 
2). Cardiac output was shown to be inversely proportional to the area under the curve as 
described by the Stewart-Hamilton equation (equation 2).  
 
M=Q C t dt
 
 
Figure 2.3 Stewart-Hamilton equation. If an indicator is injected rapidly into the right atrium, it will 
appear downstream in the pulmonary artery in a concentration that varies with time, C(t). As all the 
injected indicator (M) must leave the system, M is equal to the sum of the concentrations at each 
interval (t) multiplied by flow (Q), which is assumed to be constant.  
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Figure 2.4 Indicator-dilution curve. Changing dye concentration with respect to time 
demonstrating initial peak followed by exponential decline and second peak due to recirculation. 
 
Various dyes have been used for indicator dilution measurements, most commonly 
indocyanine green. However, few indicators conform closely to the ideal indicator which is 
stable, non-toxic, easily measured, uniformly distributed within the fluid compartment of 
interest, not lost from the circulation during the first transit and yet rapidly dissipated to 
avoid recirculation. The most common difficulties with indicator dilution techniques have 
been lack of indicator stability, inaccurate concentration measurement and indicator 
accumulation. The use of thermal indicators (thermodilution) avoids some of these 
difficulties, an approach which was first described by Fegler in 1954.29 However, 
temperature equilibration may still result in significant indicator loss during transit. In 1967, 
Branthwaite and Bradley described the measurement of cardiac output by thermal 
indicator dilution using a thermistor tipped pulmonary artery catheter.30 Indicator loss was 
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minimised because of the short path between indicator injection in the right atrium and 
measurement in the pulmonary artery. Swan and Ganz made a further adaptation in 
1970,31  adding a small inflatable balloon to the catheter tip. Flow directed placement of 
the catheter without fluoroscopic imaging allowed the routine clinical use of the pulmonary 
artery catheter. Temporary occlusion of the pulmonary artery during balloon inflation also 
allowed measurement of pulmonary artery occlusion pressure, an index of left ventricular 
preload. 
 
Traditionally, five successive measurements were made at end-expiration following 
manual injection of a cold saline bolus. An average was then taken of the three most 
closely related values. However, many centres now use an automated system; a filament 
incorporated into the body of the catheter intermittently warms aliquots of blood passing 
through the right ventricle, the output signal being an increase in temperature rather than a 
decrease. Measurements are repeated automatically every few seconds and averaged 
over ten readings. This method is as accurate as manual measurement but more 
convenient.209,210 Measurements of cardiac output by pulmonary artery catheter 
thermodilution correlate well with alternative methods including dye dilution and the Fick 
technique.30,211-214 Important sources of error include indicator loss,30,215,216 and structural 
cardiac abnormalities.217 Cardiac output varies with positive pressure ventilation, 
particularly in hypovolaemic patients.218,219 However, provided intermittent measurements 
are taken at the same point in the respiratory cycle, wide fluctuations in the measured 
value for cardiac output can be avoided. 
 
An important limitation of the pulmonary artery catheter is the risk of damage to cardiac 
valves with prolonged use. Ideally, they should be removed after 48 hours, or at least after 
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a maximum of 72 hours. Other complications include catheter knotting, pulmonary artery 
rupture and pulmonary embolism.220 It is important to note however, that several multi-
centre trials have shown that significant complications are unusual and that pulmonary 
artery catheter use is not associated with excess mortality.197-199 Use of this device is now 
declining in favour of less invasive technology, although the technique will continue to 
have a niche role in management of pulmonary hypertension and patients receiving intra-
aortic balloon counterpulsation. 
 
Trans-pulmonary indicator dilution techniques in which indicator is injected into the 
superior vena cava and measured in a systemic artery are also well described. 221,222 This 
approach is less invasive and may provide additional physiological data related to the 
pulmonary circulation.221,222 Two of the most commonly used techniques for measuring 
cardiac output at present utilise trans-pulmonary indicator dilution to calibrate continuous 
arterial pressure waveform analysis (one using a lithium indicator, the other a thermal 
indicator). 
 
2.1.3 Arterial waveform analysis 
Otto Frank first suggested calculating cardiac output by analysis of the arterial pressure 
waveform in 1899.223 Frank realised that total peripheral resistance can be calculated from 
the time constant of diastolic aortic pressure decay and arterial compliance, estimated by 
measuring aortic pulse wave velocity. Cardiac output can then be calculated from total 
peripheral resistance and mean arterial pressure (equation 3).  
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Figure 2.5 Relationship between cardiac output (CO), mean arterial pressure (MAP) and total 
peripheral resistance (TPR) 
 
In 1904, Erlanger and Hooker suggested that the principal determinant of aortic pulse 
pressure was the volume of blood ejected during each cardiac cycle. Measurement of 
pulse pressure should therefore allow the calculation of stroke volume and hence cardiac 
output.224  In 1970, Kochoukos described a more accurate method of stroke volume 
estimation involving measurement of the area under the systolic portion of the arterial 
pressure waveform (figure 3).225  
 
Figure 2.6. Stroke volume estimated from systolic portion (shaded) of arterial waveform. 
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This work was developed by Wesseling and colleagues who devised an algorithm for the 
calculation of stroke volume from aortic impedance and the change in arterial pressure 
during systole (equation 4).226,227 However, calculation of stroke volume and cardiac output 
through analysis of the arterial pressure waveform is far from straightforward. This 
complex waveform comprises both an incident pressure wave which is proportional to 
stroke volume and a reflected pressure wave created as the incident wave reflects back 
from the peripheries. Changes in arterial compliance affect both the velocity and amplitude 
of the pressure waves and will in turn be affected by changes in arterial wall tension. As a 
consequence, the arterial waveform may vary considerably, depending on physiological 
circumstances and anatomical location. Although the method of pulse contour analysis 
suggested by Wesseling may provide a reliable estimate of changes in cardiac output,228-
230
 accuracy may be influenced by changes in total peripheral resistance.231 Perhaps the 
most important difficulty with arterial waveform analysis is the fact that aortic impedance is 
dependent both on cardiac output and aortic compliance. Consequently, it is only possible 
to reliably estimate changes in stroke volume rather than absolute values. Such systems 
must therefore be calibrated before use. 
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Figure 2.7 Calculation of stroke volume using pulse contour analysis. Stroke volume (SV) is 
estimated from the integral of the change in pressure (P) from end diastole to end systole (t) i.e. the 
systolic portion of the curve until aortic valve closure. This estimate of stroke volume is also 
dependent on the impedance of the aorta (Z). 
 
An alternative method of arterial waveform analysis is to apply the physical principle of 
conservation of mass to calculate changes in pulse power. The net power change in the 
aorta is determined by the difference between the input and removal of mass. The change 
in power during a single cardiac cycle should therefore be determined by stroke volume 
(input of mass) and the distribution of blood from the aorta into the peripheral circulation 
(removal of mass). Ejection of blood into the aorta during systole causes fluctuations in 
blood pressure around a mean value. Using a mathematical technique termed 
autocorrelation, analysis of these fluctuations allows determination of changes in stroke 
volume with each cardiac cycle.232 This algorithm is not morphology based and takes 
account of changes in the arterial waveform throughout the cardiac cycle rather than 
systole alone. This approach may be more accurate because the effects of the reflected 
arterial pressure wave are taken into consideration. Once again, calibration is required to 
correct for arterial wall compliance damping and other sources of inter-individual variability. 
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2.1.4 Trans-pulmonary thermodilution and arterial waveform analysis 
In this technique, trans-pulmonary thermodilution is performed using a cold saline indicator 
injected via a central venous catheter. The measurement of the temperature of arterial 
blood is performed using a thermistor tipped catheter sited in the femoral or brachial 
artery. Cardiac output is then calculated using a modified Stewart-Hamilton equation 
allowing calibration of continuous arterial waveform analysis software which provides 
continuous cardiac output data by a pulse contour analysis method.  
 
This technology can be safely used in both conscious and unconscious patients for 
prolonged periods and correlates well with measurements made by pulmonary artery 
catheter thermodilution,233,234 and the direct Fick technique.235,236 An important limitation is 
the requirement for a specific thermistor tipped arterial catheter sited in either the femoral 
or brachial artery to allow thermodilution measurements. In most cases this necessitates 
the insertion of a new arterial catheter. Changes in compliance of the arterial tree or 
damping of the arterial pressure transducer system may cause measurement error, 
necessitating repeated calibration. This system was not appropriate for our purposes as 
the requirement for insertion of a thermistor tipped arterial cannula would have 
nececessitated arterial cannulation following surgery. 
 
 
2.1.5 Trans-pulmonary lithium indicator dilution and arterial waveform 
analysis 
This monitor utilises the lithium indicator dilution technique to calibrate software which 
performs continuous arterial waveform analysis by a pulse power method to provide 
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updated cardiac output data for each cardiac cycle. Lithium indicator dilution is a novel 
concept which was first described in 1993.221 Lithium satisfies many of the criteria for the 
ideal indicator; whilst there is minimal indicator loss during the first circulation, rapid 
redistribution allows repeated measurements.237,238  In the doses used for calibration, 
lithium chloride is considered safe, even in a 40 kg patient with non-functioning kidneys.239 
Following intravenous injection, lithium is detected by an external lithium ion sensitive 
electrode attached to a standard arterial catheter. Cardiac output is calculated using a 
modified Stewart-Hamilton equation (equation 5). A correction is applied for plasma 
sodium concentration which, in the absence of lithium, is the chief determinant of potential 
difference across the electrode. As lithium is only distributed in plasma, a correction for 
haematocrit is also required.240  
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Figure 2.8 Modified Stewart-Hamilton equation for the measurement of cardiac output by 
lithium indicator dilution. CO cardiac output; Li lithium dose; AUC area under lithium 
concentration / time curve; PCV packed cell volume. 
 
Lithium indicator dilution measurements for calibration are generally performed every eight 
hours but may be required more frequently where there is evidence of significant changes 
in arterial compliance or damping of the arterial waveform.241  In an animal study, lithium 
indicator dilution compared well with measurements taken using an electromagnetic aortic 
flow probe.242 Studies in humans suggest a good correlation between lithium indicator 
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dilution and other methods.221,243,244 Similarly, comparisons of pulse power analysis to 
intermittent determinations of cardiac output by thermodilution and lithium dilution suggest 
this method of continuous cardiac output measurement is reliable.241,245,246  
 
This combined technology has a number of advantages for the series of investigations 
reported here when compared to pulmonary artery catheter thermodilution or other cardiac 
output monitors. The method is less invasive than pulmonary artery catheterisation 
allowing use for longer periods of time in a wider range of patients. Due to the nature of 
the patients studied in, central venous catheters and arterial lines were inserted by the 
treating team as part of ususal care. There was therefore no need for insertion of 
additional arterial or venous catheters. Another advantage is that this technique can be 
employed in both conscious and unconscious patients There are, however, some 
limitations to this combined technology. The use of non-depolarising muscle relaxants may 
interfere with the lithium ion sensitive electrode resulting in difficulties with calibration due 
to baseline drift. Irregular cardiac rhythms may occasionally result in an irregular data 
output from the pulse power analysis software and, as with all arterial waveform analysis 
techniques, damping of the arterial waveform will result in measurement error. 
 
 
2.1.6 Aortic velocimetry 
Cardiac output may be calculated from measurements of aortic blood velocity and cross-
sectional area. Such techniques include the measurement of Doppler frequency shift of 
ultrasound waves and electromagnetic methods. The simplicity of these methods of 
velocity measurement is a major advantage. However, in most situations, the diameter of 
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the aorta cannot be measured directly, introducing a possible source of error. If velocity 
measurements are made on blood flowing through the descending aorta, a correction 
factor must also be applied to account for distribution of an unknown proportion of the total 
cardiac output to the upper body, introducing another potential source of error. 
 
The oesophageal Doppler technique involves the measurement of blood velocity in the 
descending thoracic aorta using an ultrasound probe placed in the lower oesophagus. The 
probe emits an ultrasound beam at a 45° angle to its long axis which is aimed towards the 
aorta by the operator. A continuous visual velocity versus time display helps to ensure 
correct probe placement (figure 2.9).  Measurement of the Doppler frequency shift of the 
reflected ultrasound waves allows calculation of blood velocity. Cardiac output may then 
be calculated by one of two methods. The first involves measurement of the aortic cross 
sectional area, measured using M mode ultrasound visualisation of the aorta and then 
multiplying this value by blood velocity to calculate flow. A correction factor is then applied 
to take account of distribution of part of the total cardiac output to the upper body, 
assuming that this ratio is constant. A simpler and seemingly equally reliable method, is 
simply to derive a value of total cardiac output from a nomogram using aortic blood 
velocity, height, weight and age.247   
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Figure 2.9 Velocity-Time trace from oesophageal Doppler probe demonstrating aortic flow 
time and peak velocity. 
 
A systematic review of eleven studies in which the nomogram based oesophageal Doppler 
technique was compared to pulmonary artery catheter thermodilution suggested minimal 
bias and good limits of agreement between the two techniques.248 The principal advantage 
of this technique is speed and ease of use and the method has proved ideal for intra-
operative use. The most important contra indication to use is severe oesophageal 
pathology, in particular varices or recent surgery. The major limitation of this technique is 
that the probe is not well tolerated by conscious patients and its use is therefore generally 
confined to anaesthetised or sedated patients. The inability to use this method in non-
sedated post-operative patients prevented the use of this technology in the series of 
experiments reported here. 
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2.1.7 Supra-sternal Doppler 
Using a non-invasive ultrasound probe positioned in the jugular notch (figure 2.10), it is 
possible to measure blood velocity in the ascending aorta. This is essentially a non-
invasive alternative to the oesophageal Doppler technique. Stroke volume and cardiac 
output are calculated using a measurement of cross sectional area of the aortic outflow 
tract. Because these measurements are taken from the aortic root, the technique is not 
affected by changes in distribution of cardiac output between the upper and lower body. 
Cardiac output measurements taken using the supra-sternal Doppler method were similar 
to those taken with an electromagnetic aortic flow probe in an animal study,249 and with 
pulmonary artery catheter thermodilution in clinical studies.250-252 The portable and non-
invasive nature of this technology is a major advantage, allowing use in any clinical 
setting. However, it may be very difficult to identify the aortic root in some subjects. 
Although the supra-sternal probe should allow ultrasound waves to be orientated at 0° to 
the direction of blood flow, in practice this alignment is affected by operator skill as well as 
the anatomy and position of the subject. Consequently, this technique may have greater 
inter-observer variability than other methods. Where identification of the aortic root proves 
difficult, the pulmonary valve may be used instead. Because measurements are taken in 
the supine position, they may be poorly tolerated by breathless patients. The main 
advantages of this technique, however, are its ease of use and portability. This was 
necessary for our study investigating the microcirculation in early sepsis as we were 
aiming to recruit these patients as soon as possible after hospital admission and often 
prior to the insertion of arterial and central venous catheters. 
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Figure 2.10 Suprasternal Doppler applied to jugular notch in supine subject for 
measurement of cardiac output. 
 
2.1.8 Bioimpedance 
Bioimpedance is a non-invasive technique which involves the application of a small 
alternating current across the chest via topical electrodes. This current is thought to 
distribute primarily to blood because of its high electrical conductivity compared with 
muscle, fat and air. Pulsatile changes in thoracic blood volume result in changes in 
electrical impedance. The rate of change of impedance during systole is measured 
allowing a value of cardiac output to be derived. A number of studies have compared 
bioimpedance to alternative methods of cardiac output measurement with inconsistent 
findings. 
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2.2 Transcutaneous tissue oxygenation 
Transcutaneous tissue oxygenation was assessed using a heated Clark type electrode. 
Continuous non-invasive measurement of oxygen tension is possible because oxygen can 
diffuse through the skin. Although normally the skin is not very permeable to gases, at 
higher temperatures skin blood flow and, hence diffusion of oxygen, is increased. Oxygen 
sensors for transcutaneous electrochemical measurements are based on polarography. 
The sensors contain a conventional amperometric transducer in which the rate of a 
chemical reaction is detected by the current drained through an electrode. The sensor 
heats the skin to 43–45 degrees Celsius (°C). The skin surface oxygen tension is 
increased as a result of three effects. Firstly, heating the stratum corneum beyond 40°C 
changes its structure, allowing oxygen to diffuse more rapidly. Secondly, the local oxygen 
tension is increased by shifting the oxygen dissociation curve to the right in the heated 
dermal capillary blood. Finally heating causes dermal capillary hyperemia. In neonates, 
this technology is often used to estimate arterial oxygenation as the dermal layer is very 
thin so that transcutaneous oxygenation can accurately track changes in arterial 
oxygenation.253 In adults the dermal layer is thicker; consequently measured 
transcutaneous oxygen tension is lower than arterial oxygen tension. Importantly the 
correlation between transcutaneous oxygenation and arterial oxygen tension depends on 
blood flow; reductions in local blood flow during shock states can therefore result in low 
transcutaneous oxygen tension measurements. For this reason reductions in 
transcutaneous oxygenation have been used as a marker of poor cutaneous blood flow 
during shock.254-258 Yu and colleagues, for example, prospectively measured 
transcutaneous oxygen and its response to an oxygen challenge alongside global 
haemodynamics in a group of 38 patients with septic shock.259 They found the ability to 
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increase transcutaneous oxygen in response to an oxygen challenge, as a marker of 
tissue blood flow, separated survivors from non-survivors. The same group went on to 
perform a randomised controlled trial using transcutaneous oxygenation targets in a group 
of patients with septic shock.260 Interestingly, they again found that the ability to improve 
transcutaneous oxygenation was a predictor of outcome and showed reduced mortality in 
the group randomised to using transcutaneous oxygenation as a resuscitation goal. 
 
2.3 Laser Doppler Flowmetry 
Laser Doppler is a non-invasive technique used for determining blood flow in the 
microcirculation. The method is based on the reflection of a beam of laser light that 
undergoes a change in wavelength when it encounters moving red blood cells. The 
technique depends on the Doppler principle whereby low power light from a 
monochromatic stable laser is transmitted via an optic fibre and scattered on contact with 
tissue and moving blood cells. As a consequence its frequency distribution broadens 
(Doppler shift). This light is transmitted via a second optical cable in the same fibre to a 
photodetector along with the laser light scattered by the static tissue. The fibres within the 
head are separated by a few tenths of a millimetre and consequently blood flow is 
assessed in a tissue volume of 1mm3 or less.  
 
 69 
 
Figure 2.11. Laser Doppler flowmetry. Low power laser light is transmitted via an optical fibre to 
the tissues. The light is scattered by tissue; some of this scattered light is collected by the optical 
fibres and transmitted to a photodetector. The resulting photo current is electronically processed to 
produce a laser Doppler flux signal. Reproduced with permission of Moor Instruments Ltd, UK. 
 
Laser Doppler flowmetry, cannot determine absolute perfusion values but instead flow is 
quantified using arbitary perfusion units. The units are given as a quantity proportional to 
the product of the average speed of the blood cells and their concentration. It is therefore 
not possible to compare absolute flux values across different studies that use different 
probes / machines or sites of measurements. Also flux does not reach the value of zero 
when perfusion is absent because Brownian motion of molecules within the interstitial 
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space contributes to the signal when flow of red cells is absent. For measurement of flux, 
probes were simply placed on the area of interest (abdominal wall or upper limb) and 
measurements taken at set intervals (Chapters 4 and 9). 
 
Post-occlusive reactive hyperaemia is the increase in skin blood flow above baseline 
levels following the release of a brief arterial occlusion. It can be characterised by an initial 
peak in flux within a few seconds of removal of the occlusion, followed by a sustained 
hyperaemia.261 The test was performed by placing a cuff on the upper arm and inflating 
the pressure to 20-30mmHg above systolic pressure. The commonly used ischaemic times 
are three and five minutes.261 A period of three minutes was used in these trials as longer 
periods were deemed likely to be poorly tolerated in the post-operative patient.  Laser 
Doppler probes were placed on the forearm, distal to the cuff, and measurements were 
taken before, during and after cuff inflation. A number of parameters can be assessed from 
the flux response. The most commonly used parameter is peak hyperaemia, although 
there is no consensus as to the most informative end point. Studies have examined the 
peak hyperaemia minus baseline flow,262 peak as a percentage of baseline 263 and area 
under the curve of the postischaemia blood flow.264 We decided to look at the relationship 
between peak hyperaemic flow and baseline flow for two main reasons. Firstly, this 
derivative appears to be the most commonly used. Secondly we felt we would obtain more 
robust data by looking at these two parameters, given that patient movement artefact 
would limit area under the curve calculations (movement artefact was common in the early 
stages post-operatively due to residual sedation) (Chapter 5). 
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Figure 2.12. Laser Doppler assessment of post-occlusive hyperaemic response 
 
Fig 2.13. Hyperaemic response measured using Laser Doppler 
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2.4 Sublingual microscopy 
Until 1999, direct visualisation of the microcirculation in humans was limited to the use of 
bulky stage microscopes, mainly used to observe the nailfold capillary bed. This 
constrained the applicability of clinical studies especially since there is uncertainty as to 
the relevance of changes in nailfold capillary flow to other microvascular beds. The 
introduction of Orthogonal Polarization Spectral (OPS) imaging by Slaaf and colleagues 
and its incorporation into a hand-held microscope allowed the study of the human 
microcirculation in exposed tissue surfaces at the bedside.265 With this technique, the 
object is illuminated by light that has been linearly polarised in one plane. The OPS 
camera then images the remitted light through a second polariser (analyser) that is 
orientated in a plane precisely orthogonal to that of the illumination. A diagram of this set-
up is shown below. 
 
 
 
 
 
 
 
 
 
Figure 2.14 Schematic of OPS imaging. Reproduced from 90 with permission from Nature 
publishing group. 
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Light emitted from the light source is passed therough a spectral filter to isolate the chosen 
wavelength and to polarise the light. The beam of light is then reflected towards the target 
tissue by a beam splitter. The light is focussed onto an area of approximately 1mm in 
diameter by the objective lens. The light that is reflected from the target is then collected 
by the same objective lens. The light passes through a polarisation analyser placed 
orthogonally to the original polariser. This allows depolarised light but not polarised light to 
form an image on the video camera. Once light has been polarised, this state remains 
even after reflection or single scatterings on contact with the target tissue. (More than ten 
scattering events are required to depolarise light.266,267) Therefore using OPS imaging, the 
only light that can pass through the analyser is light that has undergone multiple scattering 
(thus now depolarised) deep within the imaged medium. This scattered light therefore back 
illuminates any absorbing material in the foreground. In OPS, polarised green light is used 
to illuminate the tissue containing the microcirculatory area of interest.90,268,269 Green light 
(wavelength 548nm) is used as this corresponds to one of the isobestic points of oxy- and 
deoxy-haemoglobin to ensure optimal imaging of the blood vessels of the peripheral 
microcirculation. This isobestic point balanced the requirements of haemoglobin 
absorption and scattering more effectively than is the case for other isobestic points.90 This 
highlights the two fundamental features of OPS imaging, forming an image in reflected 
light requires both scattering for illumination and absorption for contrast. Despite this major 
advance in microvascular research, there are still some technical drawbacks associated 
with OPS imaging. Importantly imaging of the capillaries can be compromised by 
movement of the OPS device, the tissues and/or flowing red blood cells. During 
continuous flow, it is sometimes difficult to appreciate the granular nature of flowing blood 
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cells due to blurring. This means that computer software designed to measure flow would 
be unable to capture individual erythrocytes, so making calculation of flow very difficult. 
 
A related technique termed Sidestream Darkfield Imaging (SDF) attempts to address some 
of these problems. In SDF imaging, illumination is provided by a series of concentrically 
placed light emitting diodes (LED) surrounding a central light guide, thus providing 
sidestream darkfield illumination. The core of the light guide contains the lens system and 
is thus optically isolated from the illuminating outer ring in order to prevent contamination 
of the image with tissue surface reflections. The light emitted is also at a wavelength of 
530nm to ensure optimal absorption by haemoglobin containing red cells. To improve the 
imaging of moving structures, however, the LED’s provide pulsed light that is in synchrony 
with the the video camera frame rate, thereby performing intra-vital stroboscopy. This 
helps to partially prevent the smearing of moving objects such as flowing red cells and the 
motion induced blurring of capillaries thanks to the shorter illumination time. In a recent 
comparison of the two techniques, validation of the new technique was confirmed by 
quantatitve measures of nailfold capillary diameters and red cell velocities using OPS and 
SDF imaging.93 This study also developed an image quality system to quantitatively 
compare the quality of sublingual OPS and SDF images. Venular contrast, sharpness and 
quality were similar with both techniques but capillary imaging was superior with SDF 
imaging.93 
 
Any mucosal surface can be assessed using these techniques, but the sublingual site is 
now preferred for assessment in the critically ill for two reasons. Firstly, the sublingual 
space is readily accessible. Secondly, the sublingual mucosa has the same embryological 
origin as the splanchnic mucosa. A number of investigators have shown that 
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derangements in sublingual perfusion can track dysfunctional splanchnic flow which is 
thought to be one of the earliest indicators of systemic hypoperfusion.270-274 Creuteur and 
colleagues examined changes in sublingual and gastric CO2 alongside sublingual 
microscopy in a group of patients with septic shock.274 They found that sublingual 
microvascular flow tracked changes in gastric and sublingual CO2. An interesting study by 
Boerma and colleagues investigated the relationship between sublingual and intestinal 
(newly constructed stoma) microvascular flow in a group of patients with abdominal sepsis 
using OPS.99 They found on day 1 that there was no correlation between flow in the two 
vascular beds. By day 3, a correlation between the two vascular beds had returned (mainly 
due to normalisation of values). The authors concluded that this dispersion of flow was 
consistent with the distributive nature of septic shock.275 A recently reported study 
investigating the relationship between sublingual and intestinal mucosal microcirculatory 
perfusion used a porcine model of abdominal sepsis specifically designed to avoid the 
confounder of raised intra-abdominal pressure.276 In contrast to the previous study, these 
investigators found that the severity and time course of microcirculatory changes were 
similar in the sublingual and intestinal regions. 
 
Various scoring systems for video analysis have been developed by different investigators. 
In addition several software packages are under development. Given the high variability in 
image analysis, a round table conference involving many of the key researchers in the field 
was held in 2007. The various aspects of video acquisition and analysis were discussed 
and Delphi methodology was used to formulate concensus statements.277 We obtained 
and analysed all of our videos in accordance with these recommendations. 
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2.4.1 Image aquistion 
Sublingual microvascular flow was evaluated using sidestream darkfield imaging with a x5 
objective lens (Microscan, Microvision Medical, Amsterdam, Netherlands). Given the 
intrinsic variability of microvascular flow, it is important to average results from a number of 
sites in the organ of interest. Thus in each patient, microcirculatory videos were obtained 
from between three and five sublingual sites. Videos were recorded directly from the SDF 
imager onto a laptop computer (large LCD screen) via an analogue to digital convertor 
(Canopus ADVC 110). Below are the steps taken for image aquistion. 
 
1) Place new sterile disposable cap on the SDF imager 
2) Remove secretions from the sublingual mucosa using a suction catheter and saline 
soaked gauze 
3) Position probe on the sublingual mucosal surface – once image obtained look for 
evidence of pressure arterfact (altered large venular blood flow). Gently withdraw 
camera until image about to be lost to ensure no pressure artefact. 
4) Re-focus image 
5) Aim to record minimum 20 second video clip 
 
This was repeated three to five times at each timepoint and images stored on the hard 
drive of a laptop computer and backed up on DVD’s / external hard drive.  
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Figure 2.15 Sidestream darkfiled imaging camera (Microscan, Microvision Medical) 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.16 Sublingual microcirculation video assessment at the bedside 
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2.4.2 Image analysis 
According to concensus conference guidelines,277 it is important to differentiate capillaries 
from venules because the former contribute predominantly to organ perfusion and are 
therefore the vessel of interest. It is in practice difficult to separate venules from capillaries, 
but guidelines suggest an arbitary cut-off value of 20 µm diameter, recognising that vessel 
size can vary. The main interest of the larger vessels is as a quality control measure to 
ensure that excessive pressure was not used in obtaining the videos. In larger venules, 
rolling and adherent leucocytes can be visualised but, higher magnifications are needed, 
which often results in movement artefact. 
 
A number of semi-quantative scoring sytems exist to measure capillary density and flow. 
All the described measures were used in all studies to evaluate the sublingual 
microcirculation.  
 
1) Microvascular Flow Index (MFI) was calculated after dividing each image into four 
equal quadrants (figure 2.17). Quantification of flow was achieved using an ordinal scale 
(0: no flow, 1: intermittent flow, 2: sluggish flow, 3: normal flow) for small (<20µm) and 
large (>20µm) vessels. MFI is the average score of all quadrants for a given category of 
vessel size at a given time point. Images were recorded at a minimum of three sites at 
each time point giving a total of at least twelve quadrants for analysis.  
2) Vessel density is calculated by inserting a grid of three equidistant horizontal and 
three equidistant vertical lines over the image (Figure 2.18). Vessel density is equal to the 
number of vessels crossing these lines divided by their total length.  
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3) Flow is categorised as present, intermittent or absent to calculate the proportion of 
perfused vessels and thus the perfused vessel density.  
4) The heterogeneity index was introduced by Trzeciak and colleagues.95 This 
calculation involves evaluating the MFI in three to five sites and taking the difference 
between the highest MFI and lowest MFI in any quadrant and dividing by the mean MFI of 
all sublingual sites at the same timepoint.  
 
In each study, two observers evaluated the microcirculation videos. Inter-observer 
variability for analysis of the SDF images was assessed by calculating the Kappa 
coefficient (κ).278 
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Figure 2.17 Calculating Microvascular Flow Index (MFI). Video in quadrants for analysis of MFI 
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Figure 2.18 Calculating vessel density. Three equidistant horizontal and vertical lines overlying 
video for calculation of vessel density, proportion of perfused vessels and perfused vessel density. 
 
 
2.5 Serum and urine inflammatory markers 
Serum samples were taken at four timepoints in the randomised controlled trial of GDHT 
(see chapter 5). 4 ml of blood was collected from the patients arterial catheter after 
induction of anaesthesia but before surgery, at the end of surgery (hour 0), at the end of 
the eight hour intervention period (hour 8) and 24 hours following the end of surgery (hour 
24). Samples were collected into serum gel separator tubes (BD Biosciences) and left for 
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30-45 minutes at room temperature to ensure adequate clotting. The samples were 
subsequently centrifuged (Clinispin Horizon 853VES [Woodley Equipment Co Ltd]) at 
3000g for 10 minutes. The serum was then aliquoted into four eppendorf tubes (approx 
0.5ml) and immediately frozen at -80°C until required for analysis. 
 
The measurements of Interleukin (Il) 1-beta, Il-6, Il-8, Tumour Necrosis Factor-alpha (TNF-
α) and intercellular adhesion molecule -1 (ICAM-1) were performed using the Mesoscale 
Discovery Platform by SJ. This Multi-array ® and Multi-spot ® technology allows the 
detection of biomarkers in single and multiplex formats. The technique uses 
electrochemiluminescence detection using a trademarked molecule they term Sulfo-Tag TM 
(Ruthenium [II] tris-bipyridine-[4-mehylsulphonate] NHS ester). This label emits light upon 
electrochemical stimulation at the the electrode surfaces of multi-array ® microplates. 
Advantages of this electrochemiluminescence technique are : 
1) minimal background signals as the stimulation mechanism (electricity) is decoupled 
from the signal (light) in contrast to more traditional ELISA techniques 
2) emission at 620nm eliminates problems with colour quenching 
3) multiple excitation cycles of the label result in signal amplification and thus enhance 
light levels and improve sensitivity 
 
A 4-spot multiplex kit was used to measure Il-1beta, Il-6, Il-8 and TNFalpha. A single kit 
was used to measure changes in soluble ICAM-1. In brief, both protocols involved the 
following steps with variable incubation periods: 
 
1) Add Diluent / blocker to plate to prevent binding of analyte to any part of plate 
except capture antibody 
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2) Add calibrator (after serial dilution to produce normal curve) and sample in duplicate 
to wells according to pre-designed ‘map’ of 96 well plate 
3) Wash and add Sulfo-Taf Antibody to plates 
4) Wash and add read buffer 
5) Plates can be read on Sector 2400 (Mesoscale Discovery) 
 
The use of multiplex kits has been investigated with initial reports suggesting acceptable 
accuracy and precision.279 
 
 
 
 
Figure 2.19 Multiplex kit for cytokine analysis. Reproduced with permission from Meso Scale 
Discovery. 
 
2.6 Microalbuminuria  
Urine was collected aseptically into polypropylene test tubes from the urinary catheter of 
patients recruited to the GDHT trial. Urine samples were taken at four timepoints. T0 was 
after induction of anaesthesia but before surgery commenced. T1 was following surgery on 
admission to the critical care unit before the intervention commenced. T2 was at the end of 
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the eight hour intervention period. T3 was 24 hours following the end of surgery. Samples 
were placed in a -80 freezer within 15 minutes. Microalbuminuria was measured using 
immunoturbidimetric analysis with a Cobas tina-quant albumin reagent on the Roche / 
Hitachi modular P system. 
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Chapter 3 
Mortality and utilisation of critical care resources 
amongst high-risk surgical patients in a large NHS trust 
 
3.1 Introduction 
In a recent UK study of 4.1 million selected non-cardiac surgical procedures, a high-risk 
surgical population which accounted for only 12.5% of in-patient surgical procedures but 
more than 80% of post-operative deaths was identified.5 This study confirmed the 
suspicion that low overall post-operative mortality rates conceal the existence of a large 
sub-population of patients at much greater risk of post-operative complications and death. 
Another important finding of this analysis was that fewer than 15% of high-risk surgical 
patients were admitted to a critical care unit at any time following surgery. The small 
number of patients who did receive this level of care were discharged after a median of 
only 24 hours and subsequently lingered for many days on standard surgical wards 
(median [IQR] stay 16 [10-30] days). However, in this study more detailed analysis of 
critical care utilisation was not possible because not every critical care unit in the 
participating centres contributed data to the Intensive Care National Audit & Research 
Centre (ICNARC) database.  
 
Recent clinical trials suggest that substantial improvements in outcome may be achieved 
for high-risk surgical patients through the use of protocolised cardio-respiratory therapy 
delivered in a critical care setting.48,280 However, continued debate over both the size of 
the high-risk surgical population and the potential benefit of admitting such patients to 
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critical care represent important obstacles to the introduction of such approaches into 
routine practice.  
 
This study was designed to examine in more detail the role of critical care in the 
management of high-risk surgical patients in the United Kingdom (UK). We used methods 
similar to those employed in the previous National audit, but conducted the present study 
in a single institution, so that individual patient data could be cross-referenced using 
additional local databases and, where necessary, hospital notes. This analysis also 
provided an opportunity to confirm or refute the existence of a definable population of high-
risk surgical patients within the local surgical population prior to further work investigating 
the microvascular changes associated with surgery. The aim of this study was to identify 
patients undergoing selected high-risk non-cardiac surgical procedures within a large NHS 
Trust and describe critical care resource provision and utilisation for this population in 
relation to outcome.  
 
3.2 Methods 
The study was performed in a large NHS Trust incorporating two teaching hospitals which 
between them provide all major secondary and tertiary surgical services. This service 
evaluation was conducted with the approval of the local audit committee. One hospital has 
114 surgical beds with a thirteen bed intensive care unit that provides post-operative care 
for cardiac and other surgical patients as well as medical intensive care for oncology and 
HIV positive patients. The other hospital has 214 surgical beds with a sixteen bed 
intensive care unit that provides care for medical, non-cardiac surgical and neurosurgical 
patients and a six bed high dependency unit providing care for non-cardiac surgical 
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patients including a large number of patients admitted following traumatic injury. Using an 
analogous design to the previous national study 5, data was extracted from two databases. 
The local Hospital Episodes Statistics (HES) database is maintained by clerical coding 
staff and includes data on all clinical activity within the Trust.281 Validation is performed 
locally by Trust information managers. The intensive care audit database is maintained 
locally by dedicated intensive care audit staff and contributes data to the ICNARC case 
mix programme. These data are subject to local and central internal error checks.282 
 
Data were extracted on all adult (age ≥18 years) surgical admissions to hospital and to 
critical care between April 1st 2002 and March 31st 2005. All data relating to length of stay 
were calculated by subtracting the discharge date from the admission date. Surgical 
specialities with highly developed treatment pathways (often including critical care) such 
as cardiothoracic surgery and neurosurgery were excluded. Surgical specialities analysed 
included general and vascular surgery, orthopaedics, gynaecology, ear nose and throat, 
plastic surgery, urology, maxillofacial and oral surgery. Admissions involving endoscopy, 
day case surgery, cardio-thoracic surgery, neurosurgery, organ transplantation, obstetrics 
or the surgical management of burns were excluded. There are 6,920 surgical procedure 
codes in the Office of Population, Censuses and Surveys (OPCS) classification.283 
Surgical admissions to hospital were identified in the HES database by the presence of 
one of 4,910 codes that satisfied the inclusion criteria. Where more than one surgical 
procedure was performed during the same hospital admission, only the first procedure was 
included in the analysis. Several alternative OPCS codes may exist for any given 
procedure. In order to reduce bias arising from discrepancies in the coding process, 
procedures were categorised into elective (includes elective and scheduled cases 
according to ICNARC definition) and non-elective (includes urgent and emergency cases 
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according to ICNARC definition). Healthcare Resource Groups (HRG) are based on 
clinical similarity and resource homogeneity.283 The codes may specify the presence of a 
complicating medical condition, complexity of surgery or a particular age group. HRGs 
were then ranked according to mortality rates. High-risk surgical procedures were 
prospectively defined as those procedures included in a HRG with a mortality rate of 5% or 
more. The remaining procedures were classified as standard risk. Surgical admissions to 
critical care units were identified in the ICNARC database by source of admission, and 
were only included if the primary reason for admission was not an excluded surgical 
procedure. Critical care admissions were prospectively divided into admissions directly 
from the operating theatre and admissions to critical care following a period of post-
operative care on a standard ward. Data describing critical care resource use was verified 
through a manual check of individual patient details using the ICNARC database.  
  
Data are presented as median [IQR]. Categorical data were tested with Fisher’s exact test 
and continuous data with the unpaired t test with Welch’s correction. Analysis was 
performed using GraphPad Prism version 4.0 (GraphPad Software, San Diego, USA). 
Significance was set at p < 0.05. 
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3.3 Results 
3.3.1 Hospital admissions 
 
During the 36 months of the study, there were 26,051 hospital admissions involving one of 
the selected non-cardiac surgical procedures, with 390 (1.5%) deaths. The median age 
was 46 [32-63] years and 13,169 (50.6%) patients were male. There were 16,294 elective 
surgical admissions with 65 (0.4%) deaths and 9,757 non-elective surgical admissions with 
325 (3.3%) deaths in hospital. The duration of hospital stay was shorter for elective 
admissions when compared to non-elective admission (3 [2-7] days vs. 4 [2-12] days; 
p<0.0001). 
 
Out of 427 HRGs, 69 were associated with a mortality rate of 5% or greater. From these, 
2,414 (approximately 800 per annum) individual high-risk surgical procedures were 
identified with a total of 294 deaths (12.2%) (Figures 3.1 and 3.2). The high-risk surgical 
population accounted for 75.4% of deaths in hospital but only 9.3% of admissions. 
Complex or major surgery, advanced age, the presence of a complicating medical 
condition or a combination of these was specified by 40 (58%) of the 69 high-risk HRG 
codes compared to 119 (33%) of 358 standard-risk HRG codes. Although less than 10% of 
patients were classified as high-risk, this population utilised 46,138 in-patient bed days 
(23% of total in-patient bed days). 
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Figure 3.1 Standard and high risk populations of patients undergoing selected non-cardiac 
surgical procedures. Data presented as median [IQR] or absolute values (%). LOS: length of 
hospital stay. * denotes p<0.0001 between standard and high risk groups 
 
 
26,051 surgical 
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390 (1.50%) deaths 
 
High Risk 
 
2,414 (9.3%) patients 
294 (12.2%) deaths* 
age 67 [51-76] years* 
LOS 16 [9-30] days* 
 
Standard Risk 
 
23,637 (90.7%) patients 
96 (0.41%) deaths* 
age 44 [31-60] years* 
LOS 3 [2-6] days* 
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Figure 3.2 Population size and mortality rates for standard and high-risk general surgical 
patients. Standard-risk: patients undergoing a procedure with an overall mortality rate of less than 
5%. High-risk: patients undergoing a procedure with an overall mortality rate of 5% or more. 
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3.3.2 Critical Care admissions 
There were 1,627 surgical admissions to critical care which met the inclusion criteria with 
297 deaths (18.3%). Of these patients, 1,470 (90.4%) were admitted directly to critical care 
from the operating theatre. 214 patients were discharged prematurely from critical care 
because of bed shortages (defined according to ICNARC criteria) with 32 deaths (15.0%). 
Of the 297 patients who were admitted to critical care (either immediately postoperatively 
or subsequently) and later died, 188 (63.3%) did so after initial discharge from critical care. 
61 patients who were discharged from critical care were subsequently readmitted, of 
whom 23 (37.7%) died. 157 patients were admitted to critical care following an initial 
period of post-operative care on a standard ward, of whom 47 patients died (29.9%). The 
median duration of standard ward care for these patients was 2 [1-3] days for elective 
patients and 2 [1-7] days for emergency patients. 775 surgical patients classified by our 
criteria as standard risk were admitted to a critical care facility postoperatively (Figure 3.3). 
The overall mortality rate for these patients was 4.5%. Within this was a sub-group who 
were admitted to critical care after a period on a standard ward of whom 29 (21.2%) died; 
the duration of standard ward care for this sub-group was 2 [1-5] days. 
 
3.3.2.1 Critical Care resource utilisation by the high-risk surgical population 
Patients were classified as high-risk on the basis that they underwent a procedure with an 
overall mortality rate of 5% or greater. Only 852 of these high-risk patients were admitted 
to a critical care unit at any stage during their hospital admission (35.3% of the overall 
high-risk population) (Figure 3.4 and 3.5). Of the 294 high-risk patients who died, the 
median time from hospital admission to the first surgical intervention was 2 [1-3] days for 
elective patients and 3 [1-11] days for non-elective patients. The median time between 
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hospital admission and death was 16 [6-32] days for elective patients and 22 [7-43] days 
for non-elective patients. For those admitted to critical care, the median time between 
hospital admission and death was 28 [12-48] days compared to 15 [3-34] days for those 
not admitted to critical care. Only 144 (49.0%) high-risk patients who died were admitted to 
a critical care area at any stage during their admission and only 75 (25.6%) of these 
deaths occurred in a critical care area.  
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Figure  3.3. Sub-groups of the standard risk population of surgical patients. Data presented 
as median [IQR] or absolute values (%). 
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Figure  3.4 Sub-groups of the high-risk population of surgical patients. Data presented as 
median [IQR] or absolute values (%). LOS; length of hospital stay. 
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Figure 3.5 Number of patients from each population who were admitted to a critical care 
unit at any point following surgery. Standard-risk: patients undergoing a procedure with an 
overall mortality rate of less than 5%. High-risk: patients undergoing a procedure with an overall 
mortality rate of 5% or more. 
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3.4 Discussion 
 
The principal finding of this study is that, despite having an overall mortality of 12% and 
accounting for over 70% of postoperative deaths, only one third of high-risk surgical 
patients were admitted to critical care at any stage following surgery. Our findings suggest 
that the failure to admit such patients to critical care immediately after surgery contributes 
to the poor outcomes for the high-risk group as a whole. Premature discharge from, and 
the need to re-admit patients to critical care were both factors associated with a 
particularly high mortality rate. Similarly, mortality was high amongst the small number of  
patients admitted to intensive care following an initial period of postoperative care on a 
standard ward (30%). The median duration between surgery and critical care admission 
for this group was only two days. It seems likely that outcomes would be improved for 
these patients if they were admitted to critical care immediately after surgery to receive 
protocolised cardio-respiratory care. This approach seems to be very effective following 
cardiac surgery and provides the opportunity for use of additional interventions which may 
improve survival still further.48,280  Finally only 49% of the total population of high risk 
surgical patients who died were admitted to a critical care facility at any stage and only 
26% died in a critical care area. These observations indicate a failure to provide an 
appropriate level of care even to the highest risk patients. 
 
Whilst the number of high-risk patients admitted to a critical care unit in our institution 
(35%) compares favourably with the national study (15%),5 the findings of both studies 
clearly indicate that this resource is underprovided and/or underutilised. This conclusion is 
supported by the observation that postoperative critical care admission is routine for 
cardiac surgical patients, who have a high incidence of co-morbid disease and yet 
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undergo major surgery with an overall mortality rate in the UK of only 3.5%.284 Although in 
many instances limited resources prevent admission of high-risk surgical patients to critical 
care, it is unclear whether the lack of critical care facilities is compounded by clinicians’ 
underestimation of risk or doubts over the potential benefits of this facility. Whilst the 
mortality rate for standard risk patients admitted to critical care was significant (4.5%), 
suggesting clinicians are able to identify patients at greater risk, it is interesting to note that 
most such patients underwent elective surgery whilst our data suggest that it is the 
emergency surgical population that is in greatest need of critical care admission. This 
raises the possibility that involvement of a more senior clinician may be a key factor in the 
decision to admit a patient to critical care following surgery. 
 
The findings of this single centre study are consistent with published data describing the 
high-risk surgical population.7,8,285 The size and nature of the high-risk population in our 
institution is similar to that identified in the national UK study and although it might appear 
that a greater proportion of high risk surgical patients are admitted to a critical care area in 
our Trust, this observation may also be explained by an underestimate of critical care 
admissions in the national study.5 In keeping with the current study, reports from the 
National Confidential Enquiry into Peri-operative Deaths (NCEPOD) also describe 
advanced age, co-morbid disease, major and urgent surgery as the key characteristics of 
the high-risk patient.3,4 The high mortality rates and prolonged hospital stays described for 
high-risk patients in this study are also consistent with published data from Europe and 
North America.6,8 
 
The use of healthcare databases to test clinical hypotheses is associated with a number of 
important limitations. In particular, HES data may underestimate mortality rates because 
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the coding process is not designed to capture detailed mortality data.4,286 In the current 
analysis cross-referencing data describing individual patients between the two databases 
has allowed us to minimise this source of error. Ideally, prospective studies should be 
performed to evaluate this issue in more detail. Such a study would allow identification of 
the reasons underlying decisions regarding the allocation of critical care resources to 
individual patients. 
 
This study confirms that the high-risk surgical population accounts for the majority of post-
operative complications and deaths. Only around one third of such patients are admitted to 
a critical care unit at any stage after surgery. Where critical care admission does occur it is 
often for short periods, whilst the duration of hospital stay is prolonged. The allocation of 
additional critical care facilities to this population is likely to be a cost effective means of 
improving both short and long-term outcomes. 
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Chapter 4 
Microvascular flow and tissue oxygenation after major 
abdominal surgery: association with post-operative 
complications 
 
4.1 Introduction 
 
It is estimated that 234 million major surgical procedures are performed worldwide each 
year.1 Complications following major surgery are a leading cause of morbidity and 
mortality.3,4 High-risk surgical patients account for over 80% of deaths but only 12.5% of 
in-patient surgical procedures.5 In the UK, around 170,000 patients undergo high-risk 
surgical procedures each year, of whom 25,000 patients die and as many as 100,000 
develop complications.5 Even for those patients who survive to leave hospital, post-
operative complications remain an important determinant of long-term survival.8 It is 
essential, therefore, that efforts are made to improve outcomes following major surgery. 
 
The aetiology of post-operative complications is complex. Risk factors include advanced 
age, co-morbid disease and major and urgent surgery.5 A number of reports describe an 
association between derangements in global oxygen delivery (DO2I) or related parameters 
and poor outcome following major surgery.32,33,287 In several small studies, the use of fluid 
and inotropic therapy to enhance global oxygen delivery has led to a reduction in post-
operative complications.39,43,48 It has been suggested that the benefits of this approach are 
a result of improved tissue perfusion and oxygenation. Whilst unconfirmed, this hypothesis 
is consistent with the findings of a number of previous investigations. Surgical wound 
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infections are associated with reductions in tissue PO2 178 and may be prevented by the 
early use of supplemental inspired oxygen.170,179 The use of warming blankets to prevent 
peri-operative hypothermia may also reduce the incidence of wound infection, suggesting 
a pathophysiological process related to tissue perfusion.169,288 The findings of several 
studies suggest that reductions in microvascular blood flow during gastro-intestinal surgery 
may be associated with impaired anastomotic healing.96,100,162 However, a more detailed 
knowledge of the relationship between changes in global determinants of oxygen delivery 
and regional measures of tissue perfusion and oxygenation is required. The objective of 
this study was to describe the relationship between global oxygen delivery, tissue 
microvascular flow and oxygenation in high-risk patients receiving usual care who did and 
did not develop complications following major abdominal surgery. 
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4.2 Methods 
The study was approved by the Local Research Ethics Committee. Written informed 
consent was obtained prior to surgery. Patients admitted to a critical care unit following 
major elective abdominal surgery were eligible for recruitment. Exclusion criteria were 
refusal of consent, concurrent lithium therapy, acute myocardial ischaemia, acute 
arrhythmias, pregnancy, patients receiving palliative treatment only and weight less than 
40 kg. Patients were enrolled when a member of the research team was available. 
General anaesthesia was standardised to include intravenous fentanyl, propofol and 
atracurium for induction of anaesthesia and maintenance with inhaled isoflurane in oxygen 
enriched air alongside epidural analgesia. Clinical staff administered intravenous fluids, 
blood products and, if required, vasoactive drugs in order to maintain pulse rate, arterial 
pressure, central venous pressure, urine output, haematological and biochemical 
parameters within the normal range. Appropriate measures were taken to maintain SpO2 ≥ 
94%, haemoglobin above 8 g dl-1 and temperature at 37 °C. Following surgery, all patients 
were managed in a critical care unit. Additional fluid challenges and inotropic therapy were 
prescribed by clinical staff. Cardiac output data were made available when specifically 
requested by clinical staff. Patients did not, however, receive specific flow guided 
haemodynamic therapy in order to attain pre-determined values for stroke volume, cardiac 
index or global oxygen delivery.  
 
4.2.1 Measurements 
In addition to heart rate, mean arterial pressure and central venous pressure, cardiac 
output and DO2I were measured by lithium indicator dilution and arterial waveform analysis 
(LiDCOplus, LiDCO Ltd, Cambridge, UK).239 Arterial and central venous blood samples 
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were taken for analysis of blood gases, lactate and haemoglobin concentration (ABL 600 
and OSM3, Radiometer, Copenhagen, Denmark). Cutaneous tissue PtO2 was measured 
at two sites on the abdominal wall using a Clark electrode (TCM400, Radiometer, 
Copenhagen, Denmark). These probes are designed to warm the skin to 44 °C in order to 
minimise artefact due to local vasoconstriction. Cutaneous red blood cell flux was 
measured at two sites on the abdominal wall by laser Doppler flowmetry (Moorlab, Moor 
Instruments, Axminster, UK). Sublingual microvascular flow was evaluated using 
sidestream darkfield imaging with a x5 objective lens (Microscan, Microvision Medical, 
Amsterdam, Netherlands).59 Microvascular and tissue oxygenation data were obtained on 
the ward prior to surgery and all data were collected at two hour intervals after surgery for 
eight hours. Hour 0 refers to the time of admission to the critical care unit. Image 
acquisition and subsequent analysis was performed as described in Chapter 2. Analysis of 
the videos was performed by two observers (SJ and CL). The observers were blinded to 
all outcome and physiological data. Patients were followed up for 28 day in-hospital post-
operative complications (supplementary file), mortality, duration of hospital stay and the 
number of days patients were alive and free from critical in the first 28 days following 
admission. The major categories of complications were infectious, respiratory, 
cardiovascular, renal, neurological and gastrointestinal. 
 
4.2.2 Statistical Analysis 
For evaluating changes over time between groups, two-way repeated measures analysis 
of variance (ANOVA) was used. Post hoc t-tests were performed at the different time 
points using the Bonferroni correction for multiple testing. Analysis was performed using 
GraphPad Prism version 4.0 (GraphPad Software, San Diego, USA). Significance was set 
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at p < 0.05. The normality of data was evaulated using the D’Agostino-Pearson test. Data 
are presented as mean (SD) where normally distributed or median (IQR) where not 
normally distributed. Inter-observer variability for analysis of the SDF images was 
assessed by calculating the Kappa coefficient (κ).278 We did not perform a sample size 
calculation based on any single variable and instead elected prospectively to recruit 25 
patients. 
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4.3 Results 
Twenty five patients were recruited with a median age of 69 years (63-72). Patient 
characteristics, peri-operative haemodynamic management and outcome data are 
summarised in Tables 4.1 to 4.3. Two patients were mechanically ventilated after surgery. 
All other patients were extubated prior to critical care admission. Two patients died (8%) 
and 14 patients (56%) developed post-operative complications. The median time to first 
complication was 3 (2-6) days. Ten patients (40%) developed infectious complications 
(Table 4.4). Critical care (p<0.01) and hospital stay (p<0.001) were significantly longer in 
those patients who developed complications. There were no differences in PtO2, DO2I, 
ScvO2, cardiac index, heart rate, mean arterial pressure, serum lactate or cutaneous red 
cell flux between patients who did and did not develop complications. There was a small 
statistically significant difference in base deficit (Figure 4.1, 4.2 and 4.4 and Tables 4.5 
and 4.6). The inspired fractional concentration of oxygen after surgery at all time points 
was 0.4 (0.4-0.4). 
 
There was a significant difference in sublingual microvascular flow index (MFI) in small 
vessels (<20µm) after surgery between those patients who subsequently developed 
complications and those who did not (Figure 4.3 and Table 4.6). MFI for large vessels 
(>20µm) remained normal in all patients throughout the study period. Neither the total 
vessel density nor the small vessel (<20µm) density was significantly different between 
these groups. The proportion of perfused small vessels (<20µm) was significantly lower 
after surgery in those patients who developed complications. Perfused vessel density, a 
measure of functional capillary density, was also lower after surgery in patients who 
developed complications (Table 4.6). The density and proportion of perfused large vessels 
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(>20µm) were not significantly different between groups. We were only able to collect 
sublingual microvascular images prior to surgery in 14 patients. Despite this, MFI for small 
vessels (<20µm) was reduced in those patients who subsequently developed 
complications compared to those who did not (2.6 [2.5-2.9] vs 3.0 [3.0-3.0]; p<0.05). Large 
vessel MFI (>20µm) was 3.0 (3.0-3.0) in both groups. The kappa coefficient for inter-
observer reliability was 0.81 (95%CI 0.72-0.89). In one patient, it was not possible to 
obtain any SDF images due to painful oral mucositis related to chemotherapy. 
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 No complications 
(n=11) 
Complications 
(n=14) 
Age (years) 66 (63-72) 69 (64-73) 
Gender (%) 5 males (36%) 6 males (43%) 
P-POSSUM score 35 (31-37) 37.5 (33-43) 
History of ischaemic 
heart disease 7 (64%) 8 (57%) 
History of diabetes 
mellitus 4 (36%) 4 (29%) 
Upper gastrointestinal 
surgery (%) 4 (36%) 4 (29%) 
Pancreatic surgery (%) 3 (27%) 5 (36%) 
Lower gastrointestinal 
surgery (%) 3 (27%) 5 (36%) 
Open abdominal 
aneurysm repair (%) 1 (9%) 0 (0%) 
 
Table 4.1 Demographic characteristics of patients who did and did not develop 
complications after surgery. Data presented as median (IQR) or absolute values (%). P-POSSUM: 
Physiological and operative severity score for the enumeration of mortality score. 
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 No complications 
(n=11) 
Complications 
(n=14) 
Intra-venous crystalloid 
during surgery  (ml) 3750 (2125-4750) 4000 (2625-5375) 
Intravenous collod during 
surgery 500 (0-1000) 1000 (1000-1000) 
Total intravenous fluid 
during surgery  (ml) 4500 (3250-5000) 5375 (3500-6500) 
Intravenous crystalloid 
during study period (ml) 1000 (1000-1150) 1050 (844-1206) 
Intravenous colloid during 
study period (ml) 0 (0-500) 500 (0-1000) 
Total intravenous fluid 
during study period (ml) 1250 (1000-1650) 1250 (1100-2200) 
Number of patients 
receiving vasopressor 
therapy (%) 
2 (18%) 4 (29%) 
Number of patients 
receiving epidural 
analgesia (%) 
10 (91%) 13 (93%) 
 
Table 4.2 Data describing intra- and post-operative management for patients who did and 
did not develop complications after surgery. Data presented as median (IQR) or absolute  
values (%). 
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 No complications 
(n=11) 
Complications 
(n=14) 
28 day alive and critical 
care free days 27 (26-27) 24 (22-26)* 
Duration of hospital stay 
(days) 8 (8-9.5) 20 (14-26)** 
Mortality (%) 0 (0%) 2 (14.3%) 
 
Table 4.3 Outcome data for patients who did and did not develop complications after 
surgery. Data presented as median (IQR) or absolute values (%). *p<0.01, **p<0.001. 
 
 
 
Primary Complication Number of patients 
Infectious 10 
Cardiovascular 1 
Respiratory 1 
Gastrointestinal 2 
Neurological 0 
 
Table 4.4. Frequency of complications following surgery. Fourteen patients developed 
complications in total. 
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Hour 0 Hour 2 Hour 4 Hour 6 Hour 8 
Complications 70 (15) 75 (19) 73 (15) 73 (15) 66 (5) 
Heart rate 
(bpm) 
No complications 78 (17) 76 (17) 73 (16) 74 (15) 75 (15) 
Complications 77 (13) 79 (13) 76 (17) 74 (10) 75 (12) 
MAP (mmHg) 
No complications 89 (15) 78 (14) 79 (17) 78 (17) 75 (16) 
Complications 7 (4) 7 (4) 6 (2) 8 (7) 9 (6) 
CVP (mmHg) 
No complications 7 (3) 6 (4) 7 (5) 6 (4) 6 (3) 
Complications 2.9 (0.9) 3.0 (0.9) 2.9 (0.9) 2.9 (0.8) 2.7 (0.7) 
Cardiac index 
(l min-1 m-2) 
No complications 2.8 (0.7) 2.9 (0.8) 2.8 (0.8) 2.7 (0.9) 2.8 (0.9) 
Complications 373 (102) 394 (103) 379 (98) 384 (124) 345 (87) 
DO2I 
(ml min-1 m-2) 
No complications 361 (55) 379 (106) 361 (104) 356 (115) 369 (111) 
Complications 71 (11) 73 (9) 73 (9) 72 (9) 68 (7) 
ScvO2 (%) 
No complications 68 (9) 70 (8) 68 (6) 69 (8) 72 (7) 
Complications 1.2 (0.9-2.0) 
1.2 
(0.9-2.0) 
1.2 
(0.8-2.1) 
1.3 
(0.9-2.5) 
1.3 
(0.8-1.4) Serum lactate 
(mmol l-1) 
No complications 1.4  (1.2-1.7) 
1.0  
(0.9-1.2) 
1.1  
(0.9-1.2) 
1.0  
(0.8-1.6) 
1.1  
(1.0-1.7) 
Complications* 2.6 (2.6) 3.3 (3.1) 3.0 (3.3) 3.8 (4.6) 2.3 (1.5) 
Base deficit 
(mmol l-1) 
No complications 2.1 (2.7) 1.6 (1.9) 1.0 (2.1) 1.1 (2.1) 0.9 (2.3) 
 
Table 4.5 Cardiovascular physiology during eight hour study period. Data presented as mean 
(SD) or median (IQR). MAP: mean arterial pressure; CVP: central venous pressure; DO2I: oxygen 
delivery index; ScvO2: central venous oxygen saturation. * denotes p<0.01 between groups over time 
(two-way repeated measures ANOVA). 
 111 
Heart rate
0 2 4 6 8
60
70
80
90
hours
H
e
a
r
t
 
r
a
t
e
 
(
b
p
m
)
Mean arterial pressure
0 2 4 6 8
60
70
80
90
100
hours
M
A
P
 
(
m
m
H
g
)
Central venous pressure
0 2 4 6 8
4
6
8
10
12
hours
C
V
P
 
(
m
m
H
g
)
Cardiac Index
0 2 4 6 8
2.25
2.50
2.75
3.00
3.25
3.50
hours
C
I
 
(
L
/
m
i
n
/
m
2
)
Oxygen delivery index
0 2 4 6 8
300
325
350
375
400
425
450
hours
D
O
2
I
 
(
m
l
/
m
i
n
/
m
2
)
Central venous oxygen saturations
0 2 4 6 8
60
65
70
75
80
hours
S
c
v
O
2
 
(
%
)
 
 
Figure 4.1. Global haemodynamics during eight hour study period. Data presented as mean (SEM). MAP: mean arterial pressure; CVP: 
central venous pressure. No significant difference between groups (two way repeated measures ANOVA).  
Blue : complications, Red : no complications. 
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Figure 4.2. Markers of tissue perfusion during eight hour study period. Data presented as mean (SEM) or median (IQR). 
* denotes p<0.01 between groups over time (two way repeated measures ANOVA). 
Blue : complications, Red : no complications. 
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Figure 4.3 Sublingual microvascular flow index (MFI) of small vessels (<20µm) in patients who did and did not develop 
complications. Data presented as median (IQR). p<0.0001 between groups over time (two-way repeated measures ANOVA). * p<0.01 between 
groups at this timepoint (post-hoc t-test with Bonferroni correction) 
Blue : complications, Red : no complications. 
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Pre-op Hour 0 Hour 2 Hour 4 Hour 6 Hour 8 
Complications** 2.6 (2.5-2.9) 
2.5 
(1.9-2.8) 
2.0 † 
(1.8-2.4) 
2.5 
(2.3-2.9) 
2.3 
(2.0-2.7) 
2.7 
(1.9-2.9) 
Microvascular 
Flow Index 
No complications 3.0 (3.0-3.0) 
2.5 
(2.4-2.8) 
2.8 
(2.6-3.0) 
2.8 
(2.3-3.0) 
2.8 
(2.6-3.0) 
2.6 
(2.3-2.9) 
Complications 6.8 (5.5-7.8) 
6.5 
(5.8-7.4) 
6.1 
(4.6-7.3) 
6.9 
(6.2-7.4) 
6.3 
(4.6-7.0) 
6.8 
(5.1-7.5) Small vessel 
density 
mm-1 
No complications 5.9 (5.7-6.5) 
6.3 
(5.3-8.2) 
6.7 
(6.0-7.4) 
6.2 
(5.3-8.0) 
6.6 
(5.9-7.6) 
7.0  
(6.5-7.5) 
Complications* 79 (73-92) 
74 
(61-90) 
64 
(45-80) 
67 
(58-85) 
75 
(60-83) 
87  
(78-100) Proportion of 
perfused small 
vessels (%) 
No complications 89 (83-95) 
80 
(61-93) 
86 
(72-99) 
86 
(57-93) 
90 
(78-97) 
95 
(83-97) 
Complications* 5.7 (4.1-6.9) 
4.5 
(3.8-6.2) 
3.8 
(3.0-4.4) 
4.9 
(4.0-5.5) 
4.1 
(3.1-6.2) 
6.3 
(3.7-6.8) Perfused small 
vessel density 
mm-1 
No complications 5.6 (4.8-5.8) 
4.9 
(3.6-6.3) 
5.8 
(4.3-6.6) 
5.1 
(3.5-6.3) 
5.7 
(5.1-7.2) 
6.6 
(5.2-7.3) 
Complications 0.09 (0.0-0.50) 
0.13 
(0.0-0.3) 
0.25 
(0.07-
0.47) 
0.21 
(0.0-0.44) 
0.10 
(0.0-0.54) 
0.32 
(0.09-
0.35) Heterogeneity 
Index 
No complications 0.0 (0.0-0.0) 
0.25 
(0.09-
0.25) 
0.11 
(0.0-0.28) 
0.18 
(0.0-0.32) 
0.18 
(0.04-
0.25) 
0.09 
(0.0-0.26) 
Complications 30 (19-40) 
38 
(28-43) 
28 
(21-38) 
37 
(26-44) 
34 
(25-46) 
31 
(24-55) 
Red cell flux 
(arbitrary units) 
No complications 33 (22-41) 
34 
(26-64) 
32 
(19-55) 
35 
(30-60) 
31 
(19-40) 
41 
(27-66) 
 
Table 4.6 Sublingual small (<20µm) vessel density and red cell flux. Data presented as mean 
(SD) or median (IQR).**p<0.001 and *p<0.01 between groups over time (two-way repeated measures 
ANOVA).  † p<0.01 between groups at this time point (post-hoc t-test with Bonferroni correction). 
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Figure 4.4. Red cell flux of the abdominal wall assessed by laser Doppler flowmetry in those 
patients who did and did not develop complications. 
Blue : complications, Red : no complications. 
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Figure 4.5. Arterial and tissue oxygenation during eight hour study period. Data presented as mean (SD). PaO2: partial pressure of 
oxygen in arterial blood; PtO2: partial pressure of oxygen in tissues. No significant difference between groups (two way repeated measures 
ANOVA). 
Blue : complications, Red : no complications. 
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4.4 Discussion 
The principle finding of this study is that, in a group of patients, receiving usual care, with 
low global oxygen delivery following major abdominal surgery, impairment of 
microvascular flow was more marked in those patients who developed complications. 
Importantly, this difference in microvascular flow was present even before surgery. 
Although the incidence of complications was high, there were no associated differences in 
global oxygen delivery, cutaneous red cell flux or tissue oxygenation between patients who 
did and did not develop complications. These data suggest that impairment of 
microvascular flow may play an important role in the evolution of complications after 
abdominal surgery. Further research is required to confirm these findings and to 
investigate this area in more detail. 
 
A number of investigators have described abnormalities in gastro-intestinal total red blood 
cell flux (laser Doppler flowmetry) in patients who develop post-operative 
complications.96,100,162 This reduction in mucosal blood flow has been associated with an 
increased incidence of anastomotic breakdown following both oesophagectomy and 
colorectal surgery.96,162 Although oesophageal anastomotic flow has been shown to 
improve following the topical application of nitroglycerin,163 this effect was not observed 
with intravenous infusions of either prostaglandin E1  or nitroglycerin.162,164 We are not, 
however, aware of any previous reports of cutaneous red cell flux following gastro-
intestinal surgery. In a recent investigation, Boerma and colleagues did not identify any 
heterogeneity of microvascular flow in colonic stoma within 24 hours of elective colo-rectal 
surgery.99 Sublingual microvascular flow was not reported, although it seems likely that the 
findings would have been similar. There are several reasons why these previous findings 
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in non-septic patients contrast with those of the current study. We identified abnormalities 
of microvascular flow that were most evident in the early post-operative phase and 
appeared to be returning to normal by eight hours. In the previous study, stomal 
microvascular flow was evaluated only once in the first 24 hours after surgery and possibly 
at variable time points. Early changes in microvascular flow may have therefore been 
missed. Perhaps more importantly, we specifically recruited a high-risk group of patients 
undergoing complex surgery who were deemed to require post-operative critical care 
admission, whereas patients in the previous study were all admitted to a standard surgical 
ward. The finding of impaired sublingual microvascular flow prior to surgery in those 
patients who subsequently developed complications was unexpected. This observation 
may have related to mild hypovolaemia or to the underlying diagnosis (cancer in almost all 
cases) but does not appear to have resulted from diabetes or other co-morbid disease. 
Importantly, microvascular indices continued to deteriorate during and after surgery and 
appeared to be returning to normal by eight hours after surgery. Further work in a larger 
group of patients is required to confirm these findings and to explore the underlying 
explanation in more detail.  
 
Reductions in PtO2 have previously been associated with an increased incidence of post-
operative wound infection.178 Furthermore, peri-operative supplemental inspired 
oxygen,170,179 and therapies to increase global oxygen delivery seem to decrease the 
incidence of wound infections.31,32 Supplemental oxygen may also improve colonic 
anastomotic PtO2 in pigs.289 It is not clear why we did not identify any differences, in either 
cutaneous tissue oxygenation or DO2I between patients who did and did not develop 
complications. In the current study, cutaneous PtO2 was considerably greater than 
previously reported (10 ±3 kPa vs 6.5 ±1.5 kPa),178 perhaps reflecting the routine use of 
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supplemental oxygen in the current investigation whereas in the previous study patients 
only received supplemental oxygen if SpO2 decreased to less than 90%. In addition, in the 
current study every patient received epidural analgesia which may also improve abdominal 
wall cutaneous oxygenation.188,290 These differences may also relate to the use of a 
cutaneous Clark electrode which warms the skin in order to minimise artefact due to local 
vasoconstriction as opposed to a subcutaneous catheter. However, PtO2 values in the 
current study were similar to those previously measured using a subcutaneous catheter in 
patients receiving 40% oxygen after abdominal surgery.291 
 
Sublingual sidestream darkfield imaging is a valuable technique which allows real time 
imaging of the intact microcirculation in the clinical environment. Whilst not as versatile as 
laser Doppler flowmetry, the capacity to explore heterogeneity of flow in vessels of 
different sizes has allowed important advances in our understanding of the microcirculation 
in critical illness.59 However, this technique remains semi-quantitative and data reliability 
may be affected by technical expertise and inter-observer bias. It is uncertain to what 
extent sublingual microvascular flow correlates with that in other vascular beds.99,274 We 
used the two-way repeated measures ANOVA test to evaluate changes over the entire 
course of the study rather than at individual time points. Whilst significant differences were 
identified in three measures of microvascular flow (MFI, proportion of perfused vessels and 
perfused vessel density), more stringent post-hoc testing identified a difference at only one 
time point. It seems likely that this relates to the small sample size. A larger study is 
therefore required to confirm these important preliminary findings and to evaluate this 
subject in more detail. 
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In summary, we have identified an impairment of sublingual microvascular flow in patients 
who developed complications both prior to and following major abdominal surgery. 
However, there were no related differences in cutaneous red cell flux, PtO2 or global 
oxygen delivery. The findings of previous studies suggest that vasoactive agents may 
improve sublingual microvascular flow in septic patients.15,156,274 Further investigations are 
indicated to confirm our findings and to evaluate the effects of haemodynamic 
interventions and vasoactive agents on tissue microvascular flow and oxygenation 
following major surgery. 
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Chapter 5 
Haemodynamic optimisation improves tissue 
microvascular flow and oxygenation after major 
surgery: a randomised controlled trial 
 
5.1 Introduction 
 
Complications are common following major non-cardiac surgery and represent an 
important cause of avoidable morbidity and mortality.4,5 Estimates suggest that as many 
as 234 million major surgical procedures are performed worldwide each year, around 15% 
of which fall into a high-risk sub-group.1,5 With mortality rates of up to 12%, this high-risk 
surgical population accounts for over 80% of early post-operative deaths.5 Long-term 
survival is also significantly reduced following surgery, in particular for those patients who 
develop complications.8,292,293 Importantly, survival amongst patients who develop post-
operative complications varies widely between hospitals, confirming both the potential and 
the need to improve clinical outcomes in this population.7 
 
The association between low cardiac output, inadequate global oxygen delivery (DO2), 
reduced venous oxygen saturation (SvO2 and ScvO2) and poor outcomes following major 
surgery is well recognised.32,33,287 In several small studies, the use of these variables as 
treatment end-points for intra-venous fluid and inotropic therapy has been associated with 
improved clinical outcomes.39,40,294,295 It has long been suggested that these beneficial 
effects relate to improved tissue perfusion and oxygenation. This may prevent the 
evolution of a tissue ‘oxygen debt’ and hence reduce the incidence of complications and 
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organ dysfunction.296 This theory is consistent with the findings of a number of studies 
demonstrating that impaired tissue microvascular flow and oxygenation are associated 
with subsequent post-operative complications.96,100,162,178 In patients with severe sepsis, 
there is some evidence to suggest that abnormalities of microvascular flow may cause 
tissue hypoxia,84,297 whilst the use of vasoactive drug therapy has been shown to improve 
tissue microvascular flow in this group.15 Importantly, dopexamine, the agent most often 
used in trials of perioperative cardiac output guided therapies, has a combination of 
vasodilator and mild inotropic actions which may enhance microvascular flow and improve 
outcomes.294 The findings of recent systematic reviews suggest that cardiac output guided 
haemodynamic therapy may have particular beneficial effects on splanchnic perfusion and 
renal function.49,298 It is also possible that perioperative haemodynamic optimisation could 
favourably influence the systemic inflammatory response to tissue injury associated with 
surgery, thereby reducing the incidence and severity of complications and organ 
dysfunction. 
 
Clearly, the hypothesis that peri-operative cardiac output guided haemodynamic therapies 
result in improved tissue microvascular flow and oxygenation is plausible but, after many 
years, still remains untested. It is also uncertain whether low dose inotropic therapy offers 
incremental benefit over the use of fluid alone to achieve cardiac output related end-
points. A detailed understanding of the physiological effects of haemodynamic therapies is 
therefore necessary to provide a rational basis from which to adapt and refine their use in 
clinical practice. The aim of this investigation was to evaluate the effects of stroke volume 
guided intra-venous fluid therapy with and without low dose dopexamine on tissue 
microvascular flow and oxygenation and systemic markers of inflammation in patients 
admitted to critical care following major gastrointestinal surgery.  
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5.2 Methods 
Patients scheduled for admission to critical care following major elective gastrointestinal 
surgery were eligible for recruitment. Exclusion criteria were refusal of consent, pregnancy, 
patients receiving palliative treatment only and acute arrhythmias or myocardial ischaemia 
prior to enrolment. In addition, patients receiving lithium therapy or those with a body mass 
less than 40 kg were excluded because lithium indicator dilution measurement of cardiac 
output is not licensed in such patients. The study was approved by the Research Ethics 
Committee and Medical and Healthcare products Regulatory Agency. Written informed 
consent was obtained from all patients prior to surgery. Participants were randomly 
allocated to one of three treatment groups by computer generated random sequence in 
blocks of nine. Blocking was used to ensure that treatment groups were generated of 
equal size. Type of surgery is likely to be a confounder and therefore, groups were 
stratified according to surgical procedure (upper gastrointestinal surgery, lower 
gastrointestinal surgery and pancreatic surgery involving the gut).  Study group allocations 
were placed in serially numbered opaque envelopes.  
 
5.2.1 Clinical management 
General anaesthesia was standardised and included intra-venous fentanyl, propofol and 
atracurium for induction of anaesthesia and maintenance with inhaled isoflurane in oxygen 
enriched air and epidural analgesia. Clinical staff administered intra-venous fluids, blood 
products and, if required, vasoactive drugs in order to maintain routine physiological, 
haematological and biochemical parameters within normal ranges as follows: pulse rate 
(60-100 bpm), mean arterial pressure (60-100 mmHg), central venous pressure (CVP) (6-
12 mmHg), urine output (>25 ml/hr), haemoglobin (> 8 g dl-1), SpO2 (>94%), temperature 
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(36-37 °C), serum base excess (-2 - +2 mmol/l) and PaCO2 (35-45 mmHg). Cardiac output 
monitoring was not used during surgery. Following surgery, all patients were admitted to 
critical care. For the eight hour intervention period, either a doctor (SJ) or nurse (AVS, SLA 
– see acknowledgements) administered one of three allocated haemodynamic protocols 
as described below. These protocols are similar to those used in a previous trial.48 
CVP group: Intra-venous lactated Ringer’s solution was administered at 1 ml/kg/hr for 
maintenance requirements. Patients received additional 250 ml fluid challenges with intra-
venous colloid solution (Gelofusine, BBraun, Germany) to achieve an optimal value of 
CVP. Colloid solution was administered in one or more rapid boluses to achieve a 
sustained rise in CVP of at least 2 mmHg for 20 minutes or more. If CVP decreased, fluid 
challenges were repeated to establish whether the patient was fluid responsive. 
SV group: Intra-venous lactated Ringer’s solution was administered at 1 ml/kg/hr. Patients 
received additional 250 ml fluid challenges with intra-venous colloid solution to achieve an 
optimal value of stroke volume. Colloid solution was administered in one or more rapid 
boluses to identify whether the patient was fluid responsive. A stroke volume response to 
fluid was defined as a sustained rise in stroke volume of at least 10% for 20 minutes or 
more. Where a patient was identified as stroke volume responsive to fluid, further 250 ml 
boluses of fluid were administered until a plateau value was achieved. If stroke volume 
decreased, fluid challenges were repeated to establish whether the patient was fluid 
responsive. 
SV & DPX group: Intra-venous lactated Ringer’s solution was administered at 1 ml/kg/hr. 
Patients received additional fluid challenges with colloid solution to achieve an optimal 
value of stroke volume in an identical fashion to patients in the SV group. In addition, a 
continuous intra-venous infusion of dopexamine was administered at 0.5 µg kg-1 min-1 
(Cephalon Inc, USA). This infusion rate was not adjusted to achieve a specific value for 
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cardiac output or DO2I but was decreased or discontinued in patients with evidence of 
myocardial ischaemia or tachycardia (>100bpm or increase >20% from baseline value, 
whichever was greater).  
 
Only the member of the research team who delivered the intervention was aware of study 
group allocation. Cardiac output data were made available to clinical staff only on specific 
request. The reasons for this and any subsequent changes in treatment were documented 
by research staff. Dummy infusions were used in patients not allocated to receive 
dopexamine. All other management decisions were taken by clinical staff. 
 
5.2.2 Sublingual microvascular flow 
Sublingual microvascular flow was evaluated before surgery and at 0, 2, 4, 6 and 8 hours 
immediately after surgery using sidestream darkfield (SDF) imaging with a x5 objective 
lens (Microscan, Microvision Medical, Amsterdam, Netherlands).299 Image acquisition and 
subsequent analysis was performed as described in Chapter 2. Analysis of the videos was 
performed by two observers (AVS and SLA). The Kappa coefficient (κ) for inter-observer 
variability in SDF image analysis was 0.74 (95%CI 0.61-0.81).  
 
5.2.3 Cutaneous microvascular flow and PtO2 
Cutaneous red blood cell flux was measured before surgery and at 0, 4 and 8 hours after 
surgery at two sites on the forearm by laser Doppler flowmetry (Moorlab, Moor 
Instruments, Axminster, UK). Baseline red cell flux on the forearm was measured and 
following this, the post-occlusive hyperaemic response was examined by inflating a cuff 
around the upper arm to 20 mmHg above systolic pressure for three minutes and 
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measuring the changes in red cell flux on releasing the pressure in the cuff. The difference 
between baseline flux and peak hyperaemia was then evaluated at each time point. 
Cutaneous tissue PtO2 was measured before surgery and at 0, 2, 4, 6 and 8 hours after 
surgery at two sites on the abdominal wall using a Clark electrode (TCM400, Radiometer, 
Copenhagen, Denmark).  
 
5.2.4 Arterial and venous blood gas analysis 
Arterial and central venous blood samples were taken at 0, 2, 4, 6 and 8 hours after 
surgery from indwelling catheters for analysis of SaO2, ScvO2, base deficit and serum 
lactate (ABL600, Radiometer, Copenhagen, Denmark). 
 
5.2.5 Serum inflammatory markers 
Serum samples were obtained from all patients following induction of anaesthesia but prior 
to surgery. Further serum samples were obtained immediately following surgery, at the 
end of the intervention period and 24 hours after the end of surgery. These samples were 
centrifuged at 3000g for 10 minutes and stored at -80°C. Subsequent analysis of 
interleukin 1β (Il-1β), Il-6, Il-8, and tumour necrosis factor α (TNF-α) was performed using 
a multi-array electro-chemiluminescence technique (SECTOR Imager 2400, Mesoscale 
Discovery, USA) by SJ. Levels of soluble inter-cellular adhesion molecule 1 (ICAM-1) were 
quantified using a similar technique.  
 
5.2.6 Clinical follow-up 
Clinical outcomes data for each patient were collected by a member of the research team 
who was unaware of study group allocation and then verified by the senior investigator 
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who was also unaware of the study group allocation. Patients were prospectively followed 
for 28 days for pre-defined in-hospital complications, mortality and duration of hospital 
stay. 
 
5.2.7 Statistical Analysis 
Assuming a 5% type I error rate and an 80% type II error rate for the sample size 
calculation, it was calculated that 45 patients would be required in each group to detect a 
10 mmHg difference in PtO2 between each of the intervention groups and the control 
group.  
 
Trends in physiological variables over time within groups were tested using one way 
repeated measures analysis of variance (ANOVA) or Friedmann test. Differences in 
physiological variables between groups were tested using two way repeated measures 
ANOVA, the t-test and one way ANOVA with post hoc t-test with Bonferroni correction. 
Categorical variables were tested with the Chi squared or Fisher’s exact tests. Statistical 
analysis was performed using GraphPad Prism version 4.0 (GraphPad Software, USA). 
Analysis was performed on an intention-to-treat basis including all randomised patients. 
Significance was set at p<0.05. Data are presented as mean (SD) where normally 
distributed or median (IQR) where not normally distributed.  
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5.3 Results 
One hundred and thirty five patients were recruited between December 2007 and 
February 2009 (Figure 1). Baseline patient characteristics are presented in table 5.1. 
Despite the different haemodynamic treatment algorithms, patients in the three groups 
received similar volumes of fluid during and after surgery and there were no differences in 
vasopressor requirements (table 5.2). There was no difference in the timing of fluid given. 
The number of patients who received transfused blood during and after surgery was 
similar between the groups as was the volume of blood transfused (CVP group: 19 
patients, 870 (580-1408) ml; SV group: 12 patients, 561 (398-580) ml; SV & DPX group: 
15 patients, 580 (300-877) ml; p=0.11). One patient randomised to the SV & DPX group 
developed myocardial ischemia during surgery and, in accordance with the study protocol, 
did not receive dopexamine. In five patients the dose of dopexamine was reduced 
because of an increase in heart rate and in one patient, dopexamine was subsequently 
discontinued. On only one occasion, a clinician asked to view a patient’s cardiac output 
data because of concern that poor cardiac function might have been complicated by 
pulmonary oedema. This information did not prompt any changes in treatment. No 
patients received additional inotropic therapy during the intervention period.  
Stroke volume guided fluid therapy with dopexamine infusion was associated with 
significant increases in heart rate, cardiac index, DO2 and ScvO2. Stroke volume guided 
fluid therapy alone was associated with much smaller increases in cardiac index and DO2 
and no change in heart rate or ScvO2 (figure 5.2 and table 5.3). Sublingual large vessel 
MFI (>20µm) was 3.0 (3.0-3.0) in all groups suggesting good quality image capture 
unaffected by pressure artefact. In all three groups, microvascular flow was impaired at 
baseline (table 5.4). In the SV & DPX group, sublingual microvascular flow significantly 
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improved during the eight hour study period (figure 5.3 and table 5.4). Sublingual 
microvascular flow remained constant in the SV group but deteriorated in the control 
group (figure 5.3). Similarly, there was a significant improvement in the cutaneous 
hyperaemic response in the SV & DPX group, whereas this variable remained unchanged 
in the SV group and deteriorated in the control group (figure 5.3). In all three groups, 
cutaneous PtO2 initially increased after surgery. This improvement was sustained in the 
SV & DPX group but decreased towards baseline in the CVP and SV groups (figure 5.4). 
There were no significant differences in overall complication rates, critical care free days 
or duration of hospital stay, although the pattern of mortality was consistent with a 
beneficial effect of stroke volume guided haemodynamic therapy (table 5.5). Despite 
improvements in tissue microvascular flow and oxygenation in the SV and SV & DPX 
groups, there were no differences between the groups in terms of the serum inflammatory 
markers Il-1β, Il-6, Il-8, TNFα and ICAM-1 within 24 hours of surgery (figure 5.5). 
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Figure 5.1 CONSORT diagram; flow of patients through trial. *One patient randomised to the 
SV & DPX group developed myocardial ischemia during surgery (before the trial intervention 
commenced) and in accordance with the protocol, did not receive dopexamine. 
 
 
 
 
382 patients assessed for eligibility 
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26 did not undergo surgery as planned 
11 research staff unavailable 
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 CVP group 
n=45 
SV group 
n=45 
SV & DPX group 
n=45 
Age (years) 70 (64-78) 68 (59-77) 65 (59-74) 
Male (%) 30 (67%) 31 (69%) 28 (62%) 
ASA score 2 (2-3) 2 (2-3) 2 (2-3) 
Upper gastrointestinal 
surgery (%) 18 (40%) 18 (40%) 18 (40%) 
Pancreatic surgery 
involving gut (%) 18 (40%) 18 (40%) 18 (40%) 
Lower gastrointestinal 
surgery (%) 9 (20%) 9 (20%) 9 (20%) 
 
Table 5.1. Patient characteristics at baseline. Data presented as median (IQR) or absolute values 
(%). ASA score : American Society of anesthesiologists physical status classification system 
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CVP group 
n=45 
SV group 
n=45 
SV & DPX group 
n=45 
p 
Intra-operative period 
Intra-venous crystalloid 
during surgery (ml) 3595 (1354) 4057 (1495) 4159 (1393) 0.15 
Intra-venous colloid 
during surgery (ml) 756 (815) 835 (688) 709 (559) 0.69 
Intervention period 
Intra-venous crystalloid 
during study period (ml) 639 (281) 652 (237) 626 (250) 0.98 
Intra-venous colloid 
during study period (ml) 1104 (553) 1227 (555) 1307 (549) 0.22 
Patients receiving 
vasopressor therapy (%) 7 (16%) 8 (18%) 5 (11%) 0.82 
 
Table 5.2. Volume of intra-venous fluid administered and use of vasopressor therapy in the 
three groups. Data presented as mean (SD) or absolute values (%).  
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 Group Hour 0 Hour 2 Hour 4 Hour 6 Hour 8 
CVP 74 (13) 76 (14) 76 (14) 76 (15) 76 (15) 
SV 77 (19) 76 (17) 80 (19) 79 (17) 78 (17) 
Heart rate 
(bpm) 
§ SV & DPX 77 (11) 86 (12) 91 (12) 93 (13) 92 (12) 
CVP 80 (22) 79 (20) 79 (15) 79 (15) 77 (14) 
SV 76 (15) 81 (15) 83 (14) 79 (14) 77 (14) 
Mean arterial 
pressure (mmHg) 
† SV & DPX 80 (18) 83 (17) 84 (13) 77 (13) 74 (12) 
‡ CVP 6 (5) 7 (5) 7 (5) 8 (5) 8 (5) 
* SV 4 (5) 6(4) 6 (5) 7 (4) 7 (5) 
Central venous 
pressure (mmHg) 
† SV & DPX 5 (4) 7 (4) 7 (4) 8 (6) 8 (5) 
CVP 3.5 (1.1) 3.5 (0.9) 3.5 (0.9) 3.5 (0.9) 3.4 (0.9) 
‡ SV 3.2 (0.9) 3.5 (0.9) 3.7 (1.0) 3.7 (1.0) 3.6 (1.0) 
Cardiac index 
(l/min/m2) 
§ SV & DPX 3.3 (0.8) 4.0 (0.9) 4.3 (1.0) 4.3 (0.9) 4.4 (1.1) 
CVP 477 (146) 490 (144) 480 (152) 468 (168) 467 (159) 
† SV 449 (145) 492 (160) 495 (147) 499 (165) 484 (150) 
Oxygen delivery 
index 
(ml/min/m2) § SV & DPX 498 (157) 594 (167) 635 (198) 631 (174) 614 (209) 
CVP 80 (23) 86 (25) 84 (24) 82 (21) 81 (21) 
‡ SV 78 (23) 85 (22) 84 (22) 85 (22) 83 (22) 
Stroke volume 
(ml) 
‡ SV & DPX 80 (23) 88 (24) 90 (24) 89 (23) 88 (26) 
† CVP 1.4 (1.0-2.1) 1.1 (0.9-1.6) 1.1 (0.9-1.8) 1.2 (0.9-1.8) 1.2 (0.9-1.8) 
* SV 1.4 (0.9-2.7) 1.3 (0.9-2.2) 1.3 (0.8-2.4) 1.2 (0.8-1.9) 1.2 (0.8-1.8) 
Serum lactate 
(mmol/l)  
SV & DPX 1.9 (1.3-2.8) 1.7 (1.0-2.4) 1.9 (1.0-2.9) 1.9 (1.0-3.1) 1.7 (1.1-2.4) 
CVP -1.9 (2.6) -2.2 (2.7) -1.7 (2.8) -1.7 (2.9) -1.6 (2.6) 
* SV -2.2 (2.4) -2.1 (2.8) -1.6 (3.1) -1.0 (2.2) -1.0 (2.3) 
Base deficit 
(mmol/l)  
‡ SV & DPX -2.2 (2.1) -2.3 (2.4) -2.2 (2.4) -1.9 (2.3) -1.4 (2.4) 
 
Table 5.3. Cardiovascular physiology for the three treatment groups during eight hour study 
period. Data presented as mean (SD) or median (IQR). Significant changes over time signified by † 
(p<0.05), ‡ (p<0.01), * (p<0.001) and § (p<0.0001). 
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Figure 5.2. Changes in oxygen delivery index (DO2I) (A) and central venous oxygen saturation (ScvO2) (B) following surgery in the 
three treatment groups.  
*Significant difference between groups over time for DO2I and ScvO2 (p<0.0001) (two way repeated measures ANOVA). Significant increase in 
DO2I over time: SV group p=0.003; SV & DPX group p<0.0001. Significant increase in ScvO2 over time: SV & DPX group p<0.0001; no change in 
the SV group (p=0.22) or CVP group (p=0.98). †At hour 8, there was a significant difference in DO2I between the CVP and SV & DPX groups 
(p<0.001) but no difference between the SV and CVP groups (p>0.05). At hour 8, there was a significant difference in ScvO2 between the CVP 
and SV & DPX groups (p<0.05) but no difference between the SV and CVP groups (p>0.05). 
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Hour 0 Hour 2 Hour 4 Hour 6 Hour 8 
CVP 2.5 (0.3) 2.5 (0.7) 2.6 (0.4) 2.6 (0.4) 2.5 (0.5) 
SV 2.5 (0.4) 2.5 (0.5) 2.6 (0.4) 2.7 (0.3) 2.6 (0.4) Microvascular 
Flow Index 
† SV & DPX 2.5 (0.4) 2.4 (0.5) 2.5 (0.4) 2.7 (0.3) 2.5 (0.4) 
‡ CVP 6.1 (2.4) 6.1 (1.7) 5.8 (2.0) 5.8 (1.9) 5.3 (1.8) 
SV 5.8 (2.5) 5.7 (2.6) 5.7 (1.9) 5.7 (1.9) 6.2 (3.0) 
Perfused 
vessel density 
(mm-1) 
† SV & DPX 5.8 (2.4) 5.5 (2.4) 5.9 (2.8) 6.2 (1.8) 6.3 (3.0) 
CVP 0.83 (0.14) 0.83 (0.12) 0.81 (0.14) 0.82 (0.18) 0.81 (0.18) 
SV 0.80 (0.15) 0.80 (0.21) 0.82 (0.17) 0.84 (0.13) 0.80 (0.19) 
Proportion of 
perfused 
vessels 
SV & DPX 0.81 (0.16) 0.77 (0.14) 0.81 (0.15) 0.85 (0.12) 0.87 (0.17) 
CVP 
0.39  
(0.23-
0.51) 
0.23 
(0.12-
0.41) 
0.25 
(0.17-
0.48) 
0.28  
(0.16-
0.38) 
0.25 
(0.10-
0.54) 
SV 
0.23 
(0.10-
0.43) 
0.20 
(0.07-
0.31) 
0.22 
(0.04-
0.41) 
0.19 
(0.06-
0.31) 
0.22 
(0.08-
0.46) 
Heterogeneity 
index 
† SV & DPX 
0.27 
(0.18-
0.40) 
0.20 
(0.14-
0.44) 
0.18 
(0-0.27) 
0.13 
(0.08-
0.27) 
0.17 
(0-0.38) 
 
Table 5.4. Sublingual microvascular flow for small vessels (<20µm) during eight hour study 
period. Data presented as mean (SD) or median (IQR). Significant changes over time signified by † 
(p<0.05), ‡ (p<0.01). 
 
 136 
0 1 2 3 4 5 6 7 8
-1.5
-0.5
0.5
1.5 *
†
Time after surgery (hours)
C
h
a
n
g
e
 
i
n
 
p
e
r
f
u
s
e
d
v
e
s
s
e
l
 
d
e
n
s
i
t
y
 
(
n
/
m
m
)
0 1 2 3 4 5 6 7 8
-20
0
20
40
60
SV
SV & DPX
CVP
* †
Time after surgery (hours)
P
e
a
k
 
-
 
b
a
s
e
l
i
n
e
 
r
e
d
 
c
e
l
l
 
f
l
u
x
 
(
A
U
)
 
Figure 5.3. Changes in sublingual perfused vessel density (A) and peak-baseline cutaneous red cell flux following three minutes 
of vascular occlusion (B) from hour 0 following surgery in the three treatment groups. * Significant difference between groups over 
time for sublingual vessel density (p<0.05) and cutaneous hyperaemic response (p<0.01) (two way repeated measures ANOVA). Significant 
increase in perfused sublingual vessel density over time in the SV & DPX group (p=0.046), no change in the SV group (p=0.58) and a decrease 
in the CVP group (p=0.005). Significant increase in cutaneous hyperaemic response over time in the SV & DPX group (p=0.003), no change in 
the SV group (p=0.58) and a decrease in the CVP group (p=0.03).  
† At hour 8, there was a significant difference in perfused sublingual vessel density between the SV & DPX and CVP groups (p<0.05) but not 
between the SV and CVP groups (p>0.05). At hour 8, there was a significant difference in cutaneous hyperaemic response between the SV & 
DPX and CVP groups (p<0.001) but not between the SV and CVP groups (p>0.05). 
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Figure 5.4. Changes in tissue oxygenation (PtO2) following surgery in the three treatment groups. * Significant difference between 
groups over time (p=0.0005) (two way repeated measures ANOVA). Significant increase in PtO2 over time in the SV & DPX group (p=0.0003), 
no change in the SV (p=0.14) or CVP groups (p=0.20).  
† At hour 8, there was a significant difference in PtO2 between the SV & DPX and CVP groups (p<0.005) but not between the SV and CVP 
groups (p>0.05). 
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Figure 5.5. Changes in serum interleukin-1β (IL-1β) (panel A), interleukin 6 (IL-6) (panel B), interleukin 8 (IL-8) (panel C), tumour 
necrosis factor alpha (TNFα) (panel D) and soluble inter-cellular adhesion molecule 1 (ICAM-1) (panel E) between the three 
treatment groups. Data presented as mean (SE). There were no significant differences between the groups. 
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CVP group 
n=45 
SV group 
n=45 
SV & DPX 
group 
n=45 
p 
Complications 
(number of patients, %) 30 (67%) 26 (58%) 31 (69%) 0.51 
Cardiac complications 
(number of patients, %) 4 (9%) 3 (7%) 3 (7%) 0.90 
Infectious 
complications (number 
of patients, %) 
29 (64%) 24 (53%) 28 (62%) 0.52 
Other complications 
(number of patients, %) 10 (22%) 14 (31%) 12 (27%) 0.63 
Critical care free days 
within 28 days of 
surgery 
24 (21-26) 24 (21-26) 26 (21-27) 0.45 
Duration of hospital 
stay (days) 15 (10-26) 14 (11-26) 16 (11-28) 0.73 
Hospital mortality (%) 6 (13%) 5 (11%) 4 (9%) 0.45 
 
Table 5.5. Clinical outcomes in the three intervention groups. Data presented as median (IQR) 
or absolute values (%). Note: A number of patients developed more than one complication. Acute 
kidney injury at seven days not included in 28 day complication outcome. 
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5.4 Discussion 
This is the first study to substantiate the theory that cardiac output guided haemodynamic 
therapy can improve tissue perfusion and oxygenation. Our principal finding is that a 
treatment algorithm incorporating stroke volume guided fluid therapy and a fixed low dose 
dopexamine infusion increased global oxygen delivery and ScvO2 in association with 
significant improvements in sublingual and cutaneous microvascular flow and cutaneous 
tissue oxygenation. Stroke volume guided fluid therapy alone was associated with more 
modest improvements in global haemodynamics and microvascular flow. There were, 
however, no differences in circulating markers of the inflammatory response to surgery 
between treatment groups.   
This randomised controlled trial used physiological end-points and was not designed to 
identify differences in clinical outcomes although a post hoc analysis did identify a 
possible improvement in renal outcomes (incidence of acute kidney injury – see chapter 6) 
associated with stroke volume guided therapy. This finding is consistent with a recent 
meta-analysis suggesting that haemodynamic optimisation protects renal function in 
surgical patients.300 There was no reduction in overall complication rates in the 
intervention groups and the small difference in hospital mortality, although consistent with 
improved outcome was not significant. To achieve 80% power to detect a 25% reduction 
in the relative risk of complications would require a minimum of 150 patients in each of the 
three treatment groups.  
In common with all trials of complex interventions, it was not possible to fully blind clinical 
staff to study group allocation. We did, however, conceal study group allocation from all 
investigators apart from the member of the research team delivering the intervention. This 
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included concealment of cardiac output data and the use of dummy infusions. All 
complications were assessed according to prospectively defined criteria and verified by 
the principal investigator who was unaware of study group allocation. Lastly our stratified 
randomisation procedure ensured that the three groups were comparable.  
The importance of using cardiac output derived data to guide a carefully prescribed and 
consistently applied clinical intervention is illustrated by the findings of a previous multi-
centre randomised trial in which perioperative pulmonary artery catheterisation, in the 
absence of improved haemodynamics, failed to influence outcome.198 In the study 
reported here, three clinically relevant treatment algorithms were strictly implemented by 
members of the research team throughout the eight hour intervention period. Perhaps as 
a consequence, unlike most previous studies, the total volumes of intra-venous fluid 
administered were similar between the groups.39,40,48,295 This suggests a high standard of 
care for all patients that may have limited the apparent treatment effect of stroke volume 
guided fluid therapy. Interestingly, the findings of one previous trial suggest that, even 
where median fluid administration is similar between groups, cardiac output guided fluid 
therapy may be associated with improved clinical outcomes.41 
The relationship between derangements in cardiac output related variables and 
complications following major surgery is well described.32,33,287 The findings of some, but 
not all clinical trials and a number of meta-analyses suggest that cardiac output guided 
haemodynamic therapy can improve post-operative outcomes.39-41,298 It has long been 
assumed that the potential benefits of ‘flow guided’ peri-operative haemodynamic therapy 
relate to improved tissue perfusion and oxygenation. A number of studies have highlighted 
the significance of impaired tissue microvascular flow in the pathogenesis of post-
operative complications.96,100,162 In this context, it is interesting to note that the use of high 
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concentrations of inspired oxygen did not affect the incidence of post-operative wound 
infection or pneumonia in a recent large clinical trial.173 In the current study, the use of a 
fixed low dose inotrope infusion coupled with stroke volume guided fluid therapy resulted 
in increases in heart rate and, to a lesser extent, stroke volume which in turn increased 
DO2 and ScvO2 to values previously associated with improved clinical outcomes.33,287 We 
show for the first time that such increases in global haemodynamics are associated with 
improvements in tissue microvascular flow and oxygenation, thus validating the study 
hypothesis. Although stroke volume guided intra-venous colloid therapy alone led to much 
smaller increases in cardiac index and DO2, with no change in heart rate or ScvO2, 
microvascular flow was better maintained than in the CVP guided therapy group. The 
incremental effects of low dose dopexamine on both microvascular flow and tissue 
oxygenation are likely to relate to the β2-adrenoceptor mediated inotropic and vasodilator 
actions of this agent. It is therefore possible that changes in microvascular flow relate to 
direct effects on the microcirculation as well as global cardiac output.  
Interestingly, in a recent randomised trial, low dose nitroglycerin had no effect on 
sublingual microvascular flow in resuscitated patients with severe sepsis.157 These 
contrasting findings may reflect differences in the nature and timing of the intervention as 
well the patient population and smaller sample size. In contrast, the use of vasopressor 
and inotropic agents has been shown to improve both tissue microvascular flow and 
oxygenation in patients with severe sepsis,15,301 although these effects were not 
demonstrated in all such investigations.194,302 Whilst, these studies do suggest potential 
effects of vasoactive drugs on microvascular flow, the current study is the first to 
investigate the effects of the use of cardiac output based end-points on tissue 
microvascular flow and oxygenation. 
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The simultaneous use of three different modalities to assess different aspects of tissue 
microvascular function was an important strength of this investigation. SDF imaging is a 
non-invasive technique which provides a real time video image of the intact 
microcirculation. However, this technique is limited by semi-quantitative analysis and the 
fact that it can only be used to image the microcirculation under mucosal surfaces. Laser 
Doppler flowmetry is a technique based on the Doppler shift of reflected laser light from 
moving red blood cells. This method cannot distinguish the size or type of microvessel, 
direction of flow or heterogeneity of flow, all of which may be important in critically ill or 
high-risk surgical patients. These limitations can be addressed through the measurement 
of post-occlusion reactive hyperaemia which provides a reproducible assessment of 
endothelium dependant microvascular response.261 The cutaneous Clarke electrode 
measures the local partial pressure of oxygen by a polarographic method. If tissue 
perfusion decreases whilst PaO2 remains constant, cutaneous PtO2 will decrease thus 
linking peripheral perfusion and tissue oxygenation.303 The consistent patterns of change 
identified with each of the three modalities is therefore of particular importance. However, 
these methods have been used to assess quite different aspects of microvascular function 
and cannot be directly compared. We have presented the changes in microvascular flow in 
terms of change from the baseline values. Whilst differences are less apparent on analysis 
of absolute values, the consistency of the changes we observed between three distinct 
measures of tissue perfusion strongly suggests that these findings are robust.  
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5.5 Conclusions 
A treatment algorithm incorporating stroke volume guided fluid therapy plus low dose 
dopexamine infusion was associated with significant improvements in microvascular flow 
and tissue oxygenation but no change in the inflammatory response to surgery. These 
physiological changes may explain the beneficial effects of cardiac output guided 
haemodynamic therapy demonstrated in previous clinical trials. Our findings strongly 
support the need for large multi-centre trials to evaluate the clinical effectiveness of 
cardiac output guided haemodynamic therapy. Several such trials are now under way in 
patients with severe sepsis, those undergoing major surgery and in potential organ 
donors. 
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Chapter 6 
Renal effects of post-operative haemodynamic 
optimisation 
 
6.1 Introduction 
Post-operative renal dysfunction is common and accounts for between 18 and 47% of all 
cases of hospital acquired renal failure.304,305 Acute renal dysfunction is associated with 
increased mortality rates following both cardiac and non-cardiac surgery. 306 307 A number 
of factors play a role in its occurence including the administration of anti-inflammatory and 
nephrotoxic agents, pre-existing renal dysfunction as well as patient comorbidities and the 
type of surgery.308 It is likely that hypoperfusion plays an important role in most cases of 
postoperative renal dysfunction.305 Previous work has shown that 80% of patients who 
develop postoperative renal dysfunction had a documented period of haemodynamic 
instability perioperatively. There is no evidence that any specific pharmacological 
treatments help prevent postoperative renal dysfunction. Therefore, maintaining perfusion 
remains the mainstay in preventing deterioration in renal function. GDHT through 
optimising cardiac output and thus organ blood flow might be expected to ameliorate 
postoperative renal dysfunction. A recent meta-analysis examined 20 randomised 
controlled trials (4220 patients) of GDHT and the incidence of postoperative renal 
dysfunction.49 These authors found that postoperative acute renal injury was significantly 
reduced by perioperative haemodynamic optimisation. This was true whether the 
intervention was commenced preoperatively, intraoperatively or postoperatively. 
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Similar to the systemic inflammatory response syndrome (SIRS) and sepsis, surgical 
stress causes a disseminated inflammatory response associated with changes in 
endothelial function influenced by the action of pro-inflammatory cytokines.309,310 An early 
feature of the acute inflammatory process is capillary endothelial cell activation causing a 
rapid increase in capillary permeability to plasma proteins including albumin. The 
transcapillary escape of radiolabeled albumin from the circulation increases dramatically 
following cardiac surgery, as well as in patients with sepsis and malignancy.311 In an 
experimental model of the early stages of inflammation following surgery and peritonitis, 
increases in systemic vascular permeability were accompanied by increases in renal 
permeability to macromolecules. Thus the finding of microalbuminuria following surgery is 
a reflection of systemic vascular endothelial permeability as part of the inflammatory 
process. 
 
The degree of microalbuminuria and its time course post-operatively appears to be related 
to the extent of the surgical stress.312,313 There is also some evidence in surgical patients 
that persistent microalbuminuria following surgery may be associated with a poor outcome. 
De Gaudio and colleagues found an increase in microalbuminuria post-operatively in those 
patients who became septic.309 A threshold value of 3 mg/mmol (albumin / creatinine ratio) 
has been found to be a very sensitive predictor of poor outcomes, but at the expense of 
specificity and a low positive predictive value.314 Szakmany and colleagues found a 
significant difference between survivors and non-survivors in microalbuminuria 
immediately following major abdominal surgery.315  Whether there is any correlation 
between glomerular permeability and lung permeability remains unclear.309,315  
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Microalbuminuria has been used as a marker of inflammation following surgery in two 
interventional trials to date.316,317 The oxygen free radical scavenger, N-acetylcysteine had 
no effect on microalbuminuria, whereas low dose steroids appeared to reduce 
microalbuminuria.316,317  
 
There is some evidence to suggest that the use of inotropic therapy and intra-venous 
fluids results in a reduction in the inflammatory process and the degree of renal 
dysfunction.41,49,318,319 The aim of this analysis was to determine the effects of three 
different haemodynamic strategies following major surgery on microalbuminuria and 
indices of renal function. 
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6.2 Methods 
 
A detailed description of patient recruitment and clinical management is provided in 
Chapter 5. Urine samples were obtained from a urinary catheter which was inserted after 
induction of anaesthesia, but before surgery. It has been shown previously that 
uncomplicated catheterization does not alter urinary albumin concentrations.320 Urine 
samples were taken at four timepoints. T0 was after induction of anaesthesia but before 
surgery commenced. T1 was following surgery on admission to the critical care unit before 
the intervention commenced. T2 was at the end of the eight hour intervention period. T3 
was 24 hours following the end of surgery. Samples were placed into polypropylene tubes 
and placed in a -80 freezer within 15 minutes. The measurement of microalbuminuria to 
creatinine ratios is described in chapter 2. Serum creatinine was obtained from samples 
ordered and taken by the attending clinical team for up to seven days following surgery. 
Serum creatinine was measured using the kinetic Jaffe method (Roche modular P unit). 
Microalbuminuria was assessed using an immunoturbimetric method (see chapter 2). 
Estimated glomerular filtration rate (eGFR) was calculated preoperatively upto day 7 after 
surgery from serum creatinine, age, race and gender using the Modification of Diet in 
Renal Disease equation.321 Patients were prospectively followed for the development of 
acute kidney injury within seven days of surgery.322  
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6.3 Results 
135 patients were recruited. Baseline demographics and outcomes are detailed in Chapter 
5. Urine samples were obtained in all patients except one. Microalbuminuria to creatinine 
ratios (MACR) increased immediately following surgery and fell in the subsequent 24 
hours. Changes in MACR in the three different treatment groups are shown in figure 6.1. 
There was no difference in MACR in those patients who went on to develop complications 
versus those who did not (figure 6.2). There was no significant correlation between MACR 
and P/F ratio or hospital stay. 
 
There was a significant fall in serum creatinine from preoperative levels to 7 days 
postoperatively in all three treatment groups. However, there was no significant difference 
between treatment groups in serum creatinine over the same time period (p=0.47, two way 
repeated measures ANOVA) (figure 6.3). There was, however, a significant difference 
between treatment groups in eGFR (p=0.02, two way repeated measures ANOVA) (figure 
6.4). During the first seven days after surgery, eGFR increased significantly in the SV & 
DPX group but not in the SV or the CVP group (SV & DPX group 21 [20] ml/min, p=0.001; 
SV group 10 [33] ml/min, p=0.09; CVP group 2 [35] ml/min; p=0.73). Consequently, a post 
hoc analysis of the predefined renal outcome was performed. Ten (22%) patients in the 
CVP group developed acute kidney injury within 7 days of surgery. There was a trend 
towards fewer patients developing acute kidney injury in the SV (3[7%]) and SV & DPX 
groups (4[9%]) within seven days of surgery (p=0.055 One way ANOVA). There was a 
significant reduction in the incidence of acute kidney injury in the pooled SV and SV & 
DPX groups (p=0.03 t-test). 
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Figure 6.1 Changes in microalbumin to creatinine ratio (MACR) following major abdominal 
surgery with three different haemodynamic therapies. Data presented as median (IQR). No 
significant difference between groups. 
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Figure 6.2 Microalbumin to creatinine ratio (MACR) in those patients who did and did not 
develop complications. Data presented  as median (IQR). No significant difference between 
groups. 
Blue : complications, Red : no complications. 
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Figure 6.3 Change in serum creatinine for first seven days following surgery in the three 
treatment groups. Data presented as median (IQR). No difference between groups (p=0.47 Two way 
repeated measures ANOVA) 
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Figure 6.4 Changes in estimated glomerular filtration rate (eGFR) following surgery in three 
treatment groups. * Significant difference between groups over time (p=0.02) (two way repeated 
measures ANOVA).  
† At day 7, there was a significant difference in eGFR between the SV & DPX and CVP groups 
(p<0.05) but not between the SV and CVP groups (p>0.05). 
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6.4 Discusssion 
We found a significant decrease in serum creatinine and a corresponding increase in the 
estimated glomerular filtration rate in all groups over the first seven days postoperatively. 
There was a significant difference between groups in the change in eGFR post-operatively 
with greater improvements in the group receiving stroke volume guided fluid therapy plus 
dopexamine. This was associated with a reduced incidence of acute kidney injury in the 
pooled stroke volume optimised groups compared to the CVP group. There was no 
significant difference in the volume of fluid given either during the operation or the 
intervention period between groups. As expected MACR increased immediately following 
surgery and then fell over the subsequent 24 hours. We did not find any difference in 
MACR between treatment groups. In contrast to previous work, we did not find any 
association between changes in MACR and outcome or any correlation between MACR 
and PaO2 / FiO2 ratio.  
 
No studies of perioperative optimisation to date have analysed postoperative renal 
dysfunction as a specific outcome measure. A recent meta-analysis found that the 
incidence of postoperative AKI was significantly reduced by perioperative haemodynamic 
optimisation.49 One of the major difficulties in this area is the lack of a uniform definition of 
renal failure. The main outcome measure in this meta-analysis was worsening of renal 
function, using whichever definition had been used by the authors of the individual studies. 
Sub-group analyses were performed examining the different definitions of AKI (eg RIFLE, 
AKIN, need for RRT) and the timing of optimisation (pre-, intra- or postoperative). All of 
these analyses produced similar findings to the main outcome measure. The exact 
biological mechanism for this protective effect remains unclear, although it is possible that 
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an inadequate cardiac output perioperatively may directly lead to renal hypoperfusion, as 
well as activating neurohumoral responses that promote renal vasoconstriction. 
Maintainance of cardiac output may thus ensure adequate renal blood flow and limit renal 
vasoconstriction. 
 
We found a significant improvement in eGFR associated with GDHT, as well as a trend 
towards a reduction in the incidence of acute kidney injury (AKI). Although this analysis 
was post-hoc, it was performed on an a priori defined post-operative complication using 
the Acute Kidney Network definition of AKI. Similar to our findings, previous work has 
found an increase in MACR associated with surgery.315 In contrast to previous work, 
however, we did not find any association between MACR and clinical outcomes.314,315,323 
We also did not find any difference in MACR between treatment groups. De Gaudio and 
colleagues found that post-operative patients that developed septic complications showed 
an increase in MACR compared to those who had an uncomplicated post-operative 
course. These increases, however, occurred at the time of the septic complication and 
since we only took samples up to 24 hours post-opertaively, we would not have captured 
this data. Both Gosling and Szakmany found significant increases in MACR immediately 
following surgery in non-survivors.315,323 The mortality rate in both of these studies was 
higher than in the present study, so it is possible that our patient group was underpowered 
to find an association between MACR and mortality. Interestingly, in both of these studies 
further samples were taken within six hours of admission to ICU. In both studies, the 
MACR fell significantly over this time period. This may partly explain why we found no 
difference between treatment groups in MACR given that we sampled urine only at eight 
and 24 hours following commencement of treatment.  
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In conclusion, we found a significant improvement in estimated glomerular filtration rate 
associated with GDHT, together with a trend towards a reduction in the incidence of AKI. 
Although MACR increased with surgery, there was no association with outcome or any 
difference between treatment groups. Larger prospective studies are required to 
investigate whether GDHT reduces the incidence of AKI following major abdominal 
surgery. 
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Chapter 7 
Haemodynamic changes according to outcome 
following post-operative haemodynamic optimisation 
 
 
7.1 Introduction 
Links between surgical outcomes and perioperative haemodynamics were first 
demonstrated by Clowes and colleagues in 1960.32 William Shoemaker followed up this 
work with a series of observational studies demonstrating that a number of haemodynamic 
and oxygen transport variables were correlated with survival following major surgery.33-35 
Since then a number of investigators have evaluated changes in perioperative physiology 
and their association with outcome.324,325 This has led to the use of a number of these 
variables as endpoints for perioperative haemodynamic therapy. Although the validity of 
comparing clinical outcomes from within a randomised controlled trial of three different 
interventions may be questionable such an analysis might generate some interesting 
hypotheses and could help to improve understanding of perioperative physiology. The aim 
of this analysis, therefore, was to compare changes in post-operative physiology in those 
patients who did or did not develop complications following surgery using the cohort 
recruited to the randomised controlled trial described in Chapter 5. 
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7.2 Methods 
Data has been analysed from the randomised controlled trial of post-operative 
haemodynamic optimisation described in chapter 5. Recruitment, monitoring and the 
cardiovascular management of patients during the first eight hours after surgery are 
described in detail in the methods section of chapter 5. All patients received usual care 
following this eight hour period for the rest of their hospital stay. 
 
Routine demographic data were captured and P-POSSUM scores and ASA scores 
calculated. Complications and deaths up to 28 days following surgery were included in this 
analysis. Complications were prospectively defined (see Appendix). Clinical outcome data 
were collected by a blinded member of the research team and verified by the principal 
investigator. Physiological, microvascular and tissue oxygenation data were collected as 
described in Chapters 2 and 5. 
 
7.2.1 Statistical analysis 
Comparisons between groups were performed by t-test or a Mann-Whitney test depending 
on whether the data was normally distributed. Two way repeated measures ANOVA were 
used to compare differences between groups over time. Categorical variables were tested 
with the Chi squared or Fisher’s exact tests. Receiver operating characteristic (ROC) 
curves were constructed to identify optimal cut-off values for association with 
complications. Statistical analysis was performed using GraphPad Prism version 4.0 
(Graphpad software, USA). Significance was set at p<0.05. Data are presented as mean 
(SD) where normally distributed or median (IQR) if not normally distributed. Categorical 
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variables are described as a percentage of the group from which they are derived. 
Normality was ascertained using the D’Agostino-Pearson test. 
 
7.3 Results 
One hundred and thirty five patients were recruited between December 2007 and 
February 2009 and randomised into one of three treatment groups (see Chapter 5). 87 
(64%) of these patients developed pre-defined complications following surgery (see 
Appendix for definitions of complications). There was no difference in age, p-POSSUM 
score or the use of GDHT between those patients who went on to develop complications 
and those who did not (Table 7.1). Unsurprisingly, critical care stay and hospital stay were 
longer in those patients who developed complications (Table 7.1). There was no difference 
between groups in baseline or minimum heart rate, mean arterial pressure or cardiac 
index. The lowest recorded central venous oxygen saturations were significantly lower in 
those patients who went on to develop complications (Table 7.2). The optimal value of 
minimum ScvO2 for discriminating those patients who did and did not develop 
complications was 65.0% (sensitivity 49% and specificity 78%) (Figure 7.1). Both baseline 
and the lowest recorded transcutaneous tissue oxygenation tension were also lower in 
those patients who went on to develop complications (Table 7.2). The optimal value of 
PtO2 for discriminating those patients who did and did not develop complications was 
5.9kPa (sensitivity 45% and specificity 83%) (Figure 7.2). There was no difference in 
global haemodynamics between those patients who developed complications compared to 
those who did not except in central venous oxygen saturations (Figure 7.3). Base deficit 
was greater in those patients who went on to develop complications though there was no 
difference in serum lactate (Figure 7.4). There was no difference in microvascular flow 
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found over the study period between groups (Figure 7.5). Interestingly, however, 
transcutaneous tissue oxygenation was significantly lower throughout the whole study 
period in those patients who went on to develop complications (Figure 7.5). There were no 
significant differences in inflammatory markers between those patients who developed 
complications and those who did not (Figure 7.6). 
 161 
 
 
No complications 
(n=48) 
Complications 
(n=87) p 
Age 66.2 (11.2) 66.8 (11.8) 0.76 
P-POSSUM 36 (6) 37 (6) 0.26 
GDHT 33/48 (69%) 57/87 (65%) 0.85 
Alive and  28 day Crit care 
free days 26 (24-27) 23 (17-26) <0.0001 
Hospital stay (days) 10 (8-13) 20 (15-31) <0.0001 
 
Table 7.1 Patient demographics and hospital stay in those patients who developed 
complications and those who did not  
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No complications 
(n=48) 
Complications 
(n=87) p 
Baseline heart rate 
(bpm) 75 (14) 77 (15) 0.53 
Maximum heart rate 
(bpm) 85 (16) 91 (16) 0.053 
Baseline mean arterial 
pressure (mm Hg) 80 (17) 78 (20) 0.24 
Minimum mean arterial 
pressure (mm Hg) 71 (12) 68 (13) 0.28 
Baseline global oxygen 
delivery index (ml/min/m2) 441 (126) 491 (158) 0.08 
Minimum global oxygen 
delivery index (ml/min/m2) 385 (322-488) 411 (338-521) 0.13 
Baseline cardiac index 
(L/min/m2) 3.3 (1.0) 3.4 (0.9) 0.52 
Minimum cardiac index 
(L/min/m2) 3.0 (0.7) 3.2 (0.8) 0.32 
Baseline central venous 
oxygen saturations (%) 75 (9) 71 (10) 0.06 
Minimum central venous 
oxygen saturations (%) 70 (7.2) 65 (10) 0.0076 
Baseline cutaneous tissue 
oxygenation (kPa) 9.6 (3.8) 8.0 (3.3) 0.009 
Minimum cutaneous tissue 
oxygenation (kPa) 8.4 (3.0) 6.5 (2.8) 0.0004 
Baseline perfused vessel 
density (n/mm) 5.8 (4.7-7.5) 5.1 (4.1-6.4) 0.07 
Minimum perfused vessel 
density 4.5 (1.5) 4.4 (2.0) 0.99 
 
Table 7.2 Haemodynamic, microvascular and tissue oxygenation variables in those patients 
who developed complications and those who did not. Data presented as mean (SD) or 
median (IQR) as appropriate. Baseline refers to immediately following surgery. 
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Figure 7.1 Receiver Operating Characteristic (ROC) curve for predicting complications with 
minimum ScvO2. Area under curve 0.63 (95%CI 0.53-0.72) 
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Figure 7.2 Receiver Operating Characteristic (ROC) curve for predicting complications with 
minimum PtO2. Area under curve 0.68 (95%CI 0.58-0.77). 
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Figure 7.3. Global haemodynamics during eight hour study period. Data presented as mean (SEM). No significant difference between 
groups except ScvO2 p<0.05 (two way repeated measures ANOVA).  
Blue : complications, Red : no complications. 
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Figure 7.4 Changes in markers of tissue perfusion during study period. Data presented as mean (SEM). No significant difference 
between groups except base deficit (p<0.05) (two way repeated measures ANOVA). 
Blue : complications, Red : no complications. 
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Figure 7.5 Changes in microvascular flow and tissue oxygenation during study period. Data presented as mean (SEM). No significant 
difference between groups in microvascular flow. Significant difference in PtO2 between groups (p<0.0001) (two way repeated measures 
ANOVA). 
Blue : complications, Red : no complications. 
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Figure 7.6 Inflammatory markers in those patients who did and did not develop 
complications. Data presented as median (IQR). 
Blue : complications, Red : no complications. 
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7.4 Discussion 
The main finding from this analysis was that there were differences in central venous 
oxygen saturations, base deficit and transcutaneous tissue oxygenation between those 
patients who did and did not develop complications post-operatively. Surprisingly, there 
were no other differences in global haemodynamics or markers of tissue perfusion 
between groups. Interestingly, despite the difference in tissue oxygenation we only found 
a trend towards lower baseline sublingual microvascular flow in those patients who went 
on to develop complications and there was no difference in cutaneous microvascular flow. 
 
Clowes and colleagues provided the first data linking global haemodynamics with 
perioperative outcomes.32 They found that survivors of thoracic and emergency abdominal 
surgery tended to achieve higher cardiac outputs than those who died. William 
Shoemaker built on this early work publishing a list of haemodyanmic variables that 
correlate with survival after major surgery.33 More recent work has investigated changes in 
central venous oxygen saturations associated with surgery.324,325 Surprisingly, we found 
no difference in global oxygen delivery or cardiac index between those patients who went 
on to develop complications and those who did not. There were differences in central 
venous oxygen saturation and cutaneous tissue oxygenation, however. Although there 
was a trend to a difference in baseline sublingual microvascular flow immediately following 
surgery in those who went on to develop complications, this trend did not remain over the 
subsequent treatment period. Why we found differences in some variables but not others 
is unclear. The total volumes of intra-venous fluid administered were similar between the 
groups despite the differing endpoints. This suggests a high standard of care for all 
patients that may have minimised any differences. As mentioned previously, the validity of 
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comparing clinical outcomes from within a randomised controlled trial of three different 
interventions may have compromised this secondary analysis. A lowest recorded central 
venous saturation value of 65% was associated with complications in this analysis. This 
value is very similar to a previous analysis also performed within a randomised controlled 
trial of GDHT.287 A European multicentre study of perioperative patients undergoing major 
abdominal surgery receiving usual care, found a higher central venous saturation cut-off of 
73% for prediciting complications.325 Tissue oxygenation was also found to be lower in 
those patients who went on to develop complications. Previous investigators have 
reported similar findings, with Hopf and colleagues finding that low subcutaneous tissue 
oxygen tension was associated with an increase in the incidence of wound infections.178 
Baseline oxygen tensions in those patients who developed complications in the study 
performed by Hopf were similar to the cut-off found in the current analysis. Although we 
found marked differences between groups in transcutaneous tissue oxygenation, we 
found no difference in microvascular flow. The reason for this is unclear. We found no 
statistical difference in the pro-inflammatory response to surgery between those patients 
who developed complications and those who did not.  
 
In conclusion, we found an association between the development of postoperative 
complications and low central venous oxygen saturations and impaired tissue 
oxygenation. We found no differences in other measures of global haemodynamics or in 
microvascular flow between those patients who developed complications and those who 
did not. 
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Chapter 8 
Early microvascular changes in sepsis and severe 
sepsis 
 
8.1 Introduction 
Sepsis is a major cause of death and disability worldwide. It is estimated that 750,000 
people develop sepsis each year in North America alone.9 In the UK, approximately 
35,000 patients are admitted to intensive care with sepsis each year, of whom 45% do not 
survive to leave hospital.10 Approximately one third of these patients are admitted directly 
from the emergency department.326,327 Sepsis related deaths result from multi-organ failure 
which generally develops in the early stages of the disease.11 There is increasing 
recognition that early therapeutic intervention is key to improving survival following sepsis. 
This has led to a particular emphasis on the cardiovascular management of the septic 
patient within the first few hours of hospital admission.328 
 
Sepsis related cardiovascular changes are complex and include vasodilatation, 
hypovolaemia and myocardial depression.66,329,330 Sepsis also results in important 
derangements of the microcirculation which are associated with organ failure and death.94 
Such effects include increased endothelial permeability,331,332 endothelial-leucocyte 
adhesion,333 and a characteristic heterogeneity of blood flow which is associated with 
tissue hypoxia.84,297 Several investigations have identified abnormalities of microvascular 
flow in patients with established severe sepsis. However, understanding of the natural 
history of microvascular dysfunction remains incomplete. Recent investigations by 
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Trzeciak and colleagues have identified abnormalities in sublingual microvascular flow in 
patients soon after the commencement of early goal directed haemodynamic therapy.95,161 
These data illustrate the significance of early impairments in microvascular flow and 
suggest potentially beneficial effects of haemodynamic resuscitation on such 
abnormalities. However, these data only describe microvascular changes in severely ill 
septic patients receiving a specific form of haemodynamic resuscitation. Because of the 
considerable interest in interventions which may improve microvascular function,15,155,157 
there is a need to further describe patterns of microvascular flow in a wider group of septic 
patients at the earliest stages after presentation. The aim of this study was to evaluate the 
sublingual microcirculation of patients with sepsis and severe sepsis within six hours of 
hospital admission and compare these data to that of healthy volunteers. 
 
8.2 Methods 
This single centre, observational study was approved by the Local Research Ethics 
Committee. Adult patients within six hours of admission to the Emergency Department at 
The Royal London Hospital with confirmed or strongly suspected sepsis were eligible for 
recruitment. 334 In addition, adult hospital in-patients within six hours of identification of the 
onset of sepsis were also eligible for inclusion. Written informed consent was sought from 
patients with capacity. Where a patient did not have capacity to give consent, a relative or 
healthcare practitioner was approached to provide assent. Retrospective consent for data 
use was sought once capacity was regained. There were no exclusion criteria except 
refusal of patient consent or relatives assent. Treatment in the emergency department was 
guided by local policies. Patients admitted to the intensive care unit received treatment in 
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accordance with the Surviving Sepsis guidelines current at that time. 335 All treatment 
decisions were made by the attending physician in charge of the intensive care unit.  
  
8.2.1 Measurements 
In addition to routine haemodynamic data, sublingual microvascular flow and cardiac 
output were measured using non-invasive technology. Sublingual microvascular flow was 
evaluated using sidestream darkfield (SDF) imaging with a x5 objective lens (Microscan, 
Microvision Medical, Amsterdam, Netherlands).59 Image acquisition and subsequent 
analysis was performed according to published consensus criteria as described in chapter 
two.277 Analysis of the videos was performed by two blinded observers (AS and AVS- see 
acknowledgements). Cardiac output was measured using the supra-sternal Doppler 
technique (USCOM Ltd., Australia).336 Patients were followed up for 28 day in-hospital 
mortality. 
 
8.2.2 Statistical analysis 
There was no formal sample size calculation. Instead we planned to recruit 20 patients 
with sepsis, severe sepsis and septic shock as well as 20 healthy volunteers.  
 
Normally distributed data were tested with unpaired t-tests or one-way analysis of variance 
(ANOVA) with post-hoc Bonferroni multiple comparison tests as appropriate. The Mann-
Whitney U test or Kruskal-Wallis test with post-hoc Dunn’s tests were used when data 
were not normally distributed. Data are presented as mean (SD) where normally 
distributed or median (IQR) where not normally distributed. Normality was tested with the 
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D’Agostino-Pearson test. Significance was set at p<0.05. Analysis was performed using 
GraphPad Prism version 5.0 (GraphPad Software, San Diego, USA).  
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8.3 Results 
A total of 48 patients and 16 healthy volunteers were recruited between September 2007 
and April 2008. The healthy volunteers had a median age of 39 (36-43) years and eight 
(50 %) were male. Septic patients had a median age of 50 (30-70) years and 24 (50 %) 
were male. Baseline patient data are presented in table 8.1. Four hospital in-patients who 
had developed severe sepsis were recruited. The remaining 44 patients were recruited in 
the Emergency Department. The median time from arrival at the emergency department to 
recruitment was 159 (104-218) minutes. Nineteen patients were classified as having 
severe sepsis on the following basis: fluid resuscitation required to treat hypotension 
(n=9), persistent hypotension despite fluid resuscitation (n=7), serum lactate >4mmol/L 
(n=3). The remaining 29 patients were classified as having uncomplicated sepsis. Eight 
patients were admitted to critical care within 24 hours of enrolment. At the time of 
admission to critical care four of these patients required invasive ventilation and five 
required vasopressor or inotropic therapy. None of these patients required renal 
replacement therapy. Sublingual microvascular flow and haemodynamic data were 
collected in all patients. Two patients were receiving vasopressor therapy at the time 
measurements were taken. There were no significant differences in microvascular flow 
between these patients and the rest of the cohort. 30 patients had received intravenous 
fluid prior to measurements (volume infused 1000 mls [500-1750]). The intravenous fluids 
used were 0.9% sodium chloride, compound sodium lactate solution, or a gelatin colloid 
solution (Gelofusine B Braun). For large vessels (>20µm) MFI was 3.0 (2.9-3.0) and the 
proportion of perfused vessels was 100% (100-100) in all patients. The kappa coefficient 
with linear weighting for inter- observer variability for calculation of MFI was 0.76 (0.68-
0.84). The inter-observer coefficient of variability for vessel density was 5.9%. 
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8.3.1 Comparison to healthy volunteers 
Heart rate was significantly greater in all patients and mean arterial pressure was reduced 
in the severe sepsis group. There was no difference in cardiac index between groups 
(Figure 8.1).For small vessels (<20µm), MFI, heterogeneity index and the proportion of 
perfused vessels were significantly reduced in both groups compared to healthy 
volunteers (table 8.2 & figure 8.3). Significant reductions in perfused vessel density were 
identified in the severe sepsis group but not the sepsis group when compared to healthy 
volunteers.  
 
8.3.2 Comparison between patients with sepsis and severe sepsis 
Abnormalities of MFI and perfused vessel density for small vessels (<20µm) were more 
marked in the severe sepsis group compared to the sepsis group (table 8.2 and figure 
8.3). There was no difference in cardiac index between the sepsis and severe sepsis 
groups (figure 8.1). Mean arterial pressure was lower and serum lactate was greater in the 
severe sepsis group.  
 
8.3.3 Comparison between survivors and non-survivors 
In non-survivors, mean arterial pressure was lower and heart rate was greater but there 
was no difference in cardiac index (Table 8.3 and Figure 8.2). There was also a trend 
towards higher serum lactate concentration (p=0.05) in non-survivors. The proportion of 
perfused vessels was significantly reduced in those patients who did not survive to leave 
hospital (figure 8.4).  
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Table 8.1. Patient demographics. Data presented as mean (SD), median (IQR) or absolute 
values (%) (Fisher’s exact test or Mann- Whitney U test). 
 
Sepsis 
n=29 
Severe sepsis  
n=19 
p 
Age (years) 33 (25-58) 66 (45-82) 0.0007 
Male 12 (41%) 12 (63%) 0.24 
Apache II score 8 (5) 18 (7) <0.0001 
Critical care 
admission 2 (7%) 6 (32%) 0.04 
Hospital stay (days) 2 (1-7) 12 (5-20) 0.001 
Mortality  1 (3%) 7 (37%) 0.004 
Source of sepsis 
Respiratory  11 (38%) 8 (42%) >0.99 
Abdominal  6 (21%) 5 (26%) 0.73 
Urological  8 (28%) 2 (11%) 0.28 
Soft tissue 2 (7%) 1 (5%) >0.99 
Neurological 1 (3%) 0 (0%) >0.99 
Other 1 (3%) 3 (16%) 0.29 
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Table 8.2. Haemodynamic data and microcirculatory indices of small vessels (<20µm). Data presented as mean (SD) or median (IQR). 
*p<0.05 vs healthy volunteers, **p<0.01 vs healthy volunteers, ***p<0.001 vs healthy volunteers.;  
† p<0.05 vs sepsis group, ‡ p<0.001 vs sepsis group  
(One-way analysis of variance or Kruskal-Wallis test between groups with post-hoc Bonferroni’s multiple comparison test or Dunn’s test).  
 
Healthy Volunteers 
n=16 
Sepsis 
n=29 
Severe sepsis  
n=19 p 
Heart rate 69 (7) 115 (15) *** 114 (25) *** <0.0001 
Mean arterial pressure (mm Hg) 84 (5) 88 (15) 70 (16) * ‡ 0.0001 
Cardiac index (l min-1 m-2) 2.8 (0.7) 3.6 (1.2) 3.5 (2.3) 0.29 
Serum lactate (mmol l-1) - 1.8 (0.9) 3.1 (2.1) † 0.02 
Base excess (mmol l-1) - -0.5 (3.7) -1.1 (5.5) 0.68 
 
Microvascular flow Index 3.0 (2.9-3.0) 2.8 (2.5-2.9) * 2.7 (2.2-2.8) *** † 0.0005 
Vessel Density (n mm-1) 8.6 (1.6) 9.2 (1.4) 8.8 (1.6) 0.38 
Perfused Vessel Density (n mm-1) 8.5 (1.5) 8.0 (1.5) 6.8 (2.0) * † 0.0085 
Heterogeneity index 0.0 (0.0-0.09) 0.18 (0.09-0.39) * 0.21 (0.10-0.38) ** 0.0025 
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Survivors 
n=40 
Non survivors 
n=8 
p 
Heart Rate 113 (19) 124 (21) 0.17 
Mean arterial pressure (mm Hg) 85 (16) 64 (16) 0.001 
Cardiac Index (l min-1 m-2) 3.7 (1.6) 2.9 (2.0) 0.25 
Serum lactate (mmol l-1) 1.8 (1.2-2.4) 2.7 (1.4-5.4) 0.05 
Base Excess (mmol l-1) -0.5 (3.8) -1.9 (4.8) 0.40 
 
Microvascular flow index 2.8 (2.5-2.9) 2.4 (1.8-2.8) 0.07 
Vessel Density (n mm-1) 9.0 (1.4) 9.1 (2.0) 0.88 
Perfused vessel density (n mm-1) 7.7 (1.4) 6.5 (3.0) 0.06 
Heterogeneity index 0.17 (0.09-0.33) 0.31 (0.20-0.65) 0.11 
 
 
Table 8.3. Haemodynamics and microvascular flow indices of small vessels (<20 µm) for 
survivors and non survivors. Data presented as mean (SD) or median (IQR) (unpaired t-test or 
Mann-Whitney U test) 
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Figure 8.1 Cardiac index in healthy volunteers, patients with sepsis and patients with 
severe sepsis. No difference between groups (p=0.29, one way ANOVA) 
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Figure 8.2 Cardiac index in healthy volunteers and survivors and non-survivors of sepsis. 
No difference between groups (p=0.36, Kruskal-Wallis test) 
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Figure 8.3. Proportion of perfused small vessels (<20 µm) in healthy volunteers, patients 
with sepsis and patients with severe sepsis. Data presented as median (IQR). *p<0.05 and 
**p<0.001 vs healthy volunteers, † p<0.05 vs sepsis group. 
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Figure 8.4. Proportion of perfused small vessels (<20 µm) in healthy volunteers and 
survivors and non-survivors of sepsis. Data presented as median (IQR). *p<0.01 vs healthy 
volunteers, ‡ p<0.01 vs survivors. 
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8.4 Discussion 
The principle finding of this study was that there were significant derangements in 
sublingual microvascular flow in patients early after the diagnosis of sepsis which were 
more marked in the most severely ill patients. However, these abnormalities were less 
severe than those previously described in patients with established severe sepsis.66,156 
These findings confirm that the characteristic abnormalities of microvascular flow in 
established sepsis are already present in the earliest stages of the disease. Clinical 
interventions to improve microvascular flow should be considered at hospital presentation 
and might prevent progression to more severe microvascular abnormalities.  
 
Previous investigations have characterised changes in sublingual microvascular flow in 
patients with established severe sepsis and demonstrated that persistent microvascular 
derangements are associated with poor outcome.66,94 This work has led to interest in the 
effects of various therapeutic interventions on microvascular flow.15,155,157 However, only 
one group has investigated microvascular derangements in patients with early sepsis. 
95,161
 In keeping with our findings, these investigators described derangements of 
sublingual microvascular flow which were more severe in non-survivors,95 and improved 
following goal directed haemodynamic therapy guided by central venous oxygen 
saturation.161 It is important to note that the majority of patients recruited to these studies 
were hospital in-patients (62 % and 48% respectively) representing a different population 
to those presenting with sepsis in the emergency department. In the current study, 92% of 
patients were recruited in the emergency department. This may partly explain the 
differences in the severity of abnormalities of microvascular flow. It remains uncertain to 
what extent sublingual microvascular flow correlates with that in other vascular beds.99,274 
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Sublingual SDF imaging is a valuable technique, which allows visualisation of the intact 
microcirculation in the clinical environment. Whilst several studies have demonstrated 
improvements in sublingual microvascular flow associated with specific clinical 
interventions,15,155,156 at present there are no published data describing the use of this 
technique to guide clinical interventions. In a small number of individual cases, my 
supervisor has found it helpful to use sublingual SDF imaging as part of the clinical 
assessment of complex critically ill patients. However, at present this technique remains 
primarily a research tool and until further research establishes a clear role for routine 
clinical use, the authors would urge caution. Existing scoring systems for SDF image 
analysis remain semi-quantitative and data reliability may be affected by technical 
expertise and inter-observer bias.277 We specifically evaluated these factors and our data 
indicate that they did not contribute to a significant degree of bias. All patients were 
recruited by AS (see Ackowledgements) who recorded detailed clinical notes as well as 
collecting haemodynamic and microvascular data. At the end of the study the notes were 
reviewed in a blinded fashion to confirm the diagnostic category. This review, which 
resulted in reclassification of 13 patients, may have introduced bias and reduced the 
number of significant findings. Although we identified a pattern of global haemodynamic 
and microvascular changes which was consistent with our expectations, some 
comparisons between groups did not achieve statistical significance because of the small 
number of patients recruited. A much larger investigation would be required to confirm the 
frequency and severity of early sepsis related abnormalities of microvascular flow. Patients 
in the severe sepsis group were significantly older than those in the sepsis group. Age 
may be associated with depletion of microvessels and may therefore represent a 
confounding factor.337 
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In conclusion, our findings confirm that the abnormalities of sublingual microvascular flow 
characteristic of established sepsis are already present in the earliest stages of the 
disease. These abnormalities are greatest in the more severely ill patients. Further 
research is needed to confirm these findings in a larger population and to investigate the 
efficacy of therapeutic strategies which maintain and improve microvascular flow. 
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Chapter 9 
The effect of increasing doses of norepinephrine on 
tissue oxygenation and microvascular flow in patients 
with septic shock 
 
9.1 Introduction 
Sepsis is characterised by a complex combination of cardiovascular derangements 
including vasodilatation, hypovolaemia, myocardial depression and altered microvascular 
flow.66,329,330,338 In severe cases, arterial hypotension may persist despite aggressive 
intravenous fluid resuscitation, a condition termed septic shock.339 In health, constant 
organ blood flow is maintained by autoregulation over a range of mean arterial pressures 
(MAP) between 60 and 100 mmHg. When MAP falls below this range, organ blood flow 
also decreases in a linear fashion.340 Consequently, in septic shock, vasopressor therapy 
is recommended in order to maintain tissue perfusion and oxygenation,341 although sepsis 
related changes in vascular reactivity may alter the normal autoregulatory range 342 and 
the optimal arterial pressure end-point for vasopressor therapy remains uncertain.343 
Indeed the current recommendation to maintain MAP at greater than 65 mmHg is 
supported by only limited evidence,194,344 and some have advocated routine use of higher 
arterial pressure targets, or alternatively the restoration of MAP to pre-morbid values. 
Because the consequences of both inadequate and excessive vasopressor therapy can be 
serious,46 it is important to clarify the optimal end-points to which these potent agents 
should be titrated, as well as to investigate the effects of alternative vasopressor agents.345 
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Sepsis results in a variety of deleterious microvascular changes that are associated with 
organ failure and death.94 These derangements include increased endothelial 
permeability, endothelial-leucocyte adhesion and a characteristic heterogeneity of blood 
flow that is associated with tissue hypoxia.66,84,297 The causes of heterogeneous 
microvascular flow are not fully understood but reduced vascular tone due to impaired 
endothelial signal transduction may be one explanation.61 It is possible, therefore that 
vasopressors might correct the abnormalities of microvascular flow and hence tissue 
oxygenation associated with septic shock. 
 
The dose related effects of vasopressor therapy on microvascular flow and tissue 
oxygenation in sepsis have not previously been fully investigated. The aim of this 
investigation was to evaluate in more detail the effects of increasing doses of 
norepinephrine, targeted to achieve successively greater MAP, on microvascular flow and 
tissue oxygenation in patients with septic shock. 
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9.2 Methods 
This single centre, interventional study was approved by the local research ethics 
committee and the Medicines and Healthcare products Regulatory Agency. Adult patients 
admitted to intensive care with a diagnosis of septic shock who were deemed to require 
vasopressor therapy despite adequate fluid resuscitation were eligible for recruitment. 
Written informed consent was sought from the patient when possible. Where patients 
lacked capacity to give consent because they were unconscious, the consent of a relative 
was sought. Patients who survived were subsequently asked for written permission to use 
their data once capacity had been regained. Exclusion criteria were refusal of patient’s or 
relative’s consent, concurrent lithium therapy, acute myocardial ischaemia, acute 
arrhythmias, pregnancy, patients receiving palliative treatment only and weight less than 
40 kg.  
 
9.2.1 Clinical management and study interventions 
The clinical management of each patient was determined by clinical staff in accordance 
with care bundles based on the Surviving Sepsis Guidelines that were current at the time 
of the study.346 This included compliance with the guidelines for fluid management, low-
dose steroid therapy, tight glycaemic control, administration of drotrecogin alfa activated, 
red cell transfusion and invasive ventilation. Adherence to these care bundles is regularly 
audited on our Intensive Care Unit. The norepinephrine infusion was initially titrated by the 
research team to achieve a mean arterial pressure of 60 mmHg.  Following a period of 45 
minutes observation to ensure that the blood pressure and haemodynamics had stabilized, 
initial measurements were taken.  The norepinephrine infusion was then increased to 
achieve a mean arterial pressure of 70 mmHg, followed by another 45 minute stabilization 
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period prior to the next set of measurements.  This process was repeated with the 
norepinephrine infusion rate being increased to achieve a mean arterial pressure of 80 
mmHg and finally 90 mmHg.  Patients were monitored throughout the four hour 
intervention period for adverse events, in particular, tachycardia, arrhythmias, myocardial 
ischaemia, hypertension or other signs of excessive vasoconstriction. The physician in 
charge was free to request dose adjustment or cessation of the study at any time. 
 
9.2.2 Measurements 
In addition to routine clinical measurements, cardiac output and oxygen delivery index 
were determined using transpulmonary lithium indicator dilution combined with continuous 
arterial waveform analysis software (LiDCOplus, LiDCO Ltd, Cambridge, UK). Arterial and 
central venous blood samples were taken from indwelling cannulae after stabilization at 
each time point for analysis of blood gas tensions, lactate and haemoglobin concentration 
(ABL 600 and OSM3, Radiometer, Copenhagen, Denmark). Cutaneous tissue PtO2 was 
measured at the same time point at two sites overlying the deltoid muscle using a Clark 
electrode (TCM400, Radiometer, Copenhagen, Denmark). Laser Doppler flowmetry 
(Moorlab, Moor Instruments, Axminster, UK) was utilized to measure red cell flux at two 
sites overlying the deltoid muscle. To account for changes in blood pressure, cutaneous 
vascular conductance was also calculated by dividing red cell flux by mean arterial 
pressure (PU/mmHg).261 Sublingual microvascular flow was evaluated using sidestream 
darkfield (SDF) imaging with a x5 objective lens (Microscan, Microvision Medical, 
Amsterdam, Netherlands). Image acquisition and subsequent analysis was performed 
according to published consensus criteria.277 Analysis of the videos was performed by two 
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observers blinded to each others observations and the clinical data. All of these 
measurement tools are described in more detail in Chapter two. 
 
9.2.3 Statistical Analysis 
The primary outcome measure was the difference in sublingual microvascular flow index at 
different mean arterial pressures. Assuming a type I error rate of 5% and a type II error 
rate of 20%, we calculated that 16 patients would be required to detect a difference of 0.5 
perfused vessels mm-2 (SD of difference between measurements: ± 0.7 vessels mm-2) 
between a MAP of 60mmHg and 90mmHg. This calculation was based on data from a 
previous study of heterogeneity of microvascular flow in patients with severe sepsis. 66 For 
continuous data, differences over time were tested using a repeated measure analysis of 
variance (ANOVA) with Dunnett’s post-hoc test for comparison against baseline. Non-
normally distributed data were tested with the Friedman test. Analysis was performed 
using GraphPad Prism version 4.0 (GraphPad Software, San Diego, USA). Significance 
was set at p < 0.05. Data are presented as mean (SD) where normally distributed and 
median (IQR) where not normally distributed.  
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9.3 Results 
Sixteen patients were recruited a median of one day (0.5-3.5) after the onset of septic 
shock. Baseline characteristics are presented in table 9.1. Increasing doses of 
norepinephrine were required to increase mean arterial pressure from 60 mmHg to 90 
mmHg (p<0.0001). There were no changes in sedation or crystalloid infusion during the 
study period (table 9.2). Three patients each received a single 250ml bolus of colloid 
solution, one whilst the MAP was 60 mmHg, one at 70 mmHg and one at 80 mmHg. One 
patient was receiving an infusion of dobutamine and one an infusion of vasopressin, the 
doses of which remained constant throughout the study period (2.63 µg kg-1 min-1 and 0.04 
U min-1 respectively). A third patient received an infusion of drotrecogin alfa activated. All 
patients received low dose steroids (hydrocortisone 50mg every six hours). Four patients 
were receiving continuous veno-venous haemodiafiltration during the course of the study 
and passed no measurable volume of urine. In four patients the attending physician 
requested that we did not increase MAP to 90 mmHg due to theoretical concerns 
regarding the possibility of impaired splanchnic perfusion. None of the patients developed 
tachycardia, arrhythmias, myocardial ischaemia, signs of excessive vasoconstriction or 
any other adverse effects which could be attributed to the intervention. In one patient, it 
was not possible to collect reliable SDF images due to patient movement. 
 
There was a significant increase in global oxygen delivery (p<0.01), cutaneous PtO2 
(p<0.0001) and PtO2:PaO2 ratio (p<0.0001) as MAP increased from 60 to 90 mmHg (table 
9.3 and figure 9.1). Cardiac index and central venous oxygen saturation (ScvO2) also 
increased whilst base deficit improved. There were no changes in serum lactate or urine 
output (table 9.3). There was an improvement in cutaneous red cell flux and a decrease in 
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cutaneous vascular conductance as assessed by laser Doppler flowmetry (table 9.4). 
There were no changes in small (<20µm) or large (>20µm) vessel  MFI, vessel density, the 
proportion of perfused vessels, perfused vessel density or heterogeneity index as 
assessed by SDF imaging (table 9.4, table 9.5 and figure 9.2). The kappa coefficient with 
linear weighting for inter-observer reliability for calculation of MFI was 0.82 (95%CI 0.78-
0.86).  
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Table 9.1 Baseline patient characteristics. Data presented as median (IQR) or absolute  
values (%). 
Patient characteristics 
Age (years) 67 (55-72) 
Gender 9 males (56%) 
Body weight (kg) 75 (60-80) 
APACHE II score 23 (17-30) 
Duration of intensive 
care stay (days) 8 (5-14) 
Mortality 10 deaths (62.5%) 
Source of sepsis 
Respiratory infection (%) 7 (44%) 
Abdominal infection (%) 6 (38%) 
Urological infection (%) 2 (12%) 
Soft tissue (%) 1 (6%) 
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 n 60 mmHg 70 mmHg 80 mmHg 90 mmHg p 
Norepinephrine 
(µg kg-1 min-1) 16 0.18 (0.18) 0.25 (0.22) 0.35 (0.27) 0.41 (0.26) <0.0001 
Propofol 
(mg kg-1 hour-1) 12 1.4 (1.3-2.3) 1.4 (1.3-2.3) 1.4 (1.3-2.3) 1.4 (1.3-2.3) >0.99 
Fentanyl 
(µg kg-1 hour-1) 16 1.6 (1.4-2.0) 1.7 (1.4-2.1) 1.7 (1.4-2.1) 1.7 (1.4-2.1) 0.39 
Midazolam 
(mg kg-1 hour-1) 4 0.1 (0.1-0.2) 0.1 (0.1-0.2) 0.1 (0.1-0.2) 0.1 (0.1-0.2) >0.99 
Intravenous crystalloid 
(ml) 11 109 (89-160) 118 (74-142) 89 (67-134) 96 (48-143) 0.68 
 
 
Table 9.2 Clinical management at or between measurement time points. Data presented as infusion rate at each time point or, in the 
case of intravenous crystalloid, the volume administered during the stabilization period between time points. Data presented as mean (SD) or 
median (IQR). Significance testing with repeated measures ANOVA and Friedman test. 
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Table 9.3 Physiological data at different measurement points with increasing mean arterial 
pressure. Data presented as mean (SD) or median (IQR). a p<0.0001 b p<0.001, c p<0.01 and d p<0.05 
over time (repeated measures ANOVA and Friedman test).   ‡p<0.01 and †p<0.05 compared to 
baseline of MAP 60mmHg (post-hoc Dunnett’s test).  
 60 mmHg 70 mmHg 80 mmHg 90 mmHg 
Heart rate (bpm) 87 (17) 84 (18) 86 (18) 87 (17) 
Cardiac index (l min-1 m-2) b 3.86 (1.22) 4.24 (1.26) 4.43 (1.43) † 4.79 (1.61) ‡ 
Oxygen delivery index  
( ml min-1 m-2) c 487 (418-642) 536 (446-720) 550 (474-800) 662 (498-829) 
Systemic vascular 
resistance index 
(dynes·sec cm-5m-2) b 
1195 (448) 1260 (392) 1402 (467) ‡ 1451 (571) ‡ 
ScvO2 (%) d 71 (6.4) 72 (6.7) 73 (7.1) 74 (6.7) † 
Serum lactate (mmol l-1) 2.2 (1.4) 2.3 (1.3) 2.1 (1.2) 2.2 (1.2) 
Serum base excess (mmol 
l-1) d -2.3 (0.2, -4.2) -1.6 (0.1, -4.7) -1.5 (1.3, -3.7) -1.9 (1.3, -3.9) 
Urine output (ml hour-1) 53 (38) 63 (41) 61 (39) 55 (38) 
PaO2 (kPa) 11.3 (2.3) 11.9 (2.3) 11.5 (2.4) 10.8 (2.3) 
Cutaneous PtO2 (kPa) a 5.9 (1.7) 6.7 (2.1) † 7.1 (2.0) ‡ 7.3 (2.0) ‡ 
PtO2 : PaO2 ratio a 0.53 (0.19) 0.57 (0.21) 0.62 (0.17) ‡ 0.67 (0.19) ‡ 
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 60 mmHg 70 mmHg 80 mmHg 90 mmHg p 
Microvascular flow index 2.3 (0.4) 2.5 (0.3) 2.4 (0.3) 2.3 (0.4) 0.45 
Vessel density (mm-1) 6.9 (1.5) 7.1 (1.5) 7.1 (1.3) 6.9 (0.9) 0.96 
Proportion of perfused vessels 
(%) 75 (66-87) 84 (74-90) 85 (71-93) 77 (72-84) 0.57 
Perfused vessel density (mm-1) 5.3 (1.9) 5.9 (1.8) 5.8 (1.5) 5.3 (1.3) 0.75 
Heterogeneity Index 0.41 (0.28) 0.37 (0.25) 0.32 (0.12) 0.33 (0.22) 0.84 
Cutaneous red cell flux (PU) 26 (16-42) 27 (18-44) 27 (20-47) 33 (20-47) 0.04 
Cutaneous vascular 
conductance (PU/mmHg)                 
0.44  
(0.27-0.70) 
0.39  
(0.25-0.63) 
0.34  
(0.24-0.59) 
0.37  
(0.23-0.52) 0.003 
 
 
Table 9.4 Indices of heterogeneity of sublingual microvascular flow for small vessels 
(<20µm), cutaneous red blood cell flux and cutaneous vascular conductance with 
increasing mean arterial pressure. Data presented as mean (SD) or median (IQR). Significance 
testing with repeated measures ANOVA and Friedman test. 
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 60 mmHg 70 mmHg 80 mmHg 90 mmHg p 
Microvascular flow index 2.9 (2.5-3.0) 
2.9 (2.8-
3.0) 
2.9 (2.8-
3.0) 
3.0 (2.9-
3.0) 0.92 
Vessel density (mm-1) 2.0 (0.6) 1.7 (0.6) 2.1 (0.6) 2.0 (0.7) 0.20 
Proportion of perfused vessels 
(%) 
100  
(100-100) 
100  
(100-100) 
100  
(100-100) 
100  
(100-100) >0.99 
Perfused vessel density (mm-1) 1.9 (0.6) 1.7 (0.6) 2.1 (0.6) 2.0 (0.7) 0.20 
Heterogeneity Index 0.09  (0.0-0.09) 
0.09 
(0.0-0.14) 
0.09 
(0.0-0.09) 
0.0 
(0.0-0.09) 0.90 
 
 
Table 9.5 Indices of heterogeneity of sublingual microvascular flow for large vessels 
(>20µm) with increasing mean arterial pressure. Data presented as mean (SD) or median (IQR). 
Significance testing with repeated measures analysis of variance (ANOVA) for parametric data and 
Friedman test for non-parametric data. 
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Figure 9.1 Increases in global oxygen delivery (DO2I) (p<0.01, Friedman test) and cutaneous 
PtO2 (p<0.0001, repeated measures ANOVA) associated with the increasing dose of 
norepinephrine required to achieve an increasing target mean arterial pressure.  
PtO2 data presented as mean (SD), DO2I data presented as median (IQR).
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Figure 9.2 Significant changes in cutaneous red blood cell flux (p<0.05, Friedman test) but not sublingual microvascular flow index 
(MFI) (p=0.45, repeated measures ANOVA) associated with the increasing dose of norepinephrine required to achieve an increasing 
target mean arterial pressure. 
MFI data presented as mean (SD), Red cell flux data presented as median (IQR). 
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9.4 Discussion 
The principle finding of this study is that the use of incremental doses of 
norepinephrine to achieve increasing targets for mean arterial pressure was 
associated with increases in global oxygen delivery, cutaneous PtO2 and 
cutaneous red cell flux. Deranged indices of sublingual microvascular flow 
remained unchanged. We also identified an increase in ScvO2 and a decrease 
in base deficit as the dose of norepinephrine increased. However, in both 
cases these changes were small. There were no changes in serum lactate or 
urine output.  
 
Although a number of pharmacological interventions have been shown to 
improve microvascular flow in patients with septic shock,15,155,156 there is only 
limited data from clinical studies describing the microvascular effects of 
different doses of norepinephrine in such patients. LeDoux and colleagues 
reported that despite an increase in global oxygen delivery, gastric mucosal 
pCO2 and cutaneous microvascular flow were unchanged when mean arterial 
pressure was increased from 65 mmHg to 85 mmHg using escalating doses 
of norepinephrine.194 In a subsequent study, patients were randomised to 
MAP targets for vasopressor therapy of 65 mmHg or 85 mmHg.344 Global 
oxygen delivery and mixed venous oxygen saturation were greater in the 85 
mmHg group whilst there were no differences in renal function. 344 However, 
in a recent clinical investigation, urine output improved  as MAP increased in 
response to noradrenaline,347 contrasting with our findings and those of 
others.344 None of these investigations included a visual assessment of the 
microcirculation, although improvements in sublingual microvascular flow 
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have been described with the use of both dobutamine and vasodilator therapy 
in septic shock.15,156 A recent investigation, by Dubin and colleagues, also 
used SDF imaging to investigate the effects of increasing noradreanline to 
achieve MAP’s of 65mmHg to 85mmHg.302 These investigators found no 
improvement in sublingual microvascular flow with increasing MAP. They 
found considerable variations in the interindividual responses which appeared 
to depend upon the baseline condition of the microcirculation. Laboratory 
investigations of the effects of norepinephrine on global haemodynamics, 
tissue oxygenation and the microvasculature in sepsis have also proved 
inconsistent. In a rodent endotoxaemia model, treatment with norepinephrine 
improved tissue oxygenation,348 whereas in a more detailed investigation in a 
rodent faecal peritonitis model, norepinephrine was not associated with any 
changes in microvascular flow or tissue PO2.349 In porcine models of sepsis, 
the increased dose of norepinephrine required to achieve higher MAP targets 
was associated with improved global haemodynamics.350,351 In the first of 
these studies, this haemodynamic improvement was associated with an 
increase in regional and microvascular flow to the viscera,350 whilst in the 
subsequent study, both regional and microvascular visceral flow were 
decreased.351 In another study in non-septic pigs, no changes were identified 
in gut microvascular flow or oxygenation during norepinephrine infusion.352 
 
It is unclear why cutaneous microvascular flow and tissue oxygenation 
improved as the noradrenaline dose increased whilst sublingual microvascular 
flow remained unchanged. Previous reports suggest that microvascular flow 
and tissue oxygenation may differ between organs in sepsis.99,353 It is also 
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possible that local responses to norepinephrine differ between vascular beds 
either because of differences in metabolic demand between organs, 
heterogeneity in receptor distribution 354 or differential expression of inducible 
nitric oxide synthase (iNOS).355 It should also be emphasised that while SDF 
imaging allows direct visualisation of the microcirculation, laser Doppler 
flowmetry measures overall microvascular flow in the underlying tissues. 
Moreover, in our patients the abnormalities in sublingual microvascular flow 
were less severe than those identified in previous reports, perhaps because of 
differences in the severity of illness or vasoactive drug therapy.66,156 It is also 
possible that subtle changes in sublingual microvascular flow would have 
been identified had a much larger population of patients been studied. In 
health, autoregulation would be expected to maintain constant tissue blood 
flow within this range of arterial pressures. Consequently, one would expect a 
decrease in vascular conductance with increasing arterial pressure and hence 
constant tissue blood flow. Interestingly, despite a decrease in cutaneous 
vascular conductance there was still an increase in cutaneous red cell flux. 
This finding suggests disruption of autoregulatory mechanisms, either due to 
sepsis,342 or the administration of exogenous norepinephrine.356 
 
We used a variety of methods to obtain a more comprehensive assessment of 
alterations in microvascular flow. SDF imaging is a valuable technique which 
has been used successfully to evaluate the intact microcirculation in the 
clinical environment. However, this technique remains semi-quantitative and 
accuracy may be affected by inter-observer bias and pressure artifact from 
the SDF camera. We specifically evaluated these potential sources of error 
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and excluded any significant bias (see methods).  Although a recent study has 
shown that sedative drugs can affect sublingual microvascular flow,117 doses 
of sedation remained unchanged throughout the current study. SDF imaging 
was complemented by laser Doppler flowmetry, a technique that provides an 
objective measure of overall microvascular flow but does not allow 
discrimination between flow in larger and smaller vessels. In addition we 
evaluated cutaneous PtO2 using a Clark electrode. With this method, the skin 
underneath the probe is warmed slightly to minimise artefact due to 
vasoconstriction; this active warming may therefore have counteracted the 
local vasoconstrictive effects of norepinephrine. However, the degree of 
warming remained constant throughout the experiment and cannot, therefore 
explain the progressive increase in PtO2.  
 
Although all patients were in established septic shock and had been 
adequately fluid resuscitated, variation in the delay between the diagnosis of 
septic shock and study enrolment is a potential limitation of this study. This 
and other differences between the patients such as the use of other 
vasoactive agents, haemofiltration and drotrecogin alfa activated, may have 
influenced microvascular function and hence the response to norepinephrine. 
Nevertheless, we were able to identify consistent and significant changes in 
microvascular flow and tissue oxygenation. Finally, it is important to 
emphasise that, in the current study, we explored only the short term effects 
of norepinephrine on global haemodynamics, tissue microvascular flow and 
oxygenation. Our understanding of the longer term effects of escalating 
vasopressor doses on these variables remains incomplete. 
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In summary, the use of norepinephrine to achieve incremental targets for 
mean arterial pressure, was associated with increases in global oxygen 
delivery, cutaneous microvascular flow and tissue oxygenation in patients with 
established septic shock. However, there were no associated changes in the 
pre-existing abnormalities of sublingual microvascular flow. These findings 
suggest that in patients with septic shock, significant improvements in global 
haemodynamics and tissue oxygen delivery can be achieved using escalating 
doses of norepinephrine to achieve higher values for MAP without 
exacerbating microcirculatory flow abnormalities. Further research is required 
to confirm our findings and to explore in more detail the long-term effects of 
higher arterial pressure targets for the administration of vasopressors.   
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Chapter 10 
Conclusions and future work 
 
10.1 Summary of findings 
The care of the surgical patient is an important public health issue. Within the 
large surgical population is a smaller sub-population that is at high risk of 
morbidity and mortality. We found within our own institution that a high risk 
group of patients existed that accounted for less than 10% of surgical 
procedures but over 70% of surgical in-hospital deaths. Despite having a 
mortality rate of 12%, only one third of this high risk group were admitted to 
critical care at any stage following surgery. It seems possible that greater 
provision of critical care services may improve clinical outcomes for this 
population.  
 
The microcirculation is essential for the delivery of oxygen and nutrients to the 
tissues. It would seem, therefore, that understanding microvascular flow is 
fundamental to the treatment of critically ill patients. To date, however, 
monitoring the microvasculature has not been routine in clinical practice, in 
part due to a lack of practical techniques. The advent of OPS and SDF 
imaging has brought clinical monitoring of the intact microcirculation to the 
bedside. Whilst microvascular abnormalities have been demonstrated in many 
conditions including established sepsis, it remains unclear whether these 
changes exist in other groups of critically ill patients. We found alterations in 
sublingual microvascular flow in a group of patients undergoing major 
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abdominal surgery that were significantly greater in those patients who went 
on to develop complications following surgery. Interestingly, this difference in 
microvascular flow was present even prior to surgery. There were no related 
differences in cutaneous microvascular flow, tissue oxygenation or global 
haemodyanmics. With increasing interest in the cardiovascular management 
of septic patients in the first few hours of hospital admission and in 
interventions that alter microvascular flow, we aimed to further describe the 
pattern of microvascular flow in a group of patients within six hours of hospital 
admission for sepsis.  We found similar, but less severe, abnormalities of 
microvascular flow to those previously reported in established sepsis.  These 
changes were more marked in the more severely ill patients and in those with 
poor outcomes.  
 
The use of protocolised fluid and vasoactive therapy aimed at improving 
global haemodynamics has been demonstrated to improve patient outcomes 
in early sepsis and in perioperative patients. It is believed that this approach 
may improve tissue perfusion and oxygenation but this hypothesis has yet to 
be proven. There is currently no data investigating the effects of GDHT on 
microvascular flow in perioperative patients. Work in patients with sepsis has 
shown that the use of GDHT in early sepsis using central venous oxygen 
saturations as a goal is associated with an improvement in sublingual 
microvascular flow. In established sepsis, however, there appears to be a 
discrepancy between improvements in the macro- and microcirculation 
associated with vasoactive therapy.  
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We investigated the effects of GDHT in a randomised controlled trial of 
patients undergoing major abdominal surgery. In particular we investigated 
the incremental benefit of stroke volume guided fluid resuscitation with 
dopexamine over stroke volume guided fluid therapy alone. The control group 
received fluid resuscitation guided by central venous pressure.  We found 
significant improvements in global haemodyanamics including global oxygen 
delivery and central venous oxygen saturations in those patients receiving 
stroke volume guided fluid therapy plus dopexamine. Associated with these 
changes in global haemodynamics we found significant improvements in 
sublingual microvascular flow, cutaneous microvascular flow and tissue 
oxygenation. There were no changes in the inflammatory response to surgery. 
This study was not powered to identify differences in clinical outcomes but a 
post hoc analysis did suggest an improvement in renal outcomes. Stroke 
volume guided fluid therapy alone was associated with more modest changes. 
The incremental effects of low dose dopexamine are likely to relate to the β-
adrenoreceptor mediated inotropic and vasodilator actions of this drug. It is 
thus possible that the improvements in microvascular flow may relate to direct 
effects of the drug on the microcirculation as well as improvements in cardiac 
output. 
 
In septic shock, noradrenaline is recomeneded following fluid resuscitation to 
maintain adequate perfusion pressure. The recommendation of a mean 
arterial pressure of 65 mmHg as an endpoint for the administration of 
noradrenaline is based on limited data. We investigated the effects of 
incremental doses of noradrenaline titrated to achieve successively higher 
 208 
mean arterial pressures on tissue microvascular flow and oxygenation in a 
group of patients with septic shock. To our surprise, we found increasing 
noradrenaline was associated with improvements in cutaneous microvascular 
flow and cutaneous tissue oxygenation with no detrimental effect on 
sublingual microvascular flow. Further work is needed to explore the ideal 
endpoint for the administration of vasopressors in septic shock.  
 
Overall this thesis was successful in exploring the effects of haemodyanmic 
therapies on microvascular flow. In general, we found that haemodynamic 
therapies targeting global haemodyanmic goals in perioperative and septic 
patients were associated with improvements in microvascular flow and tissue 
oxygenation.  
 
10.2 Strengths and weaknesses 
The description of the high risk surgical population at our local institution 
found a high risk surgical population accounting for a small proportion of 
surgical procedures but over 70% of surgical deaths. Only approximately one 
third of these patients were admitted to critical care at anytime following 
surgery. The use of large healthcare databases in this way is associated with 
a number of limitations, particularly when accessing data that the database 
was not specifically designed to collect. Although we cross-referenced 
individual patient’s information between databases and where possible with 
medical notes, it is possible that errors may have occurred. The study 
performed was retrospective in design. Performing a prospective study of 
surgical patients may allow identification of the reasons underlying decisions 
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regarding the allocation of critical care resources to individual patients. The 
use of biomarkers and / or cardiopulmonary exercise testing are currently 
being investigated as methods for identifying high risk surgical patients prior 
to surgery. 
 
The simultaneous use of three different modalities to assess different aspects 
of tissue microvascular function was an important strength of the subsequent 
studies. SDF imaging is a major advance in microvascular monitoring, 
providing high quality, real time videos of the intact microcirculation. The 
technique is currently limited, however, by semiquantative analysis. It is likely 
that with software development, quantitative analysis of microvascular flow 
and density will become routine. Whether sublingual flow correlates with 
microvascular flow in other vascular beds remains unclear, although it is likely 
that there is heterogeneity of flow not only within individual microvascular 
units but also between microvascular units. Laser Doppler flowmetry is a 
versatile technique but it cannot distinguish the size and type of microvessel, 
the direction of flow or most importantly heterogeneity of flow, all of which may 
be relevant in critically ill patients. These limitations can be partially offset by 
examining the post-occlusive hyperaemic response which can provide a 
reproducible assessment of endothelium dependent microvascular reponses. 
This technique was used for the study described in Chapter 5. The cutaneous 
Clark electrode measures the local partial pressure of oxygen by a 
polarographic method. If tissue perfusion falls with stable arterial oxygenation, 
cutaneous oxygenation will also fall, thereby linking peripheral perfusion and 
tissue oxygenation. An ideal measure of tissue oxygenation would have 
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involved measurement of the splanchnic circulation, but this would require 
invasive techniques not suitable to these patient groups. 
 
The randomised controlled trial of periopertive haemodynamic therapy 
involved high standards of care for all patients involved. Patients were 
stratified according to surgical procedure prior to randomisation to ensure that 
the three groups were comparable. In common with many trials of complex 
interventions, it was not possible to fully blind clinical staff to study group 
allocation. Study group allocation was concealed from all investigators apart 
from the member of the team delivering the intervention. This included 
concealment of cardiac output data and the use of dummy infusions. All 
complications were prospectively defined and verified by the blinded principal 
investigator.  
 
Patients with established, fluid resuscitated, septic shock were recruited to 
investigate the effects of noradrenaline and increasing mean arterial pressure 
on microvascular flow. It is possible that variation in the delay between the 
diagnosis of septic shock and study enrolment is a potential limitation of this 
study. This and other differences between the patients such as the use of 
other vasoactive agents, haemofiltration and drotrecogin alfa activated, may 
have influenced microvascular function and hence the response to 
noradrenaline. Importantly, we explored only the short term effects of 
noradrenaline on global haemodynamics, tissue microvascular flow and 
oxygenation. Our understanding of the longer term effects of escalating 
noradrenaline doses on these variables remains incomplete. 
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10.3 Suggestions for further work 
This work suggests a number of investigations that may contribute to 
improving the care of the perioperative and septic patient. Postoperative 
outcomes are a result of a complex interplay between the patient’s health 
status, the surgical procedure performed and perioperative care. Outcomes 
may be influenced by the availability and use of critical care services. 
Appropriate triage of patients to intensive care postoperatively may have an 
impact on outcomes after non-cardiac surgery. Further work investigating 
critical care use for surgical patients may help delineate more clearly the 
factors which influence the decision making process of which patients are 
admitted to critical care following surgery. There is also ongoing work looking 
at pre-operative risk predictors of poor outcomes following surgery including 
the use of cardiopulmonary exercise testing and the use of biomarkers. This 
will hopefully allow clinicians to identify prior to surgery, which patients may 
benefit from critical care following surgery. 
 
In this thesis, microvascular abnormalities following major abdominal surgery 
have been associated with poor outcomes. The use of dopexamine alongside 
stroke volume guided fluid therapy has been demonstrated to have an 
incremental benefit on tissue microvascular flow and oxygenation over stroke 
volume guided fluid therapy alone in patients following surgery. The question 
of whether this would translate into an improvement in clinical outcomes, 
however, remains somewhat unclear. A number of small single centre studies 
have demonstrated improvements in clinical outcomes with GDHT. A large 
multicentre effectiveness study of GDHT in surgical patients is now needed to 
 212 
demonstrate whether a simple protocol that could be introduced easily into the 
current healthcare system improves outcomes. 
 
Microvascular flow has been shown to improve with a number of therapies in 
critically ill patients. Currently rapid quantitative analysis of microvascular 
videos allowing changes in therapy is not possible. It is conceivable, however, 
that in the future the microcirculation may be utilised as an endpoint for 
resuscitiation at the bedside. Therapies that recruit the microcirculation could 
then be commenced in those patients who demonstrate impaired 
microvascular flow. It should be noted, however though that there is not, as 
yet, any evidence of improved clinical outcome associated with improvements 
in microvascular flow. 
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Appendix – definition of complications 
 
 
Infectious Complications 
 
Sepsis, Severe sepsis and Septic shock 
Two more of the following associated with documented infection (consensus 
definition):  
i) core temperature <36 °C or >38 °C 
ii)  white cell count >12 x 109 l-1 or <4 x 109 l-1 
iii) Respiratory rate >20 breaths per minute or PaCO2 < 4.5 kPa 
iv) Pulse rate >90 bpm. Sepsis associated with organ dysfunction will be 
defined as severe sepsis. Sepsis associated with hypotension and 
need for vasopressors or inotropes despite fluid resuscitation will be 
defined as septic shock. 
 
Urinary tract infection 
A symptomatic urinary tract infection must meet at least one of the following 
criteria: 
 
i) Patient has at least one of the following signs or symptoms with no 
other recognized cause: fever (>38 °C), urgency, frequency, 
dysuria, or suprapubic tenderness 
 
And 
 
patient has a positive urine culture, that is, >105 microorganisms per 
cm3 of urine with no more than two species of microorganisms. 
 
ii) Patient has at least two of the following signs or symptoms with no 
other recognized cause: fever (>38 °C), urgency, frequency, 
dysuria, or suprapubic tenderness 
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And at least one of the following: 
 
a. Positive dipstick for leukocyte esterase and/or nitrate 
b. Pyuria (urine specimen with >10 WBC mm-3) 
c. Organisms seen on Gram stain of unspun urine 
d. At least two urine cultures with repeated isolation of the same 
uropathogen with >102 colonies/ mL in non-voided specimens 
e. >105 colonies/mL of a single uropathogen in a patient being 
treated with an effective antimicrobial agent for a urinary tract 
infection 
f. Physician diagnosis of a urinary tract infection 
g. Physician institutes appropriate therapy for a urinary tract 
infection 
 
 
Other infections of the urinary tract (kidney, ureter, bladder, urethra, etc) 
Other infections of the urinary tract must meet at least one of the following 
criteria: 
 
i) Patient has organisms isolated from culture of fluid (other than 
urine) or tissue from affected site. 
 
ii) Patient has an abscess or other evidence of infection seen on direct 
examination, during a surgical operation, or during a histopathologic 
examination. 
 
iii) Patient has at least two of the following signs or symptoms with no 
other recognized cause: fever (>38 °C), localized pain, or localized 
tenderness at the involved site 
 
And at least one of the following: 
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a. Purulent drainage from affected site 
b. Organisms cultured from blood that are compatible with suspected 
site of infection 
c. Radiographic evidence of infection, for example, abnormal 
ultrasound, computed tomography or magnetic resonance imaging 
d. Physician diagnosis of infection of the kidney, ureter, bladder, 
urethra, or tissues surrounding the retroperitoneal or perinephric 
space 
e. Physician institutes appropriate therapy for an infection of the 
kidney, ureter, bladder, urethra, or tissues surrounding the 
retroperitoneal or perinephric space 
 
Surgical site infection (superficial incisional) 
A superficial SSI must meet the following criteria: 
 
i) Infection occurs within 30 days after the operative procedure And 
involves only skin and subcutaneous tissue of the incision And 
patient has at least one of the following: 
 
a. Purulent drainage from the superficial incision 
b. Organisms isolated from an aseptically obtained culture of fluid or 
tissue from the superficial incision 
c. At least one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness, or heat, and superficial 
incision is deliberately opened by surgeon, unless incision is 
culture-negative 
d. Diagnosis of superficial incisional SSI by the surgeon or attending 
physician 
 
Surgical site infection (deep incisional) 
A deep incisional SSI must meet the following criteria: 
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i) Infection occurs within 30 days after the operative procedure if no 
implant is left in place or within 1 year if implant is in place and the 
infection appears to be related to the operative procedure 
 
And involves deep soft tissues (e.g., fascial and muscle layers) of the 
incision 
 
And patient has at least one of the following: 
 
a. Purulent drainage from the deep incision but not from the 
organ/space component of the surgical site 
b. A deep incision spontaneously dehisces or is deliberately opened 
by a surgeon when the patient has at least one of the following 
signs or symptoms: fever (>38C) or localized pain or tenderness, 
unless incision is culture-negative 
c. An abscess or other evidence of infection involving the deep 
incision is found on direct examination, during reoperation, or by 
histopathologic or radiologic examination 
d. Diagnosis of a deep incisional SSI by a surgeon or attending 
physician 
 
An infection that involves both superficial and deep incision sites should be 
classified as a deep incisional SSI. 
 
Surgical site infection (organ/space) 
An organ/space SSI involves any part of the body, excluding the skin incision, 
fascia, or muscle layers, that is opened or manipulated during the operative 
procedure. Specific sites are assigned to organ/space SSI to further identify 
the location of the infection. Listed later are the specific sites that must be 
used to differentiate organ/space SSI. An example is appendectomy with 
subsequent sub-diaphragmatic abscess, which would be reported as an 
organ/space SSI at the intra-abdominal specific site. An organ/space SSI 
must meet the following criteria: 
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i) Infection occurs within 30 days after the operative procedure if no 
implant is left in place or within 1 year if implant is in place and the 
infection appears to be related to the operative procedure 
 
And infection involves any part of the body, excluding the skin 
incision, fascia, or muscle layers, that is opened or manipulated 
during the operative procedure 
 
And patient has at least one of the following: 
 
a. Purulent drainage from a drain that is placed through a stab wound 
into the organ/space 
b. Organisms isolated from an aseptically obtained culture of fluid or 
tissue in the organ/ space 
c. An abscess or other evidence of infection involving the organ/space 
that is found on direct examination, during reoperation, or by 
histopathologic or radiologic examination 
d. Diagnosis of an organ/space SSI by a surgeon or attending 
physician 
 
Laboratory confirmed bloodstream infection 
Laboratory-confirmed bloodstream infection must meet at least one of the 
following criteria: 
 
i) Patient has a recognized pathogen cultured from one or more blood 
cultures 
 
And organism cultured from blood is not related to an infection at 
another site. 
 
ii) Patient has at least one of the following signs or symptoms:  
 
Fever (>38°C), chills, or hypotension 
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And at least one of the following: 
 
a. Common skin contaminant is cultured from two or more blood 
cultures drawn on separate occasions 
b. Common skin contaminant is cultured from at least one blood 
culture from a patient with an intravascular line, and the 
physician institutes appropriate antimicrobial therapy 
c. Positive antigen test on blood 
 
And signs and symptoms and positive laboratory results are not 
related to an infection at another site. 
 
Nosocomial pneumonia 
Ventilator-associated pneumonia (i.e. pneumonia in persons who had a 
device to assist or control respiration continuously through a tracheostomy or 
by endotracheal intubation within the 48-hour period before the onset of 
infection) will be classified separately. Care will be to distinguish between 
tracheal colonization, upper respiratory tract infections and early onset 
pneumonia. Nosocomial pneumonia will be characterized as early or late 
onset ie before or after first 4 days of hospitalization. Where repeated 
episodes of nosocomial pneumonia are suspected, a combination of new 
signs and symptoms and radiographic evidence or other diagnostic testing will 
be required to distinguish a new episode from a previous one. 
 
Nosocomial pneumonia must meet the following criteria: 
 
i) Two or more serial chest radiographs with at least one of the 
following: 
 
a) New or progressive and persistent infiltrate 
b) Consolidation 
c) Cavitation 
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And at least one of the following: 
 
a) Fever (>38°C) with no other recognized cause 
b) Leucopaenia (<4,000 WBC mm-3) or leucocytosis (>12,000 WBC 
mm-3) 
c) For adults >70 years old, altered mental status with no other 
recognized cause 
 
And at least two of the following: 
 
a) New onset of purulent sputum or change in character of sputum, or 
increased respiratory secretions, or increased suctioning 
requirements 
b) New onset or worsening cough, or dyspnoea, or tachypnoea 
c) Rales or bronchial breath sounds 
d) Worsening gas exchange 
 
Cardiovascular complications 
Myocardial ischaemia or infarction 
Acute ECG changes with appropriate clinical history and biochemical findings 
(cardiac troponin rise) 
 
Arrhythmia 
ECG evidence of rhythm disturbance resulting in hypotension or considered 
by clinical staff to be severe enough to require treatment  
 
Cardiac or respiratory arrest 
Clinical criteria according to UK Resuscitation Council guidelines 
 
Limb or digital ischaemia 
Sustained loss of arterial pulse (as determined by palpation or Doppler) or 
obvious gangrene 
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Respiratory Complications 
 
Pulmonary oedema 
Appropriate clinical history and examination with consistent chest radiograph 
 
Pulmonary embolism 
Computed tomography (CT) pulmonary angiogram with appropriate clinical 
history 
 
Acute respiratory distress syndrome  
According to consensus criteria:  
i) Suitable precipitating condition (many causes exist) 
ii) Acute onset diffuse bilateral pulmonary infiltrates on chest 
radiograph 
iii) No evidence of cardiac failure or fluid overload (PAOP < 18 mmHg) 
iv) Either 
a) PaO2:FiO2  < 40 kPa = Acute Lung InjuryPaO2:FiO2  < 27 
kPa = Acute Respiratory Distress Syndrome 
Pleural effusions 
Appropriate clinical history and examination with consistent radiograph, 
ultrasound or CT scan of the chest 
 
Gastrointestinal Complications 
 
Gastro-intestinal bleed 
Unambiguous clinical evidence or endoscopy showing blood in gastro-
intestinal tract 
 
Bowel infarction 
Demonstrated at laparotomy 
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Anastamotic breakdown 
Demonstrated at laparotomy or by contrast enhanced radiograph or CT scan 
 
Paralytic ileus 
Persistent clinical evidence of intestinal ileus and failure to tolerate enteral 
fluid or feed associated with valid cause 
 
Post-operative haemorrhage 
Overt blood loss requiring transfusion of two or more units of blood in two 
hours. 
 
Renal Complications 
Acute kidney injury 
As per AKIN criteria 
 
Neurological Complications 
Stroke 
Clinical diagnosis with confirmation by CT scan 
 
Transient ischaemic attack 
Clinical diagnosis 
 
